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Abstract 
The study was aimed at: 
1. linking anti-stress properties of Sutherlandia frutescens to its influence on adrenal steroid
biosynthesis in terms of extracts, sutherlandioside (SU) compounds and gamma-
aminobutyric acid (GABA).
2. linking anti-inflammatory and anti-hypertension properties to steroid receptor interaction,
the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR).
The influence of S. frutescens extracts, and SUs, on key steroidogenic enzymes was assayed in 
COS-1 cells and binding to adrenal P450-dependent enzymes was assayed in ovine adrenal 
mitochondrial and microsomal suspensions. The effects of the methanol extract and 
sutherlandioside B (SUB) were assayed on basal, forskolin and angiotensin II (Ang II) stimulated 
hormone levels in the adrenal H295R cell model. The effect of GABA on basal steroid production 
was investigated in H295R cells. Agonist activity of the methanolic extract and SUB, for both 
transactivation and transrepression of GR and MR mediated gene transcription, was subsequently 
investigated. 
S. frutescens extracts affected all the steroidogenic enzymes with inhibition being substrate 
specific. SUB had a greater effect on substrate binding to mitochondrial and microsomal P450 
enzymes than sutherlandioside A (SUA). SUB inhibited the catalytic activity of CYP17A1, 
CYP11B2 and 3β-HSD2 while not affecting CYP21A2. In H295R cells, while the extract 
decreased total steroid production under basal and forskolin stimulated conditions, only cortisol 
and its precursor, deoxycortisol, and mineralocorticoid metabolites were decreased significantly 
in the presence of forskolin. A SU mixture did not influence steroid production, with only cortisol 
levels decreasing significantly with SUB decreasing cortisol, deoxycortisol, androstendione and 
11-hydroxyandrostenedione significantly. The data show that the SU mixture was not able to elicit 
the same effects as SUB, suggesting that the compounds do not act synergistically. GABA 
significantly decreased adrenal steroid production in H295R cells with the greatest inhibitory 
effect observed in the production of adrenal androgens. 
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S. frutescens extracts and SUB repressed NF-κB-driven gene expression without activating GRE-
driven gene expression while neither activated MR mediated gene transcription while both 
antagonized the effects of aldosterone via the MR.  
The results of this study provide evidence linking anti-stress, anti-inflammatory and anti-
hypertensive properties of S. frutescens to the inhibition of steroidogenic enzymes and modulation 
of adrenal hormone biosynthesis. The findings suggesting that S. frutescens and SUB exhibit 
dissociated glucocorticoid characteristics underline potential therapeutic applications in the 
treatment of inflammation and hypertension. 
  
Stellenbosch University  https://scholar.sun.ac.za
  
vi 
 
Opsomming  
Die studie het ten doel gehad om: 
1. die koppeling van die anti-stres eienskappe van ekstrakte van Sutherlandia frutescens, die 
sutherlandiosiede (SU) en gamma-aminobottersuur (GABA) aan die plant se invloed op 
adrenale steroïedbiosintese. 
2. die koppeling van anti-inflammatoriese- en anti-hipertensie-eienskappe aan steroïed-
reseptor interaksie in terme van die glukokortikoïedreseptor (GR) en die 
mineralokortikoïedreseptor (MR). 
Die invloed van S. frutescens ekstrakte en SU op sleutel steroïedogenise ensieme is in COS-1-selle 
ondersoek. Die binding aan adrenale P450-afhanklike ensieme is ook ondersoek deur gebruik te 
maak van skaapbynier mitochondriale en -mikrosomale suspensies. Die invloed van ‘n metanol 
ekstrak en sutherlandiosied B (SUB) is op basale, forskolien en angiotensien II (Ang II) 
gestimuleerde hormoonvlakke in die H295R-bynierselmodel geassesseer. Die effek van GABA op 
basale steroïedproduksie in H295R-selle is ook ondersoek. Agonistiese aktiwiteit van die 
metanolekstrak en SUB, vir beide transaktivering en transrepresie van GR- en MR-gemedieerde 
geen transkripsie, is vervolgens ondersoek. 
S. frutescens ekstrakte het al die steroidogeniese ensieme beïnvloed en  het substraatspesifieke 
inhibisie getoon. SUB het 'n groter effek as sutherlandioside A (SUA) op substraatbinding aan 
mitochondriale- en mikrosomale P450-afhanklike ensieme gehad. SUB inhibeer die katalitiese 
aktiwiteit van CYP17A1, CYP11B2 en 3β-HSD2 terwyl CYP21A2 nie deur hierdie verbinding 
ge-affekteer word nie. Die ekstrak het totale steroïedproduksie onder basale en forskolien-
gestimuleerde toestande in H295R-selle verlaag. Slegs kortisol-, sy voorloper deoksikortisol- en 
mineralokortikoïedmetabolietvlakke is egter beduidend verlaag in die teenwoordigheid van 
ekstrakte. Steroïedproduksie is nie deur 'n SU-mengsel beïnvloed nie en slegs kortisolvlakke het 
beduidend afgeneem. Daarenteen het SUB kortisol-, deoksikortisol-, androsteendioon en 11-
hidroksi-androsteendioon vlakke beïnvloed. Die data toon dat die SU mengsel nie dieselfde effekte 
as SUB kon ontlok nie, wat daarop dui dat die verbindings nie sinergisties optree nie. GABA het 
'n aansienlik afname in byniersteroïedproduksie in H295R-selle tot gevolg gehad, met die grootste 
inhibitoreise effek op die produksie van adrenale androgene. 
Stellenbosch University  https://scholar.sun.ac.za
  
vii 
 
S. frutescens ekstrakte en SUB het NF-κB-gedrewe geenekspressie onderdruk sonder om GRE-
gedrewe geenekspressie te aktiveer maar geen invloed getoon op die MR gemedieerde 
geentranskripsie getoon nie. Beide die ekstrak en SUB het as aldosteroon antagoniste via die MR 
opgetree. 
Die resultate van hierdie studie bied bewyse wat die anti-stres-, anti-inflammatoriese en anti-
hipertensiewe eienskappe van S. frutescens verbind met die inhibisie van adrenale 
steroïedogeniese ensieme en gevolglike modulering van adrenale hormoonbiosintese. Die 
bevindinge dui duidelik daarop dat S. frutescens en SUB dissiatiewe glukokortikoïedeienskappe 
vertoon, en wys op moontlike terapeutiese toepassings in die behandeling van inflammasie en 
hipertensie. 
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Chapter 1: Introduction 
Recent commercial interest in herbal therapies has resulted in increased scientific research into 
the validity, efficacy and safety of herbal medicines in South Africa.  The potential integration 
of complementary and alternative medicines into conventional medicinal practices in South 
Africa has also contributed to increased scientific interest in herbal therapeutics (van Wyk, 
2011). Although initial studies focussed on the effects of whole plant extracts, the identification 
of specific compounds within extracts has been of particular interest in developing medicines. 
Chemical profiling of different solvent extracts has resulted in the identification of specific 
compounds, many of which have been associated with specific therapeutic applications. 
Sutherlandia. frutescens, a common southern African herbal remedy, has been traditionally 
used to treat a variety of ailments including stress, anxiety, inflammation and cancers (van 
Wyk, 2008). This study investigated the anecdotal claims of the use of S. frutescens in the 
treatment of stress, anxiety, depression and inflammation by investigating the effects of 
extracts and compounds on adrenal steroidogenesis and downstream steroid receptor 
interactions, specifically the glucocorticoid receptor (GR) and mineralocorticoid receptor 
(MR), respectively.  
Chapter 2 describes the anecdotal therapeutic claims associated with S. frutescens −studies that 
have confirmed therapeutic applications of the extracts and the compounds identified within 
the extract that may elicit biological effects. For the purposes of this study, studies describing 
the effects of S. frutescens on inflammation, cancers, stress and anxiety as well as 
immunodeficiency disorders were highlighted. In addition, compounds that may be responsible 
for eliciting the aforementioned effects were addressed with particular focus on amino acids, 
flavonoids and triterpenoids. The triterpenoids were deemed especially important in the context 
of this study as these compounds share structural similarities with adrenal steroid hormones. 
As therapeutic effects cannot be elicited without compounds within the extract reaching the 
appropriate biological target, the manner in which structure-related characteristics may 
influence the bioavailability of the compounds were addressed. Recent reports regarding safety 
and efficacy aspects of the use of S. frutescens were included in the overview.  
Previous studies have shown that S. frutescens extracts may interact with adrenal cytochrome 
P450 (P450) enzymes (Prevoo et al., 2008), potentially resulting in the reduction of 
corticosteroid production. In Chapter 3, the regulation, biosynthesis, peripheral actions and 
transport mechanisms of corticosteroids with particular focus on adrenal steroidogenesis, the 
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structure and function of these steroids and the adrenal steroidogenic enzymes that catalyse 
their biosynthesis are discussed. In addition, upstream regulation, mainly via the hypothalamic-
pituitary-adrenal (HPA)-axis, and the downstream effects of corticosteroids through 
interactions with the GR and MR were also included. 
We hypothesized that the anecdotal anti-inflammatory effects of S. frutescens could be 
attributed to the influence of the extract on adrenal steroidogenesis and the downstream 
activation of steroid receptors. We further hypothesized that the presence of compounds, such 
as the sutherlandioside (SU) compounds and gamma-aminobutyric acid (GABA), in S. 
frutescens may contribute to anecdotal effects. In this study, we thus aimed to: 
 Determine the effect of a methanolic extract of S. frutescens on single adrenal 
steroidogenic enzymes and on steroid production in the H295R adrenal cell model. 
 Quantify the SU and GABA content of the extract used in this study.  
 Determine the effects of SUs on single adrenal steroidogenic enzymes and in vitro 
steroid production. 
 Determine the downstream effects of the methanolic S. frutescens extract and SUB by 
investigating their transcriptional activities via the GR and MR. 
 Determine the effects of GABA on adrenal steroid production in H295R cells. 
Chapter 4 addresses the main hypothesis of the study and the in vitro effects of a methanolic 
S.frutescens extract on adrenal steroidogenesis as well as GR and MR mediated transcription. 
The presence of SUB and GABA within these extracts was confirmed by liquid 
chromatography coupled with tandem mass spectrometry (LC–MS/MS) and the effects of these 
compounds on adrenal steroidogenesis was investigated. Findings pertaining to the potential 
anti-inflammatory, anti-stress and anti-hypertensive applications of the extract are also 
described in Chapter 4. Results contained in Chapter 4 have been published in part (Sergeant 
et al., 2017) and the publication has been added to this thesis as Addendum I. In addition to the 
main hypothesis, it was hypothesized that GABA may influence adrenal steroid production at 
the site of production in the adrenal gland and subsequently investigated the influence of 
GABA on steroid production by P450 enzymes in H295R cells. These results are presented and 
discussed in Chapter 5.  
Chapter 6 concludes this body of work and describes the potential implications of the novel 
findings reported in this study. Findings are summarised to conclude the thesis −the anti-
Stellenbosch University  https://scholar.sun.ac.za
  
3 
 
inflammatory and anti-hypertensive effects of the extract, as well the motivation for the use of 
S. frutescens as a supplementary aid in anti-inflammatory and anti-stress treatments. 
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Chapter 2: Sutherlandia frutescens as a medicinal plant 
Introduction 
S. frutescens, also known as Lessertia frutescens and cancer bush, has been used in southern 
Africa for the treatment of a wide spectrum of ailments, many without scientific validation. 
Some of the first records of the medicinal use of decoctions made from the aerial parts of these 
plants date back to the Khoi San and Nama people, who used S. frutescens to treat fevers and 
to wash wounds. Even the present day inhabitants of the Western Cape still commonly use S. 
frutescens as a traditional herbal medicine (van Wyk, 2008). 
Therapeutic applications 
The use of S. frutescens as herbal remedy has been mostly associated with traditional use and 
the distribution of traditional S. frutescens derived medicines still largely depends on traditional 
healers, herbalists and so-called bush doctors. After harvesting fresh S. frutescens leaves, pods, 
flowers and/or stems, the parts are dried, mashed into a fine powder and served as an infusion. 
Traditional healers are known to prepare the S. frutescens infusions according to the type and 
severity of disease as indicated by the patient (van Wyk and Albrecht, 2008). Traditionally the 
aerial parts of the plant are used to reduce fevers and wash wounds, whereas teas made from 
the leaves and stems are used to treat cancer, fever, stomach ailments, diabetes, depression and 
inflammation (Thring and Weitz, 2006; van Wyk and Wink, 2004). Although S. frutescens is 
most commonly associated with traditional herbal medicines, tablets, gels, capsules and 
ointments have been produced and are available commercially (van Wyk, 2008; van Wyk, 
2011). Limited local commercialization of S. frutescens products has occurred with limited 
scientific validation, however there have been studies to scientifically appraise its medicinal 
value. These studies, specifically those relevant to this thesis, will be discussed in the sections 
below. 
Inflammation 
The treatment of chronic inflammation with herbal medicines has been a topic of investigation 
for many years (Iwalewa et al., 2002). Traditional healers often use a single plant to treat a 
wide range of diseases and there is often a common target for all these ailments such as the 
inflammatory response. Although the inflammatory response is considered as a whole, specific 
parameters, such as cytokine production, glucocorticoid production and the transcriptional 
activities of steroid receptors have been identified as potential targets for anti-inflammatory 
treatment. In addition, chronic inflammation appears to be an underlying issue in many disease 
states, including chronic heart failure, hypertension, diabetes and cancers (Kotas and 
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Medzhitov, 2015). Scientific research into the effect of S. frutescens on the inflammatory 
response and the application thereof as an anti-inflammatory treatment far outweighs the study 
of this botanical as a treatment for other disease states.  
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used to treat inflammation since 
the early 1970s (Whitehouse, 2011). Despite the wide application of NSAIDs in the treatment 
of inflammation, the chronic use of these drugs is usually associated with negative side effects 
that have been attributed to these drugs non-selectively inhibiting both cyclooxygenase (COX)-
1 and 2 (Brune and Patrignani, 2015). The therapeutic use of NSAIDs in the treatment of 
inflammation arises from the inhibition of the inducible COX-2 enzyme in inflamed tissues. 
COX-1, however, is constitutively expressed in tissues such as the kidney and stomach and is 
responsible for the biosynthesis of prostaglandins that are engaged in homeostasis. The 
inhibition of COX1 contributes to the adverse effects associated with the use of NSAIDs 
(Seibert et al., 1994). The ability of drugs or compounds to specifically inhibit COX-2 has 
therefore been of particular interest in finding anti-inflammatory treatments. Kundu et al. 
(2005) showed that methanolic extracts of S. frutescens was able to inhibit 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced COX-2 expression in mouse skin when 
applied topically (Kundu et al., 2005). Similarly, Na et al. (2004) showed that COX-2 activity, 
as well as its induction by nuclear factor kappa B (NF-κB), are significantly inhibited by the 
presence of S. frutescens extracts (Na et al., 2004). Further investigations into the anti-
inflammatory potential of S. frutescens extracts revealed that the extracts have the ability to 
significantly reduce inflammation in albumin induced paw edema in mice. In the same study, 
the use of S. frutescens extracts in pain relief was investigated. Hot plate and acetic acid models 
were used to induce pain and the effects of S. frutescens extracts (500-800 mg/kg) were 
compared to the analgesic effects of diclofenac (100 mg/kg) and chloropropamide (250 mg/kg). 
The S. frutescens root extract was shown to significantly reduced thermally and chemically 
induced nociceptive pain stimuli in mice (Ojewole, 2004). 
Tissue damage at the site of inflammation is another negative side effect that can potentially 
result from chronic inflammation. The accumulation of reactive oxygen species (ROS) during 
the inflammatory response as a result of increased inflammatory mediators has been linked to 
tissue damage due to oxidative stress. Increased oxygen uptake, caused by the increase in 
inflammatory mediators, and the consequential increased metabolism of molecular oxygen 
causes the accumulation of ROS. Antioxidants inactivate ROS through conversion to less 
harmful compounds that can easily be eliminated from the body. Cell damage or cell death may 
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occur due to the resulting oxidative stress when there is an imbalance between ROS and 
antioxidants in the favour of ROS, (Fernández-Sánchez et al., 2011). The role of antioxidants 
in the protection of tissues during chronic inflammation should thus not be disregarded.  
Although there have been studies to show that S. frutescens extracts display no antioxidant 
potential, several other studies have confirmed that extracts from these plants do display 
antioxidant activities. Tai et al. (2004) demonstrated that there was no significant suppression 
of nitric oxide (NO) production after induction with lipopolysaccharides (LPS) or cytokine 
expression in mouse cells (Tai et al., 2004). However, other studies confirmed that these 
extracts exhibited hydrogen scavenging potential at concentrations as low as 10 µg/mL and 
therefore did display significant antioxidant potential (Fernandes et al., 2004; Katerere and 
Eloff, 2005). Another investigation into the antioxidant potential of S. frutescens showed that 
solvents used to prepare S. frutescens extracts influenced the ROS scavenging capacity of the 
extracts (Tobwala et al., 2014). Jiang et al. showed that ethanolic extracts of S. frutescens 
suppressed the induction of ROS production in neurons and microglial cells through inhibition 
of the interferon gamma (IFN-γ) induced phosphorylated-extracellular signal-regulated kinase 
(p-ERK)1/2 signalling pathway. This pathway plays a central role in many metabolic processes 
which in turn suggest that the ethanolic extract of S. frutescens may have anti-inflammatory 
properties through the prevention of tissue damage caused by ROS (Jiang et al., 2014). Similar 
results were obtained in a study by Lei et al. and although their study confirmed that a S. 
frutescens extract could suppress NO production through IFN-γ induced p-ERK1/2 signalling 
pathways, neither the sutherlandins (A-D) nor sutherlandiosides (SUA-D) induced a similar 
effect (Lei et al., 2014). It was suggested that chlorophyll, present in the leave extracts, 
contribute to the anti-inflammatory effect of a crude ethanolic leaf extract (Lei et al., 2015a). 
On the other hand, mice, fed a diet containing S. frutescens, showed no significant modification 
of host inflammatory response towards either gram negative or gram positive bacteria (Lei et 
al., 2016). 
One of the few studies demonstrating the effect of S. frutescens on gene transcription analyzed 
the up- and down-regulation of LPS and IFN-γ stimulated genes in a murine macrophage cell 
line. S. frutescens treatment differentially influenced expressed genes (which are involved in 
inflammatory signalling pathways, such as NF-kB and mitogen-activated protein kinases 
(MAPK), and resulted in approximately 38 % of the immune stimulated genes being modulated 
in terms of up- or down-regulation of their expression (Lei et al., 2015b). 
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In addition, it has been shown that high concentrations of these extracts (6 mg/mL) increase 
cellular metabolism resulting in the increased production of reducing equivalents such as 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2). The 
reducing equivalents donate electrons to the electron transport chain which leads to increased 
adenosine triphosphate (ATP) production which is utilized for the active reabsorption of 
nutrients in the kidney. However, the increased flux of ions along the electron transport chain 
depolarizes the mitochondrial membrane and ROS are produced. This effect thus makes the 
mitochondria in the proximal convoluted tubule and the distal convoluted tubule susceptive to 
oxidative stress. The depolarization of the mitochondrial membrane also signals pro-apoptotic 
factors (Phulukdaree et al., 2010). 
The majority of investigations into the potential of S. frutescens extracts to be used as anti-
inflammatories and anti-oxidants have studied the effects of the whole extracts and only select 
studies have considered individual compounds that may elicit these effects. It has been shown 
that the anti-oxidant capacity of L-canavanine is comparable to that of curcumin and that D-
pinitol was able to decrease extracellular prostaglandin levels in macrophages by 14 % (Caires 
et al., 2011). Further immunomodulating effects where observed in the presence of 
polysaccharides isolated from S. frutescens extracts. It was shown that mixtures containing 
high molecular weight polysaccharides showed greater inhibitory effects compared to low 
molecular weight polysaccharides when assayed in the complement fixation test (Zhang et al., 
2014).  
Glucocorticoids play a major role during the inflammatory response and influence pro-
inflammatory and anti-inflammatory gene transcription via the GR. In addition to their effects 
on the inflammatory response, exposure to elevated glucocorticoid levels has also been linked 
to depression and stress. To our knowledge, there are no previously published studies that 
specifically investigated the effect of S. frutescens extracts on glucocorticoid production in 
adrenal steroidogenesis and/or the influence of these extracts on GR mediated gene 
transcription. However, there are several compounds, such as Compound A and ginsenosides, 
which have been shown to influence the GR mediated effects (de Bosscher et al., 2005; Du et 
al., 2011; Lee et al., 1997).  
Inflammation has long been known to affect the progression of several cancers and although 
conventional cancer treatments include chemo-and/or radiotherapy or surgery, it has been 
shown that one in seven malignancies can be linked to chronic inflammation or infection. The 
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inflammatory mechanisms that have been linked to the progression of cancers include anti-
apoptotic proteins, invasive and metastatic genes, promoters of cell proliferation and the down 
regulation of some transcription factors. The realization that cancer is a complex disease that 
may depend on several factors has led to the investigation of multi-targeting therapies, many 
of which originate from natural sources (Yadav et al., 2010).  
Cancer  
The anti-proliferative effect of S. frutescens was demonstrated by the addition of the extract to 
several human carcinoma cell lines, including Jurkat, MCF-7, HL-60 and MDA-MB-468 cells 
(Tai et al., 2004). Other studies confirmed that S. frutescens extracts inhibited mammary 
adenocarcinoma proliferation of MCF-7 cells by approximately 50 % while also inhibiting the 
growth and changing morphology of the cells (Stander et al., 2007; Vorster et al., 2012). A 
comparison of the results obtained by the apoptotic studies in MCF-7 cells indicate that the 
ethanolic extract may contain compounds that are more effective in inducing apoptosis 
compared to the aqueous extract. In addition, the extract was found to affect the expression of 
several differentially expressed genes, including those expressing the tumor necrosis factor 
receptor superfamily (Stander et al., 2007). Morphological disintegration and changes in 
cellular membranes of Jurkat, Chinese Hamster Ovarian (CHO) and Caski cell lines further 
demonstrated the apoptotic effects of S. frutescens (Chinkwo, 2005), while apoptosis 
promoting effects were confirmed in lymphocytes (Korb et al., 2010). Esophageal cancer cells 
treated with S. frutescens also displayed typical signs of apoptosis such as cell shrinkage and 
plasma membrane blebbing (Skerman et al., 2011). 
Although earlier investigations showed the anti-cancer effects of S. frutescens, studies in recent 
years have focused on potential signalling pathways that may be affected by the extracts. In 
addition to nuclear condensation and membrane integrity, Leisching et al. showed that an 
ethanolic extract of S. frutescens affected the phosphorylation state of important molecules in 
the phosphoinositide 3-kinase (PI3-K) signalling pathway, thereby inducing apoptosis 
(Leisching et al., 2015). As the PI3-K signalling pathway is linked to the progression of cancer, 
the latter study suggested that S. frutescens may have therapeutic application in various cancers 
(Sokolowski et al., 2016).  
S. frutescens extracts appeared to influence the progression of prostate cancer as the extract 
was able to repress approximately 50 % of Hedgehog-signalling responsive genes in 
TRAMPC2 cells (Lu et al., 2015). As Hedgehog signalling has been associated with advanced 
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prostate cancer, as well as other cancers and metastases, the repression of genes within this 
pathway by S. frutescens has significant implications in potential cancer treatments. In addition, 
TRAMP mice fed a diet containing S. frutescens, up to 1 % w/w, were shown to have reduced 
formation of prostate carcinoma. The compounds within the extracts were also assayed for 
repressive activity toward Hedgehog-signalling genes and it was found that SUD was the more 
potent contributor to the repressive effect of the extract (Lin et al., 2016; Lu et al., 2015). 
Further confirmation that the apoptotic activity of S. frutescens could be attributed to 
interference with signalling pathways was obtained when van der Walt et al. showed that an 
ethanolic extract induced the activation of caspases (CASPs) 8, 9 and 3/7, as well as increased 
expression of CASP9 and FAS ligand (FASLG) genes, all of which have been associated with 
apoptosis (van der Walt et al., 2016). 
Although the anti-mutagenic effect of S. frutescens had previously been demonstrated using 
the Ames test, a test designed to determine the mutagenic potential of compounds (Reid et al., 
2006), this effect was recently confirmed in the presence of tobacco specific carcinogens 
(Gelderblom et al., 2017). Although it was suggested that the sutherlandins and SUs may be 
responsible for the anti-mutagenic effect of the extract, these compounds have not, to date, 
been associated with anti-mutagenic activity. Furthermore, the tobacco specific carcinogens 
investigated in this study could be inactivated through interfering with P450 enzymes as it has 
previously been shown that S. frutescens can inhibit progesterone (PROG) and pregnenolone 
(PREG) metabolism by P450 enzymes. Furthermore, recent studies have shown that disrupted 
endocrine systems play major roles in the development of cancers as well as cancer relapses 
caused by endocrine resistance that had developed due to chemotherapies (Casco and Soto-
Vega, 2016). 
Stress and depression  
Literature suggests that the use of S. frutescens extracts has commonly been linked to stress-
relieving effects with anecdotal reports by native tribes having used extracts made from the 
dried leaves to treat victims of shock, trauma and severe depression (van Wyk, 2011; van Wyk 
and Albrecht, 2008). Stress-related disorders often relate to a dysfunctioning endocrine system 
as the production of the human glucocorticoid, cortisol, plays a major role in the response to 
stress.  
The stress response is regulated by the HPA-axis under the control of corticotrophin release 
hormone (CRH) and adrenocorticotropic hormone release from the brain in reaction to stimuli 
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such as stress, hunger or inflammation. Both hunger (Ott et al., 2011) and inflammation (Straub 
et al., 2011) cause persistent activation of the HPA-axis, whereas stress responses have been 
shown to vary considerably between individuals (Trestman et al., 1991). Activation of the 
HPA-axis leads to increased cortisol production and secretion from the adrenal gland, however, 
glucocorticoids also exert an inhibitory feedback effect on the HPA-axis so that the body can 
return to a homeostatic state once the stress stimuli has dissipated. In a diseased or chronic 
stress state, the feedback inhibition by glucocorticoids is no longer effective resulting in 
elevated circulating glucocorticoid levels (Silverman and Sternberg, 2012). Although the stress 
related increase in glucocorticoids is initially beneficial, chronically elevated glucocorticoid 
levels lead to chronic inflammation, heart disease (Adameova et al., 2009), diabetes (Rosmond, 
2003), cancers, osteoporosis and an array of psychiatric disorders (Kadmiel and Cidlowski, 
2013). 
Prevoo et al. suggested that S. frutescens could inhibit glucocorticoid production due to the 
inhibitory effect the extract exhibited towards the catalytic activity of adrenal steroidogenic 
P450 enzymes, P450 17α-hydroxylase/17,20-lyase (CYP17A1) and P450 21-hydroxylase 
(CYP21A2) (Prevoo et al., 2004, 2008). The study showed that the extract inhibited steroid 
substrate binding to CYP21A2 and CYP17A1 in adrenal microsomal preparations, however, 
the triterpenoid fraction of the extract did not significantly inhibit PREG binding at the 
concentrations assayed. The triterpenoid fraction used in this study may have been a mixture 
of SU A-D (Fu et al., 2008) and other SUs that have recently been identified in extracts (Zaki 
et al., 2016). An in vivo study showed that corticosterone (CORT) levels in stressed rats were 
significantly reduced by the presence of the extracts, together with reduced testosterone and an 
overall reduced CORT:testosterone ratio (Smith and Myburgh, 2004a). The latter finding was 
significant with regard to the use of S. frutescens extract as treatments in anxiety disorders and 
cancers as changes in the cortisol:testosterone ratios in humans may affect behavioral changes 
(Romero-Martínez et al., 2013) as well as the progression of some cancers (Fabre et al., 2016). 
Smith and van Vuuren, 2014, showed in an in vivo study that S. frutescens extracts affected 
steroidogenesis increasing plasma CORT levels in male Wistar rats following a single dose. In 
addition, the latter study showed that the down regulation of the GR, induced by stress, was 
eliminated after administration of low dosages (4mg/kg body weight) of S. frutescens extract 
(Smith and van Vuuren, 2014). 
Although the reduction of circulating glucocorticoid levels appears to be a significant target 
for treating stress and inflammatory related disorders, the actions of the glucocorticoids at 
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target tissues remain a very important factor in the treatment of these disorders. It is therefore 
not uncommon for chronic stress to induce disorders such as insulin resistance, obesity and 
Type 2 diabetes (Black, 2006). 
Diabetes 
Diabetes is generally associated with insulin resistance through which glucose uptake from 
circulation is inhibited, however low grade chronic inflammation may also contribute to the 
development of Type 2 diabetes (Guo et al., 2015). Insulin resistance is a known side effect of 
glucocorticoid excess and is a common symptom of glucocorticoid excess disorders such as 
Cushing’s syndrome. Although many potential targets have been identified for the mechanism 
through which glucocorticoids induce insulin resistance, malfunctioning pancreatic beta cells 
as well as the GR and MR have been investigated. In the context of this study, the potential 
effect of S. frutescens on diabetes mellitus (Type 2) will be discussed as traditional infusions 
prepared from the leaves of this plant have been used to treat this clinical condition.  
In vivo studies have shown that in streptozotocin induced diabetic rats, blood glucose 
concentrations were decreased after administration of S. frutescens (800 mg/ kg bodyweight). 
In addition, these rats maintained lowered blood glucose concentration longer than a 
conventional hypoglycemic agent (chlorpropamide) (Ojewole, 2004). Chadwick et al. showed 
that rats fed a high fat diet that induced insulin resistance displayed improved glucose clearance 
after the administration of S. frutescens (Chadwick et al., 2007). Furthermore, it was shown 
that S. frutescens administration to insulin resistant mice increased glucose uptake in the 
muscle significantly, and although increased, the glucose uptake in adipose tissue and liver was 
not significantly different to the control group. These studies also showed that the extract 
reduced free fatty acids and triglycerides in circulation when compared to the control group, 
together with reducing circulating free fatty acids when compared to the non-insulin resistant 
control group (Mackenzie et al., 2009; MacKenzie et al., 2012). 
The effect of S. frutescens on hepatocytes was investigated by assessing parameters descriptive 
of insulin resistance such as deoxy-glucose uptake, glucose secretion into the culture medium 
and intracellular lipid accumulation. The treatment of the cells with S. frutescens affected the 
transcriptional activities of 27 potential gene targets for the treatment of insulin resistance. The 
influence of the extract on these genes suggests various likely mechanisms through which S. 
frutescens may exert its anti-diabetic effects (Williams et al., 2013). Several compounds within 
the extract may contribute to the anti-diabetic effects observed, although earlier studies 
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investigating S. frutescens as a potential anti-diabetic treatment suggested that pinitol and L-
canavanine within the plant extracts may be responsible for the anti-diabetic effects (Sia, 2004).  
Immunodeficiency disorders 
The traditional use of S. frutescens as an immunostimulating tonic for immunocompromised 
individuals, such as human immunodeficiency virus (HIV) patients, has been recognized by 
the South African Ministry of Health (Mills et al., 2005b), despite little conclusive scientific 
data. Although initial investigations indicated that the use of S. frutescens may be beneficial, 
recent data have suggested that extracts may have detrimental effects.  
Studies first showed that a methanolic S. frutescens extract stimulated recombinant HIV-1 
reverse transcriptase (RT) activity (Bessong et al., 2005), while Harnett et al. demonstrated that 
S. frutescens extracts inhibited the HIV-1 RT activity and suggested that the tannins present in 
the extract may contribute to the inhibitory effect (Harnett et al., 2005). In addition to these 
conflicting results, it was found that the use of extract may affect anti-retroviral drug 
metabolism as S. frutescens was found to inhibit P450 3A4 (CYP3A4), a hepatic cytochrome 
P450 enzyme involved in drug metabolism (Mills et al., 2005a).  
Further investigations led to the realization that the extracts may induce apoptosis in cluster of 
differentiation (CD) 4+ cells and T lymphocytes, as well as elevating the concentration of cells 
expressing CD69, suggesting that the observed apoptosis may be due to activation-induced 
lymphocyte cell death (Korb et al., 2010). As immunocompromised individuals have low CD4+ 
cell counts, further reduction of these cells would aggravate their condition. However, Wilson 
et al. demonstrated that HIV viral load and CD4+ cells and T lymphocyte counts were not 
significantly different in HIV seropositive individuals receiving S. frutescens when compared 
to the control group (HIV positive, but not receiving S. frutescens). The total burden of 
infection, quantified as the number of days of infection-related occurrences, was significantly 
greater in the group receiving S. frutescens with two subjects contracting tuberculosis while 
receiving isoniazid preventative therapy (Wilson et al., 2015). This effect may be due to the 
anti-oxidant and anti-inflammatory effects of the extract which, in a healthy individual, would 
be beneficial. However, in an immunocompromised individual the anti-inflammatory effect 
may reduce the host’s immune system further and in doing so might advance latent infections 
such as caused by Mycobacterium tuberculosis (Folk et al., 2016). However, a recent study has 
shown that S. frutescens and alpha-linolenic acid, isolated from the extracts, inhibited the 
metabolic action of shikimate kinase, a key enzyme in the metabolic pathway of M. 
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tuberculosis. A dichloromethane extract showed the greatest inhibitory effect (IC50= 0.1 
µg/mL) when comparing extraction methods, whereas alpha-linolenic acid showed a inhibitory 
effect (IC50 = 3.7 µg/mL) comparable to that of the ethanolic or aqueous S. frutescens extracts 
(IC50 = 1.7 and 5.1 µg/mL) (Masoko et al., 2016). In addition, under immunocompromised 
conditions, S. frutescens appears to aggravate the inflammatory response by further enhancing 
Jun amino-terminal kinases (JNK)-activated pro-inflammatory pathways. Africa and Smith 
showed that S. frutescens results in increased inflammatory leukocyte movement across the 
blood brain barrier in co-cultured HL2/3 and blood brain barrier cells (Africa and Smith, 2015).  
Although extracts have been shown to have significant effects in the aforementioned diseases, 
clinical conditions and in vitro studies, investigations into specific compounds identified within 
S. frutescens extracts and the association of these compounds with particular effects are limited. 
As mentioned previously, neither the SUs nor sutherlandins displayed potential as an 
antioxidant, however the repression of prostate cancer specific genes by SUD suggests a 
potential anticancer application. Furthermore, D-pinitol has been associated with anti-diabetic 
effects and with decreased extracellular prostaglandin levels in macrophages. In addition to 
these compounds, a number of other compounds have been identified in S. frutescens extracts 
and are discussed next. 
Compounds identified within S. frutescens extracts 
The medicinal effects of S. frutescens have been attributed to a variety of compounds that are 
present in extracts. It has been demonstrated that the pharmacological composition of the 
extracts may be influenced by the geographic location of the plant, harvesting and extraction 
methods and therefore extracts and infusions made from these plants may have varying 
medicinal effects. As specific compounds within extracts have been associated with specific 
medicinal effects, the analyses of extracts and the quantification of specific compounds in 
different populations, affected by growth conditions and by harvesting methods, is crucial to 
studies investigating bioactivities of S. frutescens. 
Amino acids 
Amino acids are abundantly present in extracts and quantitation analyses showed that all 20 
naturally occurring amino acids are found in S. frutescens extracts. In addition to these amino 
acids, GABA, L-canavanine, L-arginine, L-asparagine and D-pinitol have been identified to be 
major constituents in extracts. Many of the therapeutic applications of S. frutescens have been 
associated with the presence of these compounds. Alanine, proline and L-asparagine were 
Stellenbosch University  https://scholar.sun.ac.za
  
14 
 
shown to represent approximately 60 % of the total amino acid quantified in the extracts 
(Mncwangi and Viljoen, 2012). While the non-protein amino acid L-canavanine is ±0.08 mg/g 
in leaf extracts, D-pinitol ± 18 mg/g was present at the highest concentration in leaf extracts, 
followed by GABA ± 3.5 mg/g. GABA was present at ± 1.7 mg/g in seed extract, and D-pinitol 
was present in the lowest concentrations ± 0.25 mg/g) (Shaik et al., 2010). Although surprising, 
the GABA levels were lower in the seed extracts than in the leaf extracts which may be 
explained by the tendency of GABA levels to remain low in the seeds of legumes and to be 
rapidly increased after germination (Kuo et al., 2004). 
L-canavanine, associated with anti-cancer effects of S. frutescens, displays toxic effects due to 
its ability to interfere with the interaction between arginine and arginyl tRNA synthetase, since 
L-canavanine and arginine are structurally similar (Fig 2.1A). However, the inhibition of 
arginine metabolizing enzymes by L-canavanine may only occur when arginine concentrations 
are low and the low concentrations at which L-canavanine in S. frutescens has been reported 
suggests that it would not contribute significantly to toxicity of S. frutescens (Shaik et al., 
2010). In addition, the inhibition of arginine metabolism may affect nitrogen uptake and in so 
doing add to the anti-oxidant potential of the extracts by reducing the production of NO (Caires 
et al., 2011). It has also been shown that arginine substitution by L-canavanine might be more 
effective under inflammatory conditions and may also have an influence on autoimmunity 
(Akaogi et al., 2006).  
 
Fig. 2.1: Chemical structures of A) L-canavaninea, B) GABAb and C) D-pinitolc.  
a National Center for Biotechnology Information. PubChem Compound Database; CID=439202, 
https://pubchem.ncbi.nlm.nih.gov/compound/439202 
b National Center for Biotechnology Information. PubChem Compound Database; CID=119, 
https://pubchem.ncbi.nlm.nih.gov/compound/119 
c National Center for Biotechnology Information. PubChem Compound Database; CID=164619, 
https://pubchem.ncbi.nlm.nih.gov/compound/164619 
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GABA (Fig 2.1B), an inhibitory neurotransmitter, has been associated with the anti-anxiety 
and sedative effects of S. frutescens and studies have shown that mood disorders can often be 
associated with reduced GABA levels (Abdou et al., 2006). Furthermore, GABA has been 
shown to increase immunoglobulin (Ig) A levels, thereby enhancing the immune system during 
stress. Outside of the central nervous system (CNS) GABA has been shown to be involved in 
the inhibition of tumor cell migration (Ortega, 2003), as well as influencing steroid production 
through affecting the HPA-axis (Cullinan et al., 2008; Metzeler et al., 2004).  
D-pinitol, shown in Fig. 2.1C, has been associated with the anti-diabetic effects of S. frutescens 
and reports have shown that D-pinitol is able to induce insulin-like effects in streptozotosin-
induced diabetic rats as well as displaying anti-hyperglycemic effects (Bates et al., 2000). In 
addition to reports showing the favourable effect of D-pinitol on glucose uptake, this compound 
has been shown to display anti-inflammatory (Singh et al., 2001) and anti-hyperlipidemic 
(Geethan and Prince, 2008) effects. The latter study showed that D-pinitol decreased blood 
glucose levels, as well as free fatty acids, triglycerides, total cholesterol and phospholipids. 
Although D-pinitol has mostly been associated with anti-diabetic effects, studies have shown 
that the presence of this compound in aqueous S. frutescens extracts may decrease the 
absorption of atazanavir, an anti-retroviral drug, in Caco-2 cells (Müller et al., 2012). 
Flavonoids and triterpenoids 
The polyphenol fraction of plant extracts is known to contain a range of compounds, most of 
which are yet to be identified. These compounds also elicit a diverse range of medicinal effects, 
however in the scope of this thesis, only compounds that have been identified within S. 
frutescens extracts will be discussed.  
Flavonoids, which have been classified into flavones, isoflavones, flavanols, flavan-3-ols and 
anthocyanidins, are naturally abundant in plants as bioactive secondary metabolites. The effect 
of flavonoids has been a popular topic of investigation in recent years and it has been shown 
that these compounds show anti-inflammatory effects by suppressing NF-κB production after 
the onset of LPS-induced inflammation (Funakoshi-Tago et al., 2016). In addition, flavonoids 
have been identified as a potential therapy to treat intestinal inflammation associated with 
obesity (Gil-Cardoso et al., 2016). The anti-oxidant activity has been attributed to the inhibitory 
effect of the flavonoids on LPS-signalling pathways (Chanput et al., 2016). The recent 
implication of flavonoids in cardio-protective functions have shown that specific structural 
characteristics allow for improved cardio-protective effects directly after myocardial 
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ischemia/reperfusions in rats (Testai et al., 2013). In addition, Zhang et al. showed that 
flavonoids possess hepato-protective properties (Zhang et al., 2014). Although flavonoid 
compounds within S. frutescens extract have been shown to be present in relatively low 
concentrations (Shaik et al., 2011), the sutherlandins A-D (Fig 2.2) have also been identified 
within the S. frutescens extracts (Avula et al., 2010).  
Very little data is available regarding the effects of the sutherlandins specifically in anti-
inflammatory, cardio-protective or hepato-protective processes. Although Tobwala et al. 
showed that a decrease in the flavonoid content of the extract resulted in a decrease in ROS 
scavenging potential of the extract (Tobwala et al., 2014), a subsequent investigation showed 
that sutherlandins A-D and SU A-D contributed very little to the anti-inflammatory effects 
observed when murine macrophages were exposed to ethanolic S. frutescens extracts (Lei et 
al., 2015a). 
 
Fig. 2.2: Chemical structures of sutherlandins 1) A, 2) B, 3) C and 4) D identified in S. 
frutescens extracts. Reproduced from Avula et al., 2010. 
S. frutescens extract have also been shown to contain triterpenoid compounds. These 
compounds are present in varying concentrations in plant extracts and have been linked to a 
number of medicinal properties. SUB has been identified as the major triterpenoid in S. 
frutescens extracts, followed by SU A, C and D (Fig 2.3)  (Albrecht et al., 2012; Avula et al., 
2010; Brownstein et al., 2015; Fu et al., 2010, 2008; Olivier et al., 2009). Studies have shown 
that triterpenoids are able to inhibit nociceptive responses (Wu et al., 2011) and elicit anti-
inflammatory, cardio-protective (Bishayee et al., 2013; Han and Bakovic, 2015) and anti-
cancer effects (Bai et al., 2016; Yadav et al., 2010). It has recently been shown that ursolic 
acid, a pentacyclic triterpenoid carboxylic acid, displays both anti- and pro-inflammatory 
effects (Babalola and Shode, 2013; Ikeda et al., 2008).  
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Fig. 2.3: Chemical structures of SU A-D (1-4) isolated from S. frutescens extracts. Reproduced 
from Fu et al., 2008. 
Although limited data regarding the effect of SUs on anti-inflammatory, cardio-protective or 
anti-cancer properties generally associated with triterpenoids is available, recent studies have 
shown that anti-cancer effect of S. frutescens could be attributed, in part, to the presence of 
SUD as this SU could suppress the Gli/hedgehog signalling pathway in prostate cancer cells 
(Lin et al., 2016). Furthermore, studies have shown that the triterpenoid glycoside fraction 
obtained from a S. frutescens extract affected atazanavir metabolism in human liver 
microsomes, indicating a possible herb-drug interaction (Müller et al., 2012). The fact that the 
structures of the SUs are similar to that of steroid hormones and steroid hormone metabolites, 
may suggest that these compounds can elicit biological effects through interactions with 
steroidogenic enzymes and steroid receptors. This interaction may partly explain anti-
inflammatory and cardio-protective properties, however no data has been published to support 
this. 
Other bioactive components. 
As plant extracts naturally contain many structurally and functionally diverse compounds, all 
of these compounds have not yet been investigated for biological activities. Compounds, other 
than that discussed in previous sections, which have been identified in S. frutescens extracts 
and shown to possess biological activities, are described here.  
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Polysaccharide fractions of S. frutescens extracts were shown to possess immunomodulating 
properties when assayed in the complement fixating activities. High molecular weight 
polysaccharide fractions, fractions containing higher concentrations of xylose and galactose-
rich fractions, displayed higher bioactivity compared to the other fractions assayed. Treating 
the polysaccharide fractions with pectinase also resulted in higher biological activities when 
compared to untreated fractions (Zhang et al., 2014).  
Recently, alpha-linolenic acid was identified and isolated from S. frutescens extracts. The 
identification of this compound in the extract has prompted investigations into the anti-
tuberculosis effects of S. frutescens as this extract was shown to inhibit recombinant shikimate 
kinase which is considered to be an effective drug target for the development of anti-
tuberculosis drugs (Masoko et al., 2016).  
Cardenolides, cardiac glycosides (Fig 2.4) that are used as protection against herbivores in 
plants, have recently been identified in leaf and seed extracts of S. frutescens. The presence of 
these compounds suggests that the extracts may have cardio-protective properties as these 
compounds have been used extensively to treat congestive heart failure (Braga et al., 1996; 
Shaik et al., 2011). The use of cardenolides to treat heart failure may be rooted in their ability 
to affect ion transport mediated by sodium-potassium adenosine triphosphatase (Na+,K+-
ATPase) (Florkiewicz et al., 1998). Furthermore, cardenolides have recently been shown to 
play a significant role in the treatment of non-small cell lung cancer as these compounds induce 
lysosomal membrane permeability (Mijatovic et al., 2006). 
 
Fig. 2.4: Typical cardenolide structures. Reproduced from Schoner and Scheiner-Bobis, 2007. 
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Bioavailability of compounds 
Many bioactive compounds have been shown to elicit various medicinal effects, however, in 
most cases these studies have been conducted in vitro and little in vivo data is available. In 
addition to this, it is not uncommon for an effect observed in vitro to be abolished in vivo. The 
difference observed in vivo and in vitro can be attributed to the bioavailability of the natural 
compound in the target tissue. As most herbal remedies are taken orally, these compounds 
would be subjected to digestion, metabolism by gut flora and hepatic enzymes and potential 
transport within circulation. It is therefore not uncommon that compounds do not reach their 
intended target in the active form assayed, if these compounds reach these targets at all. The 
bioavailability, absorption and degradation of compounds within plant extracts after oral 
ingestion will thus affect their overall biological activities. 
Lipinski’s rule of five has been used as a guideline to identify potential new drugs that would 
be bioavailable after oral intake. This rule describes four physicochemical characteristics 
describing limitations for molecular weight (≤ 500 Da), lipophilicity (log P ≤ 5) and the number 
of hydrogen donors and acceptors (H-bond donors ≤ 5 and H-bond acceptors ≤ 10) (Lipinski, 
2004). These characteristics are used to predict the aqueous solubility and intestinal 
permeability of compounds and have been linked to ± 90 % of oral medications that have 
reached phase II clinical trials. The use of this rule has however impacted drug discovery and 
development as many potential drugs that may not adhere to these rules, have been overlooked 
even though Lipinski himself cautioned against applying the rule unilaterally.  
Compounds with relatively simple chemical structures found within S. frutescens extracts are 
most likely to be readily available and to be absorbed from the intestines. GABA, D-pinitol 
and L-canavanine are amino acids and it is likely that these compounds would therefore 
undergo the same absorption and metabolism as natural amino acids. However, the more 
complex molecules within the S. frutescens extracts, such as flavonoids and triterpenoids, may 
be less likely to be absorbed in the structure that they have been assayed in in vitro assays 
(Thwaites et al., 2000).  
A recent study has shown that a single dose of 300 mg of S. frutescens could result in a gastro-
intestinal (GI) concentration of extract remarkably greater than the minimum concentration 
required for the inhibition of hepatic P450 enzymes, while the greatest inhibitory effect was 
observed for metabolism by CYP3A4 and 3A5 (Fasinu et al., 2013). The interaction of 
triterpenoids with P450 enzymes is not surprising as these compounds are synthesized by plant 
Stellenbosch University  https://scholar.sun.ac.za
  
20 
 
P450 enzymes in higher plants (Yamazaki, 2014). Other studies indicated that protopanaxatriol 
(PPT)-type ginsenosides are metabolized by P450 enzymes, specifically CYP3A4, in rat and 
human liver microsomes (Etheridge et al., 2007). Nicotinamide adenine dinucleotide phosphate 
hydrogen (NADPH)-dependent metabolism by P450 enzymes showed that the major site of 
oxygenation of the triterpenoids and aglycone is on the C20 aliphatic branch side-chain. 
Furthermore, C20-24 epoxides were produced by oxygenation of the C24-25 double bond. 
These oxygenation reactions appear to play significant roles in the elimination of ginsenosides, 
however the specific P450 enzyme isoforms responsible for these reactions are unclear as these 
experiments were performed in microsomal fractions (Hao et al., 2010). 
It has been shown that plasma triterpenoid levels remain low after oral administration due to 
extensive metabolism in the GI tract, poor membrane permeability and the low solubility of 
the triterpenoid aglycone (Tawab et al., 2003). After ingestion triterpenoids, such as 
ginsenosides, are metabolized in the gut by intestinal bacteria, often resulting in the 
deglycosylation of the molecule via subsequent sugar moiety cleavage reactions (Kim et al., 
2013; Qi et al., 2011). The digestion and absorption of triterpenoids in Wistar rats was 
investigated by feeding rats glycosidic extracts of Saraitia grosvenori and it was shown that 
mogroside V, a triterpenoid isolated from S. grosvenori, and its metabolites were found in the 
small intestine and the blood samples collected. Mogroside V had been degraded to tetra and 
triglucose mogroside conjugates and no free triterpenoids were detected. Approximately 60% 
of the triterpenoids administered were detected in the fecal matter collected 24 hours after 
administration (Murata et al., 2010). This confirms the low absorption of triterpenoids from the 
small intestine that has previously been shown. Previous studies have also shown that glycoside 
compounds can be detected as glucuronic and sulfuric acid conjugates in vivo after oral 
administration to rats (Moon et al., 2000; Piskula, 2000).  
Studies have shown that the association of monosaccharide and disaccharide moieties to 
triterpenoid compounds, specifically at C3 and C28, influence their pharmacokinetic 
parameters (Tang et al., 2015). Although the pre-systematic metabolism of ginsenosides may 
result in relatively low plasma levels, it has been shown than these triterpenoids are present in 
hepatic tissues at much higher concentrations than plasma and other tissues (Gu et al., 2009). 
In addition, the analyses of ileal fluids after the ingestion of raspberries showed the presence 
of β-courmaroyl glucarate derivatives and thus the ability of the compounds to be delivered to 
target tissues and elicits drug-like effects (McDougall et al., 2016). It has been also been shown 
that the addition of small molecule fractions of extracts to steroidal saponins increases the 
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bioavailability of these compounds which may explain the relatively high bioavailability of 
whole plant extracts and limited bioavailability of triterpenoid compounds (Tang et al., 2015). 
Further technologies have also been developed to increase the bioavailability of compounds. 
These include the application of nano-sized drug carrier particles including liposomes and 
micelles, while cyclodextration creates a pseudo-amphiphilic effect to increase bioavailability 
(Aqil et al., 2013; Krishnaiah, 2010). 
Potential drug-herb interactions 
The interactions between drugs and herbs are of great significance, especially since herbal 
remedies are being used more frequently in conjunction with pharmaceuticals. The majority of 
traditional medicines have not been screened for drug-herb interactions and due to the variety 
of compounds present in traditional medicine, it is plausible that these medicines may interfere 
if taken in conjunction with drugs and elicit unfavourable effects. Although the majority of 
drug-herb interactions have been associated with negative effects, these interactions could 
potentially increase the effects of the drug or decrease adverse side effects associated with the 
use of the drug. A well-documented example of a synergistic drug-herb interaction is the use 
of garlic and captopril which resulted in decreased blood pressure and a greater inhibitory effect 
on angiotensin-converting enzyme (Asdaq and Inamdar, 2010).  
The most common drug-herb interactions are associated with pharmacokinetic effects often 
resulting in changes in pharmacokinetic parameters, plasma concentrations or elimination half-
life of pharmaceuticals (Shi and Klotz, 2012; Valli and Giardina, 2002). These effects are often 
elicited either through the inhibition or stimulation of hepatic P450 enzymes or potential drug 
carriers in circulation. The most common method of pharmacokinetic interference is the 
competitive inhibition of the metabolizing enzyme through the binding of a herbal medicine or 
compound to the active site of the enzyme (Pelkonen et al., 2008). Approximately 70 % of 
currently used drugs are metabolized by only ten P450 isoforms of which CYP3A4 is the most 
abundant and is responsible for the metabolism of the majority of drugs and xenobiotic 
currently in use (Pelkonen et al., 2008). CYP3A7 and CYP3A5 are also present in the livers of 
a small percentage of the Caucasian population and together with CYP2D6, which is much less 
abundant than CYP3A4, metabolizes numerous drugs.  In addition to CYP3A4 and CYP2D6, 
the oxidative metabolism of drugs is mostly mediated by CYP2B6, CYP2C9 and CYP2C19 
(Guengerich, 2008). Most drugs that are metabolized by only one P450 isoform are more 
susceptible to harmful herb-drug interactions than drugs that are metabolized by numerous 
P450 isoforms.  
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In the majority of cases, the inhibition of hepatic P450 enzymes is the most frequent cause of 
drug-drug interactions. The P450 enzymes may inhibit the metabolism of pro-drugs to their 
active form and may, as reported in many cases, subsequently lead to toxicity through the 
inability of the body to clear the drugs effectively. Although the majority of the interactions of 
drugs with P450 enzymes may be due to competitive and reversible inhibition, mechanism-
based inhibition has also been observed.  
The stimulation of P450 enzymes is usually associated with the activation of gene transcription, 
increased messenger RNA (mRNA) biosynthesis or protein degradation. The mechanisms of 
induction are slow and generally constitute ligand-dependent activation of transcriptional 
activities via nuclear receptors, most notably pregnane X, androstane and hydrocarbon 
receptors (Lin, 2006). CYP3A4, CYP2D6 and CYP1A2 have been shown to be susceptible to 
herb-mediated induction and may thus result in inefficacy of drugs (Shi and Klotz, 2012). 
 The effects of drug-herb interactions are not limited to the inhibition or induction of P450 
enzymes with potential drug transporters, such as P-glycoprotein located in the gastrointestinal 
tract, liver and blood brain barrier, being a popular aspect of investigation. The secretion of 
absorbed drugs has been associated with the actions of P-glycoprotein and it has been shown 
that this transporter secretes the drugs into the intestinal lumen. Interference with the normal 
action of this transporter could thus result in elevated or decreased drug levels, depending on 
the interaction of the herb or drug with the transporter. The fact that many bioactive compounds 
or drugs act as substrates for P-glycoprotein and CYP3A4 has shown that in this transport-
metabolism system transporter proteins may act as a barrier in the efficient uptake of bioactive 
compounds taken  orally (Pal and Mitra, 2006).  
In vitro assays utilizing S. frutescens extracts showed that the extracts inhibited ATP-binding 
cassette transporters, including P-glycoprotein, and organic anion transporting polypeptides in 
cells over expressing these transporters. Furthermore, the extract was found to inhibit CYP1A2, 
CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4 and CYP3A5, while inhibition 
of the latter two was the most sensitive to the extracts. Mechanism based inhibition of CYP3A4 
was observed in the presence of the extract and the metabolism of midazolam, a bioactive drug 
administered orally, was also decreased in the presence of the extract, resulting in 40 % less 
drug clearance (Fasinu et al., 2013). Awortwe et al. however showed that CYP1A2 was more 
susceptible to inhibition by the extract than CYP3A4 (Awortwe et al., 2014). In addition, SUB 
has also been shown to interfere with hepatic P450 enzyme action by inhibiting CYP3A4 
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without affecting CYP2D6 (Madgula et al., 2008). No investigations into the effect of SUs on 
drug transporters have been published to date.  
In addition to inhibiting hepatic P450 enzymes and drug transporters, S. frutescens extract have 
been shown to affect the metabolism of anti-retroviral drugs. The administration of S. 
frutescens to neverapine treated rats did not result in significantly increased neverapine in 
plasma, although pharmacokinetic parameters for neverapine were decreased indicating a 
stimulatory effect of the extract on CYP3A2 (rodents do not express CYP3A4). The induction 
of CYP3A2 was further indicated by increased intestinal CYP3A2 mRNA levels (Minocha et 
al., 2011). Taken together with previous studies, this finding suggests that S. frutescens may 
inhibit and/or induce the hepatic drug metabolizing P450 enzymes and would likely be 
responsible for considerable drug-herb interactions. 
Safety and efficacy 
In spite of the drug-herb interactions described above, the safety of S. frutescens extracts is still 
of major concern. In vitro studies have shown that the extracts elicit apoptotic and cytotoxic 
effects, however, it should be noted that these studies utilized up to 7.5 mg/mL in cell models 
(Chinkwo, 2005; Ngcobo et al., 2012; Stander et al., 2007; Vorster et al., 2012). This 
concentration is relatively high, considering the marketed dosage of S. frutescens tablets is 800 
mg per day. The latter dosage was utilized in a double-blinded study investigating the safety 
and efficacy of S. frutescens in healthy adults. The use of S. frutescens has not been associated 
with severe side effects, although symptoms such as “cotton” mouth, dizziness and slight 
diuresis have been reported. In healthy adults, no significant changes were observed for vital 
signs, blood or biomarker indices when compared to the control group, with elevated appetites 
being the most significant difference between the treatment and placebo group (Johnson et al., 
2007). However, when S. frutescens was administered to HIV seropositive adults, the HIV viral 
load and CD4+ T-lymphocytes were similar in control and treatment groups. In addition, the 
total burden of infection was significantly greater in the group receiving S. frutescens with two 
subjects contracting tuberculosis while receiving isoniazid preventative therapy (Wilson et al., 
2015). This effect may be due to the inhibitory effect of the extract on hepatic P450 enzymes 
as described above. Although S. frutescens has been assumed to be safe for use and data show 
that the use of the extracts in healthy adults has not been linked to any severe side effects, data 
regarding effects of the extract in a diseased state is limited. 
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Conclusion 
The greater majority of the South African population (± 75%) still relies on traditional medicine 
as either part of or their entire primary healthcare system. Remedies such as S. frutescens 
decoctions are widely used with little or no knowledge about the impact of the constituents of 
the plant on the disease state. The scientific validation of the use of S. frutescens extracts as a 
therapeutic aid in the supplementary treatment of hypertension, diabetes and stress may 
stimulate the use of this herbal remedy by the general public. Although many pharmaceuticals 
are readily available to treat these ailments, pharmaceuticals often elicit non-specific actions 
which lead to adverse side effects. Since no significant side effects have been associated with 
the use of S. frutescens (Johnson et al., 2007), other than potential interference of the 
metabolism of conventional drugs, this herbal remedy may provide safe, affordable treatment 
for the aforementioned ailments as well as in HIV seronegative adults (Wilson et al., 2015).  
South Africa is one of the three richest floristic areas in southern Africa and in spite of 
increasing commercial and scientific interest in traditional herbal medicines, no commercially 
marketable drug has materialized from the scientific investigations in South Africa. Several 
indigenous species have been exploited internationally, such as Streptomyces natalensis, 
Pelargonium sidoides, and compounds isolated from these species have been included in 
various foreign patents (Drewes, 2012). Although there seems to be a vast increase in the 
scientific validation of the use of herbal medicines, the commercialization and consequential 
economic enrichment appears to be lacking. It is necessary to promote the sustainable 
development of the natural plant industry in developing countries such as South Africa. The 
successful integration between science and traditional medicines has the potential for great 
economic gain, as well as scientific gain, through the validation of the claims associated with 
these medicines.   
In traditional medicinal practices it is not uncommon to find that traditional healers use a single 
plant to treat a vast range of different ailments that may seem unrelated, but it is more than 
likely that there is a common target for all these ailments that may be influenced by one or 
more of the compounds present in these extracts. This hypothesis may be substantiated by the 
collection of in vitro studies discussed in this chapter, displaying strong association between 
the targets for anti-inflammatory, anti-oxidant and anti-cancer effects. In addition to these 
effects, the identification of cardenolides in a S. frutescens extract, together with the strong 
association between cardenolides and anti-inflammatory effects, suggest that the extract and 
compounds within the extract could be employed in cardio-protective treatments.  
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The effects of S. frutescens has mostly been demonstrated in studies conducted in simple cell 
models that target simplified systems.  However, disease states are more complex than the 
models utilized to study the effects of the extracts. Although data from in vivo models are 
limited, the in vitro studies that have been conducted show that whole S. frutescens extracts, as 
well as compounds within the extract, exert significant effects at target tissues. Although the 
mechanism by which degradation, absorption and metabolism of these compounds occur is still 
largely unknown, the interaction with hepatic P450 enzymes indicate potential metabolic routes 
impacting on the bioavailability of the compounds within the extracts. Since the extracts 
inhibited several hepatic P450 enzymes, we hypothesized that S. frutescens would also interact 
with adrenal P450 enzymes. The potential mechanisms of these interactions, the adrenal P450 
enzymes and their roles in steroid metabolite production are discussed in the following chapter.  
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Chapter 3: Corticosteroid biosynthesis, transport and peripheral effects. 
Introduction 
The ability of an organism to maintain its internal environment by adjusting physiological 
processes is essential for survival − a regulatory process referred to as homeostasis. The daily 
activities of all organisms expose them to perturbations in their internal environment due to 
food intake, physical exercise, psychological stress, etc. These activities may cause a change 
in the homeostatic state of the organism and the survival of the organism is highly dependent 
on its ability to ward off these perturbations and return to a homeostatic state. The 
corticosteroids, glucocorticoids and mineralocorticoids, play a major role in the maintenance 
of homeostasis as these hormones are involved in metabolism, inflammatory responses and 
many cardiovascular functions. The regulation of the biosynthesis, secretion and delivery of 
corticosteroids to target tissues is thus critical for survival, with the dysfunction of their 
regulatory mechanisms having detrimental effects (Messaoudi et al., 2012; Spies et al., 2011).  
Corticosteroids are biosynthesized in the adrenal gland by adrenal steroidogenic enzymes that 
include P450 enzymes and hydroxysteroid dehydrogenases (HSDs) (Miller and Auchus, 2011). 
The major glucocorticoid in humans is cortisol, CORT in rats, and upon receiving a stimulus, 
the HPA-axis is activated and cortisol biosynthesis and secretion from the adrenal gland 
increases. Under normal physiological conditions, the elevated cortisol levels will initiate 
negative feedback inhibition of the HPA-axis and cortisol levels will be decreased to that of 
the homeostatic state. However, in chronically stressed individuals, the feedback inhibition is 
impaired and cortisol levels remain elevated (Harris et al., 2013).  
The major mineralocorticoid in humans is aldosterone (ALDO) and although the 
glucocorticoids can also elicit mineralocorticoid effects through interaction with the MR, these 
effects are mitigated by several protective mechanisms at target tissues. The mineralocorticoids 
are less versatile than the glucocorticoids, but are responsible for maintaining essential 
cardiovascular functions (McCurley and Jaffe, 2012; Messaoudi et al., 2012). 
In this chapter, adrenal corticosteroid biosynthesis, corticosteroid transport and the interactions 
of corticosteroids at receptor level are the main points of discussion. 
Regulation of corticosteroid biosynthesis  
The biosynthesis and secretion of corticosteroids is regulated by many physiological factors; 
although two main processes are involved in their regulation. Firstly, the circadian rhythm is 
responsible for the release of the corticosteroids in a daily, rhythmic pattern under normal 
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physiological conditions. Secondly, the HPA axis is involved in the regulation of the 
homeostatic state through controlling fluctuations in corticosteroid concentrations due to daily 
activities, which may include physical exertion, food intake, or stressful stimuli. These 
corticosteroids ensure the regulation of glucose, protein and lipid metabolism, water and 
electrolyte balance, pro- and anti-inflammatory responses and the regulation of cardiovascular 
functions.  
Circadian rhythm  
The physiology of most organisms differs remarkably between day and night. The circadian 
clock, an intrinsic biological clock, is both self-sustainable and entrained by external stimuli 
such as daylight and is largely responsible for the daily, rhythmic corticosteroid release. Three 
basic systems are involved in maintaining the circadian rhythm: 1) environmental signals such 
as daylight and food intake (input), 2) the suprachiasmatic nucleus (SCN) that is an intrinsic 
rhythm generator responsible for the expression of “CLOCK” genes and 3) output rhythms 
which result in the secretion of corticosteroids (Chung et al., 2011). The regulation of the 
circadian rhythm is depicted in Fig 3.1. 
 
Fig. 3.1: Schematic representation of the regulation of the inputs influencing daily fluctuations 
in cortisol secretion as part of the circadian rhythm. Reproduced from Chung et al., 2011. 
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Circulatory corticosteroid levels are increased during the active periods of the circadian rhythm 
with the highest corticosteroid concentrations detected at the start of the activity period. The 
rhythmic secretion of cortisol from the adrenal gland is controlled by the HPA-axis, which in 
turn is activated in response to stimulation from the SCN (the central clock). The rhythmic 
production and secretion of arginine vasopressin (AVP) is also under regulation of the SCN. 
Alternatively, a more local circadian regulatory function involves the stimulation of the adrenal 
gland by the splanchnic nerve which forms part of the SCN-autonomic nervous system (ANS). 
The latter system is involved in resetting the local adrenal clock (local clock). In addition to 
the actions of the central clock in the SCN, intrinsic mechanisms of the adrenal clock affect the 
daytime glucocorticoid stimulation by adrenocorticotropic hormone (ACTH), however the 
influence of this system on the steroidogenic pathway and the resulting cortisol production is 
of greater significance. The expression of steroidogenic acute regulatory protein (StAR), a rate 
limiting enzyme in steroidogenesis, is directly influenced by the circadian locomotor output 
cycles kaput (CLOCK): brain muscle ARNT-like 1(BMAL1) heterodimer which functions as 
a clock-controlled gene specific to the adrenal gland. The cyclic expression of StAR results in 
the circadian oscillation in cortisol production through adrenal steroidogenesis (Chung et al., 
2011). 
HPA axis  
Psychological, e.g. stress, and somatic stimuli, e.g. hunger (Ott et al., 2011) and inflammation 
(Straub et al., 2011), cause the activation of the HPA-axis through the release of CRH, from 
the paraventricular nucleus (PVN) located in the hypothalamus (Fig. 3.2). After secretion into 
the hypophyseal portal blood, CRH binds to CRH-binding plasma proteins and is transported 
to the anterior pituitary where CRH induces the production and secretion of ACTH from 
proopiomelanocortin (POMC) through sequential cleavage reactions by prohormone 
convertases PC1/3. In addition to stimulation by CRH, ACTH production and secretion can 
also be induced by AVP which activates protein kinase C through its effect on a vasopressin 
1b (V1b) receptor (Aguilera, 1994). POMC transcription is induced through the activation of 
adenylate cyclase and results in the production of smaller molecules — pro-ACTH and β-
lipoprotein. The subsequent cleavage of pro-ACTH produces ACTH, and two small peptides. 
It has been suggested that these peptides may contribute to the steroidogenic activity of ACTH 
(Ackland et al., 1983), although the functions of these peptides are relatively unknown. ACTH 
binds to the melanocortin type 2 receptor (MCR2), which is expressed in the zona fasciculate 
and glomerulosa of the adrenal gland, activating the production of cyclic adenosine 
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monophosphate (cAMP) from ATP through the activation of adenylate cyclase which is 
induced by the dissociation of G-proteins from the receptor (de Joussineau et al., 2012). The 
increase in cAMP activates cAMP-dependent protein kinase A (PKA) which phosphorylates 
targets such as StAR (Glaser and Kiecolt-glaser, 2005). StAR transports cholesterol into the 
mitochondria for conversion by P450 side-chain cleavage (CYP11A1). The transport of 
cholesterol into the adrenal mitochondria is the rate limiting step in steroidogenesis as the 
adrenal steroidogenic enzymes are irreversible and once committed to the pathway, cholesterol 
will be converted to cortisol and, to a lesser extent, ALDO under ACTH stimulation. In the 
case of somatic stimuli, the HPA-axis is continuously stimulated, whereas the normal stress 
response is associated with great variation between subjects with some displaying no resulting 
elevation of cortisol (Trestman et al., 1991). 
 
Fig. 3.2: Schematic representation of the regulation of glucocorticoid production by the HPA-
axis. (GC, glucocorticoids). Reproduced from Chung et al., 2011. 
 
After the dissipation of the stress stimulus, glucocorticoids inhibit the secretion of CRH and 
ACTH through feedback inhibition which is mediated primarily through hippocampal GR and 
MR (Harris et al., 2013). Previous studies have shown that the absence of negative feedback 
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by glucocorticoids results in hypersecretion of ACTH and subsequently cortisol (Kadmiel and 
Cidlowski, 2013). The dysfunction of the inhibition of cortisol production through feedback 
inhibition of the HPA-axis is associated with the development of chronic stress and 
inflammation and synthetic glucocorticoids are thus a common therapy for these disorders 
(Keller et al., 2016; Sigalas et al., 2012).  
Under normal physiological conditions, plasma ALDO concentrations are maintained by 
plasma renin which acts independently from ACTH. Under conditions of stress, ACTH may 
play a role in increasing ALDO concentrations as described above. Renin is produced in the 
kidney and is secreted in response to K+, Ca2+, angiotensin II (AngII) and natriuretic peptides 
(Spat and Hunyady, 2004). Renin converts angiotensinogen to angiotensin I (AngI), which is 
converted to AngII through a cleavage reaction catalyzed by angiotensin converting enzyme 
(ACE). AngII interacts with the AngII receptor Type 1 (AT-1 receptor) to maintain plasma 
volume and blood pressure by increasing the transcription of aldosterone synthase (CYP11B2) 
and ultimately, ALDO production. Furthermore, it leads to an increase in the contraction of 
vascular smooth muscle, catecholamine secretion from the adrenal medulla, enhances 
sympathetic nervous system (SNS) activities and increases the release of AVP, which in  turn 
may also act on the HPA-axis (Fig. 3.2) (Spat and Hunyady, 2004). AngII causes the 
depolarization of the cellular membrane and stimulates hormone sensitive lipase and StAR. In 
addition to the latter mechanism, AngII also induces ALDO secretion by activating the 
phospholipase C/inositol 1,4,5-triphophate pathway which results in the release of Ca2+ ions  
from the endoplasmic reticulum (ER), activating T-type Ca2+ channels (Spät et al., 2016). 
The stress response is also associated with the increased secretion of mediators such as 
norepinephrine (NE), serotonin and acetylcholine. These mediators stimulate cells in the PVN, 
in the hypothalamus, to produce CRH and subsequent POMC secretion from the anterior 
pituitary. ACTH, produced from POMC, activates adrenal steroidogenesis and the production 
of cortisol. During acute stress, growth hormone and glucagon may also act as stress hormones. 
In this scenario, the inhibitory neurotransmitter, GABA, through its interaction with CRH 
neurons that act on the PVN, also plays an important role in the regulation of the HPA-axis 
(Cullinan et al., 2008; Kakizawa et al., 2016). GABA, produced and secreted from neurons, 
activates neuronal GABAA ion channels and/or the GABAB receptor in the plasma membranes. 
GABA receptor subunits and glutamate decarboxylase (GAD), which catalyses the 
biosynthesis of GABA, play a prominent role in the GABAergic system. In addition, the 
expression of both subunits and enzyme has been shown to be similar in other endocrine tissues 
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such as the adrenal, testis and ovary (Metzeler et al., 2004). While GABA is the natural ligand, 
neurosteroids are considered to be allosteric modulators which bind directly to GABAA 
receptor and function either in an excitatory or inhibitory manner by affecting the 
hyperpolarization state of the synapses (Belelli and Lambert, 2005; Gunn et al., 2015; Wang, 
2011). These positive/negative allosteric modulatory affects have been shown to be one of the 
mechanisms through which neurosteroids affect rapid, non-genomic effects that play an 
important role in the stress response (Chisari et al., 2010; Zorumski et al., 2013). 
Steroid biosynthesis 
Corticosteroid biosynthesis occurs mainly within the adrenal gland and these steroids are 
associated mostly with genomic effects, while other corticosteroid metabolites are 
biosynthesized in the central nervous system tissues (brain and spinal cord) where they are 
associated with rapid, non-genomic effects (Strömberg et al., 2005). As both these mechanisms 
are important in describing the overall peripheral effects of corticosteroids, the biosynthesis of 
adrenal and neurosteroids will be discussed below. However, as the main focus of this study is 
adrenal steroidogenesis, the biosynthesis of neurosteroids in the brain will be discussed only in 
terms of their effects on neurotransmission via GABA receptors which is known to affect the 
HPA-axis.  
Adrenal steroidogenesis  
Adrenal steroidogenesis can be divided into three major branches: 1) glucocorticoid production 
which occurs in the zona fasciculata, 2) mineralocorticoid production which occurs in the zona 
glomerulosa and 3) androgen production which occurs in the zona reticularis (Fig 3.3) (Vinson, 
2003). Adrenal steroidogenic enzymes are usually unidirectional and do therefore not allow 
steroid flux to drive precursor production when steroid hormone levels are increased. The 
hydroxylation reactions catalyzed by the P450 enzymes are thus irreversible, however, some 
HSD catalyzed reactions are essentially reversible in an in vitro environment (Miller and 
Auchus, 2011).  
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Fig. 3.3: Expression patterns of steroidogenic enzymes in the adrenal gland. Reproduced from  
Turcu and Auchus, 2016. 
 
Adrenal P450 enzymes catalyze the biosynthesis of the steroid hormones in the 
mineralocorticoid, glucocorticoid and androgen pathways (Fig 3.4). These steroids are all 
derived from the precursor steroid, cholesterol, with CYP11A1 catalyzing its conversion to 
PREG. In the mineralocorticoid pathway, limited to the zona glomerulosa of the adrenal cortex, 
PREG is converted by 3β-hydroxysteroid dehydrogenase type 2 (3β-HSD2) to PROG and 
subsequently to deoxycorticosterone (DOC) by CYP21A2. DOC is converted to ALDO via 
CORT and 18-hydroxycorticosterone (18OH-CORT) by CYP11B2. In the glucocorticoid 
pathway, 17OH-PREG, a product of the CYP17A1 conversion of PREG, is converted to 
cortisol via 17 hydroxy-PROG (17OH-PROG) and deoxycortisol, catalyzed by 3β-HSD2, 
CYP21A2 and P450 11β-hydroxylase (CYP11B1) respectively. In the androgen pathway, 
dehydroepiandrosterone (DHEA), the product of 17OH-PREG, is converted to 
androstenedione (A4) by 3β-HSD2 (Miller and Auchus, 2011; Payne and Hales, 2004). We 
recently showed that A4 is also a substrate for CYP11B1 which catalyzes the formation of 11-
hydroxyandrostenedione (11OHA4) from A4 (Swart et al., 2013).  
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Fig. 3.4: Human adrenal steroid biosynthesis. The metabolism of cholesterol by the major 
steroidogenic enzymes yielding ALDO, cortisol and 11OH-A4 in the mineralocorticoid- 
glucocorticoid- and androgen pathways, respectively. 
 
 Neurosteroid biosynthesis in the brain 
In addition to steroids produced in endocrine tissues, several PREG and DOC metabolites are 
biosynthesized in the brain (Paul and Purdy, 1992). These steroid metabolites, termed 
neurosteroids, elicit diverse effects pertaining to stress, mood, behavioral changes, sedation 
and anxiety (Zorumski et al., 2013). It was originally assumed that the steroids eliciting the 
aforementioned effects were produced in the adrenal (or other endocrine tissues) and that no 
steroid biosynthesis occurred in the brain. However, CYP11A1, CYP17A1, 3β-HSD2, 
CYP21A2, 11β-HSD, GR and MR mRNA have been detected in the human amygdala, 
cerebellum, spinal cord and hippocampus. In contrast, CYP11B1 mRNA was not detected in 
the cerebellum or hippocampus, and it has been suggested that glucocorticoid related effects 
were dependent on circulatory glucocorticoids (Yu et al., 2002). Although studies have shown 
that ALDO is produced in the brain, these studies showed that corticosteroid production in the 
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brain is very low and thus may not contribute significantly to circulating corticosteroids levels. 
Therefore, the effects elicited by the corticosteroids in the brain are dependent on corticosteroid 
production in other endocrine tissues with the majority of corticosteroids produced in the 
adrenal (glucocorticoids and mineralocorticoids (Gomez-Sanchez et al., 2005). 
As is the case in adrenal steroidogenesis, cholesterol is the precursor for steroid biosynthesis 
in the brain. After being transported into the inner mitochondrial membrane by StAR, 
cholesterol is converted to PREG by CYP11A1. PREG is subsequently converted to PROG by 
3β-HSD2, where after PROG and DOC, produced from PROG by CYP21A2, are reduced to 
their 5α-metabolites by 5α-reductase (Fig. 3.5). The 5α-reduced products, 5α-
dihydroprogesterone (5α-DHPROG) and 5α-dihydrodeoxycorticosterone (5α-DHDOC), are 
converted to the neuroactive steroids viz. 3α,5α-tetrahydroprogesterone (3α,5α-THPROG) and 
3α,5α-tetrahydrodeoxycorticosterone (3α,5α-THDOC), by 3α-hydroxysteroid oxidoreductase 
(Rupprecht and Holsboer, 1999). These steroids elicit effects via GABAA receptors by acting 
as GABA agonists in neurotransmission (Weng and Chung, 2016). PREG is also converted to 
DHEA via the typical adrenal steroidogenic reactions (Fig.3.4) and their sulfonated conjugates, 
PREG sulfate (PREGS) and DHEA sulfate (DHEAS), produced by Sulfotransferase (SULT) 
2A1, elicit antagonistic effects towards the GABAA receptor (Rupprecht, 2003). Downstream 
sex hormones, such as testosterone and estradiol, have also been shown to modulate GABAA 
receptor activity with increased testosterone levels associated with adverse behavioral changes 
such as violence (Miczek et al., 2003).  
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Fig. 3.5: Biosynthesis and metabolism of neuro-active steroids. The dotted lines represent 
intermediates not shown. 5α-DHDOC, dihydrodeoxycorticosterone; 5α-DHP, 
dihydroprogesterone; 3α,5α-THDOC, tetrahydrodeoxycortico-sterone; 3α,5α-THP, 
tetrahydroprogesterone. Reproduced from Rupprecht and Holsboer, 1999. 
 
Overview of cytochrome P450 enzymes 
P450 enzymes were named after the ability of these enzymes, in their reduced states, to absorb 
light at 450 nm. These membrane bound enzymes are oxidative enzymes which contain ± 500 
amino acids and a heme group with conserved genetic sequences in all 57 CYP genes identified 
in the human body (Lander et al., 2001). Six P450 enzymes are involved in adrenal 
steroidogenesis, however, only the enzymes depicted in Fig 3.4 will be discussed as these 
enzymes are relevant to this study. CYP11A1, CYP11B1 and CYP11B2 are associated with 
the mitochondrial membrane (Type 1 enzymes), whereas CYP17A1 and CYP21A2 are 
associated with the ER  (Type II) (Miller, 2005). In addition to the adrenal P450 enzymes, 3β-
HSD2 and SULT2A1 together with low levels of 11β-HSD and 17β-HSD3 and 17β-HSD5, are 
also expressed in the adrenal gland and are involved in adrenal steroidogenesis.  
Active site structure and substrate binding 
The P450 enzyme family share approximately 20% sequence identity and a similar general 
protein fold (Hasemann et al., 1995). The enzyme’s structural core consists of four helices — 
three of which are arranged in parallel (helices D, L and I) and the other, antiparallel (helix E). 
The heme, bound in the Cys-heme-ligand loop, is located between helices I and L. The Cys-
heme-ligand loop contains the conserved P450 amino acid sequence (FxxGx(H/R)xCxG) of 
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which Cys is conserved throughout P450 enzymes. The Cys residue is responsible for the 
characteristic Soret peak observed at 450 nm when the reduced enzyme is bound to carbon 
monoxide (Omura and Sato, 1964). Cys characteristically binds to backbone amides through 
hydrogen bonding, while the I helix, containing the (A/G)Gx(E/D)T amino acid sequence in 
the middle of the helix, constitutes the wall of the heme pocket. The Thr residue, which is 
highly conserved, is nestled in the active site and it has been suggested that it is involved in the 
catalytic activity of the enzyme (Imai et al., 1989). In spite of the highly conserved protein fold 
of the P450 enzymes, enough diversity exists to allow for the binding of structurally diverse 
substrates. Although this is not the case for adrenal P450 enzymes that are highly specific 
towards their substrates, CYP3A4 for example can metabolize xenobiotics and commercial 
drugs displaying diverse substrate binding abilities. In addition, it has also been shown that 
P450 enzymes may bind to more than one substrate at a time (Korzekwa et al., 1998). 
Substrate binding to P450 enzymes is facilitated by six substrate recognition sites (SRS), as 
depicted in Fig. 3.6. The SRSs are SRS1 within the B-helix, SRS2 and SRS3, which comprise 
parts of the F and G helices, SRS4 in the I helix, SRS5 which constitutes the β4 hairpin and 
SRS6 comprised of the connecting region of the K helix. All of these SRSs line the inside of 
the P450 active pocket, influencing substrate specificity while retaining flexibility within the 
regions to accommodate an induced-fit binding mechanism. The latter mechanism favours 
substrate binding and results in catalytic activity of the enzyme towards the substrate. Point 
mutations within the SRS have been shown to affect substrate binding significantly, potentially 
resulting in endocrine disorders (Gotoh, 1992; Pylypenko and Schlichting, 2004). 
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Fig. 3.6: Ribbon representation of the conserved P450 fold depicting SRSs and helices labeled 
as discussed in the text. Reproduced from Denisov et al., 2005. 
Catalytic cycle 
The catalytic cycle, common to all P450 enzymes, comprises the two-electron reduction and 
the formation of oxygenated intermediates (Estabrook et al., 1971) and is depicted in Fig. 3.7. 
After substrate binding (reaction 1, Fig. 3.7), the redox potential of the heme is increased (-300 
mV to -170 mV) as a result of a conformational change being induced in the enzyme. Electrons 
are transferred from the reduced enzyme-substrate complex after substrate binding, resulting 
in the increased affinity of the enzyme for oxygen as the free enzyme has very low affinity for 
oxygen. One oxygen molecule subsequently reduces the heme at the 6th axial position, causing 
the bound electron to be transferred to the bound oxygen molecule. The resulting oxygenated 
P450 enzyme-complex is highly unstable and requires the transfer of the second electron by 
the electron carrier. At this step, some microsomal P450 enzymes may acquire the electron 
from cytochrome b5, although this reaction is species specific. The heme-bound oxygen 
subsequently reacts with the protons which result in the release of H2O from the active site, 
and an activated oxygen molecule which reacts with the substrate in the substrate-enzyme 
complex where after the product is released. The overall reaction is represented by equation 
4.1 (Coon, 2005; Denisov et al., 2005; Werck-reichhart and Feyereisen, 2000).  
RH + O2 + NADPH + H
+ → ROH + H2O + NADP+  Equation 4.1 
Studies in liver microsomes showed that molecules more hydrophobic in nature are more likely 
to bind to the active site of the P450 enzymes and the affinity of the P450 enzymes for a 
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particular substrate increases with a decrease in hydrophilicity. This phenomenon could be 
attributed to the hydrophobic nature of the enzyme active pocket due to the hydrophobic amino 
acid residues located in the pocket. The conformational changes induced by substrate binding 
ensures appropriate substrate alignment to the activated oxygen molecule. The conformational 
changes induced by the binding of the substrate and the hydrophobicity of the active pocket 
relate to the stereospecificity of P450 enzymes (Xu et al., 2010). 
 
Fig. 3.7: Catalytic cycle of P450 enzymes. RH represents the steroid substrate (or drug in the 
case of hepatic P450 enzymes) and ROH represents the steroid product formed. Reproduced 
from Coon, 2005. 
 
Electron transfer 
The transfer of electrons is of critical importance in the catalytic cycle of P450 enzymes as 
described above. There are however two mechanisms though which electron transport occurs, 
depending on the location of the enzyme. Fig. 3.8A shows the electron transport from electron 
carriers to the mitochondrial P450 enzymes — CYP11A1, CYP11B1 and CYP11B2. In 
mitochondria the flavin redox cofactor, flavin adenine dinucleotide (FAD), of ferrodoxin 
reductase (FeRed), also known as adrenodoxin reductase, is bound to the inner membrane 
where it gains two electrons from NADPH, reducing it to NADP+. The iron-sulphur cluster of 
ferrodoxin (Fedx), also known as adrenodoxin, accepts the electrons and subsequently transfers 
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the electrons to the P450 heme. The transfer of the electrons is guided by the negatively and 
positively charged residues present in Fedx (-) and FeRed (+) and the P450 (+) enzymes. In the 
case of CYP11A1, three electron pairs are required for the conversion of cholesterol to PREG 
(Miller and Auchus, 2011; Papadopoulos and Miller, 2012). 
 
Fig. 3.8: Electron transfers mechanisms employed by A) mitochondrial and B) microsomal 
P450 enzymes. Reproduced from Miller and Auchus, 2011. 
The electron transfer system utilized by microsomal P450 enzymes is depicted in Fig. 3.8B. 
P450 oxidoreductase (POR), bound to the ER, accepts the electron pair from NADPH which 
is transferred to the FAD moiety of POR. The conformational change induced by the electron 
gain rearranges the FAD and flavin mononucleotide (FMN) moieties so that their isoalloxazine 
ring structures are in close proximity, allowing the transfer of the electron from FAD to FMN. 
The 2nd electron transfer induces another conformational change, returning the protein to its 
original conformation while the FMN moiety of POR reacts with the appropriate binding site 
of the P450 enzyme, mediating catalysis through interaction with the P450 heme. The 
interaction between the FMN moiety of POR and the redox-binding site of P450 is mediated 
by the negatively charged residues on the FMN moiety and the positively charged residues in 
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the P450 binding site — an interaction similar to the one observed between Fedx and the 
mitochondrial P450 enzymes. The steroid substrate is bound to the enzyme on the side of the 
heme ring located opposite to the FMN moiety. This interaction is modified in human 
CYP17A1 as the binding of the steroid in the active pocket of the enzyme is facilitated by the 
allosteric influence of cytochrome b5 (Lee-Robichaud et al., 1995; Miller and Auchus, 2011). 
Spectral properties 
P450 enzymes were discovered when an unusual absorption spectrum at 450 nm was observed 
when assaying the redox kinetics of cytochrome b5 in liver microsomes. Absorption was 
observed at 450 nm after carbon monoxide saturation of the sample and as carbon monoxide 
saturation does not affect α and β bands of cytochrome b5, investigators could not attribute the 
phenomenon to the presence of cytochrome b5. The results suggested that the pigment contained 
a heavy metal ion due to saturation by carbon monoxide, however, it did not resemble any of 
the known hemo or metalloproteins (Garfinkel, 1958; Klingenberg, 1958). 
Researchers speculated that this new pigment was a cytochrome b5 isoform and named it P450 
(Omura and Sato, 1964). When reduced with ethyl isocyanide, the pigment displayed a 
difference spectrum characteristic of a hemoprotein showing intense bands in the Soret region. 
Results also showed that the treatment of microsomes with detergents did not obliterate the 
pigment and allowed it to bind to carbon monoxide and remain spectrally independent in its 
reduced form. After solubilization, the pigment displayed a distinctly different spectrum after 
carbon monoxide saturation displaying a peak at 420 nm, subsequently referred to as the P420 
and confirmed the hemoprotein nature of the pigment. 
The spectral data was used to calculate an extinction coefficient (91 cm-1mM-1) for the carbon 
monoxide reduced-difference spectrum of the pigment (420 – 490 nm) (Omura and Sato, 1964), 
which was used to determine the concentration of P450 enzymes present in microsomes. The 
method has since been used to determine the P450 enzyme content of many other tissues and 
was also applied in the current study.  
As previously discussed, the binding of substrate to a P450 enzyme induces a conformational 
change associated with a change in spin state. The enzyme-substrate complex displays an 
absorbance maximum at 391 nm when in the high spin state and while the absorbance 
maximum of reduced enzyme-substrate complex shifts to 408 nm, the reaction with molecular 
oxygen shifts the absorbance maxima to 418 nm. The observed shifts in maximum absorbance 
and the resulting spectra are a result of the energy level of the heme locus which may be 
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affected by the environment of the heme-locus and the hydrophilicity of the heme-ligand, as 
well as the bound substrate or inhibitor (Kominami and Takemori, 1982). The binding of 
substrates to P450 enzymes results in difference spectra — Type I, II (Fig 3.9) and reverse 
Type I were identified depending on the occupation of the P450 enzyme active site. 
 
 
Fig. 3.9: Type I and II difference spectra obtained after the binding of a substrate or inhibitor 
to P450 enzymes visualized under UV light. Reproduced from Omura et al., 1993.  
Type I difference spectra typically represents the interaction between the enzyme and its 
substrate, displaying a maximum and a minimum peak at 390 and 420 nm, respectively. The 
Type I substrate characteristically shifts the heme spin state equilibrium from a low to a high 
spin state resulting in the displacement of a water molecule and an iron shift to the thiolate 
ligand from the planar porphyrin. The majority of P450 substrates are classified as Type I 
substrates and spectral analyses is utilized to determine the amount of bound vs unbound 
enzyme, i.e. the amount of high spin vs low spin enzyme (Kumaki et al., 1978; Omura et al., 
1993). 
Type II difference spectra absorb maximally in the range of 425-435 nm and minimally 
between 390-405 nm. These spectra are usually observed in the presence of inhibitors of P450 
enzymes and can be induced in the presence of nitrogen-rich, sulphur or oxygen containing 
compounds, as well as compounds with unbound electrons (Kumaki et al., 1978; Omura and 
Sato, 1964). 
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Reverse Type I spectra are characteristically induced by compounds that bind to sites other 
than the active site of the P450 enzymes, absorbing maximally in the range of 409-445 nm and 
minimally between 365-410 nm. These spectra are usually induced by lipophilic compounds 
that cause the displacement of the water molecule after substrate binding has occurred. Studies 
have shown that the majority of compounds which elicit a reverse type I spectrum display 
competitive inhibition characteristics and follow typical Michealis-Menton saturation kinetics, 
however some isoforms have been shown to display non-hyperbolic kinetics (Hlavica and 
Lewis, 2001).  
Adrenal steroidogenic enzymes 
Adrenal steroidogenesis, with particular focus on corticosteroid production, typically involves 
five P450 enzymes and 3β-HSD2. Although 11β-HSD1 and 11β-HSD2 are typically expressed 
in peripheral tissue with only low levels detected in the adrenal gland, these enzymes play a 
critical role at the target sites of glucocorticoids and mineralocorticoids and will be discussed 
in this section. Additionally, SULT2A1 will be discussed as it is expressed in the adrenal and 
in the adrenal cell model that was utilized in this study. 
CYP11A1 
CYP11A1, a single, 20 kb gene product, catalyzes the conversion of cholesterol to PREG and 
isocaproaldehyde in the rate limiting step of steroidogenesis (Fig. 3.10). The conversion of 
cholesterol constitutes three sequential oxidation reactions, requiring a total of three oxygen 
and three NADPH molecules. The reaction is facilitated by the mitochondrial electron transfer 
system utilizing FeRed as previously described in this chapter. Cholesterol undergoes 
hydroxylation at C22 with the subsequent hydroxylation at C20 to produce 20,22R-
hydroxycholesterol. The latter steroid intermediate is cleaved between C20 and C22 to produce 
PREG and isocaproaldehyde, which is ultimately converted to isocaproic acid (Burstein and 
Gut, 1976; Teicher et al., 1978).  
CYP11A1 is expressed in all three zones of the adrenal cortex, as well as in other steroidogenic 
tissues such as the placenta, testis and ovary. In addition, studies have shown that CYP11A1 is 
expressed in skin, in the nervous system, peripheral and central, as well as cardiac tissues 
(human and rodent) (Pelletier et al., 2001). 
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Fig. 3.10: Reactions catalyzed by CYP11A1 in the mitochondrial membrane. Cholesterol is 
converted to PREG via three sequential oxidation reactions, each utilizing one molecule of 
NADPH and one molecule of oxygen. The six carbon side chain is cleaved during the final 
oxidation reaction yielding isocaproaldehyde and PREG. Reproduced from Payne and Hales, 
2004. 
 
CYP17A1 
CYP17A1, together with 3β-HSD2, represents a significant branch point within adrenal 
steroidogenesis, ultimately influencing the steroid flux in the glucocorticoid-, 
mineralocorticoid- and androgen pathways. CYP17A1 is associated with the ER while utilizing 
the microsomal electron transfer system for electron transport in which it catalyses the 
conversion of more than one substrate. CYP17A1 catalyzes the 17α-hydroxylation and lyase 
reaction of PREG, requiring one molecule of oxygen and one molecule of NADPH for each 
reaction (as shown in Fig.3.11) to form 17 hydroxy-PREG (17OH-PREG) which is 
subsequently cleaved at the C20-C17 bond to produce DHEA. CYP17A1 also catalyzes the 
17α-hydroxylation of PROG yielding 17OH-PROG, however, in humans the lyase reaction 
does not progress to A4.  The lyase activity is not present in all species and it has been found 
that for example, both human and bovine CYP17A1 lyase activity displays preference for 
17OH-PREG as substrate leading to the production of DHEA, whereas the rodent enzyme 
shows preference for 17OH-PROG leading to A4 production. This species specific variation in 
lyase activity has been attributed, in part, to human and bovine species requiring cytochrome 
b5 for the promotion of the lyase activity (Lee-Robichaud et al., 1995) and has been associated 
with post-translational modifications of the enzymes (Miller and Tee, 2014). Rat CYP17A1, 
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not expressed in the adrenal cortex (Pelletier et al., 2001), also requires cytochrome b5 for its 
lyase activity, but the fold change induced is less than that observed in bovine and human 
species. The lyase activity of CYP17A1 is regulated by the availability of electrons for this 
reaction and is thus regulated by cytochrome b5, high concentrations of POR and serine 
phosphorylation of the enzyme (Suzuki et al., 2000). 
Human CYP17A1 also converts PROG to 16 hydroxy-PROG (16OH-PROG), usually in a 
17OH-PROG:16OH-PROG ratio of 3:1, while this was not observed for baboon CYP17A1 
(Swart et al., 2002). The ability of CYP17A1 to produce 16OH-PROG from PROG has been 
attributed to the presence of an alanine residue at position 105 in the human protein, rather than 
the leucine residue present in other species. 16OH-PROG is not metabolized further in the 
adrenal and significant concentrations have been detected in plasma and urine samples. The 
function of this steroid intermediate has been linked to antagonistic effects, competing with 
PROG, testosterone and β-estradiol at their target tissues and it has been found to act as an 
agonist of the human PROG receptor (PR) (Storbeck et al., 2011). 
 
Fig. 3.11: CYP17A1 catalyzes the conversion of PREG to DHEA and PROG to 17OHPROG 
through two mixed function oxidase reactions. One molecule of oxygen and one molecule of 
NADPH is utilized for each of the hydroxylation and cleavage reactions while electrons are 
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supplied by the microsomal electron transfer system. Reproduced and adapted from Payne and 
Hales, 2004.  
 
3β-HSD2 
The HSDs catalyze the reduction and oxidation reactions of steroid hormones and require 
NADH or NADPH as donors and NAD+/NADP+ as electron acceptors of reducing equivalents. 
HSDs differ from P450 enzymes with regard to the fact that HSDs are often represented by 
multiple isoforms, whereas P450 enzymes are transcribed from one distinct gene. 
3β-HSD/isomerases are bound to the membranes of mitochondria and ER, depending on the 
cell type in which they are expressed (Pelletier et al., 2001). Multiple isoforms of this enzyme 
exists in various species, with the highest number of isoforms identified in mice (Payne et al., 
1997). In humans, two distinct isoforms have been identified — 3β-HSD1 and 3β-HSD2, both 
of which have dehydrogenase/isomerase activity. The reactions catalyzed by 3β-HSD are 
critical for the production of steroid levels, together with CYP17A1, in the three steroidogenic 
pathways in the adrenal with the steroid flux also depending on the catalytic activity of 3β-
HSD (Goosen et al., 2010). 3β-HSD catalyzes the conversion of PREG to PROG, 17OH-PREG 
to 17OH-PROG and DHEA to A4 by sequential dehydrogenase and isomerase reactions (Fig 
3.12) (Thomas et al., 1995). The dehydrogenation reaction reduces NAD+ to NADH and results 
in the formation of a ∆5-3 keto-steroid intermediate which remains bound to the enzyme. 
NADH, also bound to the enzyme, induces the isomerization of the intermediate through 
conformational changes and produces the ∆4-steroids (Thomas et al., 1995). Although 
cytochrome b5 has not been shown to bind to 3β-HSD directly, studies have shown that 
cytochrome b5 augments 3β-HSD’s activity allosterically by increasing the affinity of the 
enzyme towards NAD+ (Goosen et al., 2013). In addition, human and murine 3β-HSD has been 
shown to convert A4 to dihydrotestosterone while reducing NAD+. NADP+ has not been 
associated with the latter reaction catalyzed by 3β-HSD (Clarke et al., 1993). 
Although 3β-HSD2 is considered to be one of the major branch point enzymes in 
steroidogenesis, associated with the regulation of cortisol production, recent evidence suggests 
that another isoform, 3β-HSD1, plays a major role in ALDO production. However, 3β-HSD1 
is expressed at much lower levels that 3β-HSD2 (Konosu-Fukaya et al., 2014). 
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Fig. 3.12: 3β-HSD catalyzes sequential dehydrogenization and isomerization reactions 
converting   PREG to PROG and DHEA to A4. Reproduced from Payne and Hales, 2004. 
 
SULT2A1 
Steroid sulfates are derived either directly from cholesterol or through the sulfonation of 
steroids (Strott, 2002). The latter reaction is catalyzed by the SULT enzymes and although 
there are approximately 44 isoforms of this enzyme, only SULT2A1 will be discussed for the 
purposes of this study. 
SULT2A1, the major SULT in the adrenal gland, sulfonates PREG, 17OH-PREG, DHEA and 
A4, but not cholesterol directly. The reaction catalyzed by the SULT enzymes utilizes 3’-
phosphoadenosine-5’-phosphosulfate (PAPS), which is synthesized from ATP, as sulfate 
donor. PAPS is synthesized from the conversion of ATP and sulfate to adenosine 
phosphosulfate (APS) by ATP sulfurylase, which is subsequently converted from APS to PAPS 
by APS kinase using the phosphate from another ATP molecule (Strott, 2002). In humans, the 
latter two reactions are catalyzed by one enzyme either ubiquitously expressed, PAP synthase 
type 1 (PASS1), or expressed in the major sites of DHEA sulfonation, PAP synthase type 2 
(PASS2), which is in the liver and adrenal glands. Inhibition of DHEA sulfonation by PAPSS2 
leads to an increase in free DHEA which can be converted to adrenal androgens. The 
perturbation of the DHEA:DHEAS ratio has been shown to correlate with an increased risk of 
cancers, especially prostate cancer (Nowell and Falany, 2006). 
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CYP21A2 
CYP21A2 is expressed in all three zones of the adrenal cortex (Parker et al., 1985) and is 
essential for the production of cortisol, the major glucocorticoid, and ALDO, the major 
mineralocorticoid. The enzyme catalyzes the conversion of PROG to DOC and 17OH-PROG 
to deoxycortisol. As CYP21A2 is located in the ER, it employs the microsomal electron 
transfer system requiring one molecule of oxygen and NADPH (Fig 3.13).  
In the zona glomerulosa, PROG serves as the substrate for CYP21A2. As CYP17A1 is not 
expressed in this zone, only DOC is produced as no 17OH-PROG is produced for conversion 
to deoxycortisol and ultimately ALDO production takes preference in this zone (Rice et al., 
1990).  
 
Fig. 3.13: CYP21A2 catalyzes the conversion of PROG to DOC and 17OH-PROG to 
deoxycortisol by C21 hydroxylation which requires one molecule of oxygen and one molecule 
of NADPH. Reproduced fom Payne and Hales, 2004. 
 
CYP11B1 and CYP11B2 
CYP11B1 and CYP11B2 are positioned in the inner membrane of the mitochondria and 
catalyze the final reactions in glucocorticoid and mineralocorticoid production. CYP11B1 
converts deoxycortisol and DOC to cortisol and CORT, respectively, through an 11β-
hydroxylation reaction (Fig 3.14), whereas CYP11B2 converts DOC to ALDO through three 
sequential reactions involving CORT and 18OH-CORT as intermediates (Fig 3.15). It has been 
suggested that the conversion of DOC to ALDO by CYP11B2 occurs without the release of 
Stellenbosch University  https://scholar.sun.ac.za
  
48 
 
the intermediates, much like the conversion of cholesterol to PREG by CYP11A1 (Kawamoto 
et al., 1992). However, these intermediates can be detected in adrenal cell models such as 
H295R cells (Schloms et al., 2012). Furthermore, CORT is not utilized by CYP11B2 in the 
production of ALDO confirming that ALDO is produced though the conversion of DOC and 
the reaction is catalyzed by CYP11B2 only (Kawamoto et al., 1992). Three CYP11B isoforms 
are expressed in the rat adrenal with the B1 and 2 isoform catalyzing reactions as described 
above (with the exception of cortisol production due to the lack of CYP17A1 expression) and 
B3 producing 18OH-CORT from DOC, but lacking the 18-oxidase activity (Mellon et al., 
1995). 
 
Fig. 3.14: CYP11B1 catalyzes the conversion of DOC to CORT and deoxycortisol to cortisol 
by 11β-hydroxylation, which requires one molecule of oxygen and one molecule of NADPH. 
Reproduced from Payne and Hales, 2004. 
 
CYP11B1 and CYP11B2 are closely linked and found on the same human chromosome 
approximately 40 kb apart (Lifton et al., 1992). CYP11B1 and CYP11B2 are expressed only 
in the adrenal cortex with CYP11B1 expressed in the zona fasciculate and reticularis (Curnow 
et al., 1991). CYP11B2, although expressed to a much lesser extent than CYP11B1, is 
expressed exclusively in the mitochondria of the zona glomerulosa (Domalik et al., 1991).  
Recent investigations have provided evidence for the involvement of CYP11B1 in the 
conversion of A4 to 11OHA4, while CYP11B2 showed no effect on 11OHA4 production. In 
addition, testosterone was significantly hydroxylated by CYP11B1 and CYP11B2, however 
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the production of 11β-hydroxytestosterone (11OHT) was not as efficient as the production of 
11OHA4 by CYP11B1 (Swart et al., 2013). 
 
Fig. 3.15: CYP11B2 catalyzes the conversion of DOC to ALDO via three sequential reactions 
utilizing one molecule of oxygen and one molecule of NADPH per reaction. Reproduced from 
Payne and Hales, 2004. 
 
11β-HSD1 and 11β-HSD2 
11β-HSD enzymes are commonly co-expressed with the MR in glucocorticoid responsive 
tissues, such as the kidney, since these enzymes catalyze the interconversion of cortisol and 
cortisone, eliciting an MR-protecting function, as well as CORT and dehydrocorticosterone 
(11-DHC) (Fig. 3.16). Studies have shown that the MR has equal affinities for cortisol and 
ALDO (Arriza et al., 1987) and as plasma cortisol concentrations are generally 100 to 1000-
fold greater than that of ALDO, cortisol is converted to its inactive form, cortisone, by 11β-
HSD2 (Funder, 2005; Funder et al., 1988). The ability of 11β-HSD1 to either catalyze the 
oxidation of cortisol to cortisone or vice versa depends on the cofactors available for the 
reaction (Stewart et al., 1988). Both 11β-HSD isoforms are membrane bound, hydrophobic 
enzymes that bind to either cortisol/cortisone or CORT/11-DHC, however the functions of 
these enzymes differ (Stewart et al., 1988).  
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Fig. 3.16: 11β-HSD1 and 11β-HSD2 catalyze the interconversion of cortisol and cortisone. 
Reproduced from Hu et al., 2013. 
 
In the presence of NADP+, cortisol is oxidized to cortisone and in the presence of NADPH 
cortisone is reduced to cortisol by 11β-HSD1. However, the oxoreductase activity of 11β-
HSD1 requires relatively high ratios of NADPH:NADP. These high ratios are maintained 
through the regeneration of NADPH from NADP during the conversion of glucose-6-
phosphate to 6-phospho-gluconolactone which is catalyzed by hexose-6-phosphate 
dehydrogenase (Cooper and Stewart, 2009). The reduction of cortisone is, however, the 
dominant reaction in cells transfected with recombinant 11β-HSD1. Furthermore, the enzyme 
can only catalyze the reactions in the presence of relatively high concentrations of steroid 
(Moore et al., 1993). Synthetic glucocorticoids that are commonly used in in vivo experiments, 
such as prednisolone (an 11-ketosteroid), often lack biological activity, which can be induced 
by reducing these steroids to their 11β-hydroxylated states. This transformation is often 
catalyzed by 11β-HSD1 in the liver (Agarwal et al., 1990).  
Although 11β-HSD1 and 11β-HSD2 do not display a high percentage of sequence identity, 
they perform physiologically related functions but catalyze opposing reactions. 11β-HSD2 is 
unidirectional and catalyzes the conversion of cortisol to cortisone through oxidation, utilizing 
NAD+ and is expressed in mineralocorticoid target tissues to inactivate glucocorticoids and 
ensure that only mineralocorticoids elicit effects in these tissues (Oakley and Cidlowski, 2013; 
Rusvai and Naray-Fejes-Toths, 1993).  
Corticosteroid transport 
Once produced in the adrenal, the hormones are secreted into the bloodstream and transported 
to target tissues. Steroids are generally transported by three protein carriers — albumin, 
corticosteroid-binding globulin (CBG) and sex hormone binding globulin (SHBG) (Hammond, 
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2016). The interaction between these transporters and the steroid hormones controls the free 
(active) vs bound (inactive) ratio of steroids in circulation and thus controls the capacity of the 
steroids to access their intended sites (Siiteri et al., 1982). It has generally been assumed that 
unbound steroids are the active steroids which would elicit downstream responses in target 
tissue with most disease states linked to steroid imbalances being diagnosed based on 
circulatory steroid levels (Mendel, 1989). However, this view may be naïve and an 
oversimplification as the ability of steroids to reach their site of action depends on 
compartmentalization, vascular permeability, extravascular fluid and extracellular matrix 
constituents, and the position of the target cells within the target tissues (Hammond, 2016).  
Albumin is typically a low affinity, low specificity and high abundance carrier, whereas CBG 
and SHBG constitute high affinity, high specificity and low abundance plasma protein carriers. 
Albumin binds to the majority of steroids and although its affinity for the steroid substrate is 
relatively low (µM range), it is present in relatively high concentrations in plasma, 
approximately 1000-fold higher than CBG or SHBG, allowing it to buffer free versus bound 
steroid concentration effectively (Dunn et al., 1981). ALDO is mainly transported by albumin 
in the bloodstream, whereas DOC, which elicits mineralocorticoid-like effects, is transported 
by CBG. 
CBG, from the serine proteinase inhibitor family, binds to free plasma glucocorticoids and 
PROG, which are cleaved from CBG by specific proteases at the site of delivery. CBG is 
synthesized in the liver, however, studies have shown that extra-hepatic biosynthesis may occur 
in the kidneys of immature rodents. Mice pups displaying CBG inefficiencies, do however not 
show any abnormal renal development (Scrocchi et al., 1993). Similarly, humans presenting 
with CBG inefficiencies may present as hypotensive patients, however no associations have 
been made with renal disease in these cases (Emptoz-Bonneton et al., 2000). 
Initial studies suggested that the steroid binding sites of CBG were located in the core of the 
protein, however, it has been confirmed that these sites are located on the surface of the protein 
(Bolton et al., 2014; Gardill et al., 2012), showing that the steroids react with specific amino 
acid residues within the steroid-binding site (Lin et al., 2010). The studies showed the 
mechanism through which CBG bound steroids with high affinity, and that proteolysis of the 
reactive center loop (RCL) resulted in the irreversible loss of binding. Furthermore, it was 
shown that natural mutations within the essential residues of the binding site resulted in the 
loss of the binding affinity of CBG for glucocorticoids (Lin et al., 2010). Variants of CBG with 
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differing cortisol binding abilities complicate the calculation of free cortisol, which is often 
used as a biomarker in diseased states (Bae, 2015; Henley et al., 2016). 
Acute inflammation results in a rapid decrease in plasma CBG, associated with the proteolysis 
of the RCL, resulting in an increase in circulating albumin-bound and free cortisol levels. In 
addition, increased adrenal glucocorticoid output, as a result of adrenal stimulation by ACTH, 
may also exacerbate the reduced steroid binding capacity of CBG, further leading to increased 
free cortisol levels. Increased glucocorticoid and interleukin-6 (IL-6) production during 
inflammation also contributes to the down-regulation of CBG production in the liver and in so 
doing maintains low CBG plasma levels. In the recovery phase after the inflammatory 
response, the CBG levels are returned to normal (Smith and Hammond, 1992).  
Glucocorticoid and mineralocorticoid receptors 
Steroid receptors exert differential control of gene expression influencing development, 
reproduction and homeostatis in eukaryotes. Steroid receptors, also known as class I nuclear 
receptors, include the PROG receptor (PR), estrogen receptor (ER), androgen receptor (AR), 
GR and MR (Mangelsdorf et al., 1995). After biosynthesis and transport, corticosteroids elicit 
their biological effects through interactions with the GR and MR in target tissue. In this section, 
we discuss the structural domains of steroid receptors and the mechanism of action of the GR 
and MR. 
Structural domains of steroid receptors 
Steroid receptors are similar in structural organization as is shown in Fig 3.17 and early 
investigations using partially purified nuclear receptor proteins showed two distinct subunits 
— a ligand-binding domain (LBD) located at the C-terminal of the protein and a DNA-binding 
domain (DBD) located towards the center of the receptor (Birnbaumers et al., 1983). The LBD 
is moderately conserved and, as the name suggests, contains a highly specific interior binding 
site for its ligand as well as a transcriptional activation function (AF-2) which is regulated by 
the ligand. AF-2 is involved in the recruitment of co-activating proteins, which in turn, 
influence the general transcriptional activation components and is involved in activating 
chromatin-remodeling proteins (Xu and Li, 2003). The LBD is also involved in self-assembly 
reactions, such as dimerization and tetramerization, which are essential for DNA-response 
element binding (Kumar and Chambon, 1988).  
The DBD anchors the receptor to elements within the receptor-regulated promoters, while also 
transmitting information allosterically from other receptor domains. The LBD and DBD are 
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joined via the hinge region consisting of a short amino acid sequence. Although there is still 
some speculation regarding the functionalities of the hinge region, studies have shown that it 
increases transcriptional activation after undergoing phosphorylation (Lee et al., 2006). AF-1 
is located to the N-terminal side of the DBD and functions as a transcriptional activator in a 
ligand independent manner. AF-1 can, however, also synergize with AF-2 (Takimoto et al., 
2003). 
 
Fig. 3.17: Schematic representation of the structural organization of steroid receptors. AF, 
activation function; DBD, DNA-binding domain; H, hinge; LBD, ligand-binding domain. The 
components of the DBD is shown as an insert below the schematic of the receptor, illustrating 
the relative locations of the P-box, D-box, T-box, A-box, helix 1, helix 2, and the C-terminal 
extension (CTE). Reproduced from Bain et al., 2007.  
 
Crystallographic investigations have shown that the LBD consist of 12 α-helices that form three 
antiparallel helix sheets, described as the α-helical sandwich. The receptor’s ligand binding site 
is located in the inside of the structure and is lined by the helixes. The affinity and specificity 
of the LBD toward the ligand is determined by the hydrophobicity of the active pocket that is 
aligned to the shape of the ligand. In addition, several polar groups within the active pocket 
assist in binding and orientating the ligand (Bledsoe et al., 2002; Li et al., 2005). The AF-2 
region within the LBD is involved in steroid coactivator recruitment and is found in a 
hydrophobic groove on the LBD, consisting of numerous helices including helix 12.  
Agonist ligands are able to modulate the conformational mobility of the LBD and helix 12 and 
in so doing, regulate the interactions between the LBD and cofactors. The LBD has two 
possible conformations in the absence of an agonist: 1) helix 12 is positioned away from the 
core of the LBD resulting in an incomplete hydrophobic groove (Bourguet et al., 1995) or 2) a 
range of varying conformations within the domain with only a few in their active form (Johnson 
et al., 2000). Cofactor recruitment is induced after the binding of the ligand to the hydrophobic 
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groove and the stabilization of helix 12. The latter can occur through ligand-stabilized helices 
close to the binding site (Shiau et al., 1998), direct interaction between the ligand and helix 12 
(Bledsoe et al., 2002) or allosteric interactions between the coactivator-binding and ligand-
binding pockets (Nettles et al., 2004). Antagonists block cofactor binding by allowing helix 12 
to bind to the hydrophobic groove, mimicking cofactor binding and resulting in altered 
transcriptional activities (Shiau et al., 1998). Co-repressors may also alter transcriptional 
activities through sterically hindering helix 12 and preventing the formation of the hydrophobic 
groove (Xu et al., 2002). The presence of an antagonist ligand could further stabilize the 
binding of the co-repressor by creating a greater area for co-repressor binding.  
The GR DBD, one of the first receptor subunit structures to be elucidated, is still used as a 
representative model for steroid receptors. The globular DBD consists of two zinc-finger 
structures, each consisting of four cysteine residues and a zinc atom (Freedman et al., 1988). 
Further structural components of the DBD include helix 1 (N-terminal helix) and helix 2 (C-
terminal helix). These helices contribute to the overall stability of the DBD through interactions 
with the major groove. Binding of the GR to the DNA-binding via the DBD may induce 
dimerization (Rastinejad et al., 2013), and the dimer interface consists of residues that are found 
in the C-terminal zinc finger, called the D-box. The P-box, on the other hand, consists of 
residues that are paramount to sequence-specific DNA binding and is found in helix 1. 
Dimerization requires interactions between the DNA binding site and the P-box, which in turn 
induces conformational changes within the D-box and results in the recruitment of the second 
monomer (Baumann et al., 1993). 
The sequences located on the N-terminal side of the DBD are mostly unstructured and do not 
display strong folding associations. However, secondary and tertiary folding can be induced 
through the interaction of molecules such as DNA or proteins or through altering the conditions 
of the solution. The effect elicited by DNA on the N-terminal structures of steroid receptors 
confirms that promoter binding sites act as functional ligands by influencing the receptor 
allosterically (Lefstin and Yamamoto, 1998). 
Mechanisms of GR signalling  
The GR, like the steroid receptors discussed above, consists of 3 domains — the transactivation 
domain (N-terminal with AF-1), the DBD which binds to the glucocorticoid response elements 
(GREs) and the LBD (C-terminal) (Fig 3.18) (Kumar and Thompson, 2005). In addition to the 
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structures described above, two nuclear localization signals (NL1 and NL2) have been 
identified and are found within the LBD and in the DBD/hinge region. 
 
Fig. 3.18: Representation of the human GR domains. Potential sites for posttranslational 
modifications with amino acid residues that would be subject to modification are shown, as 
well as the AF-1 and 2 receptor domains and receptor regions involved in transactivation, 
dimerization, hsp90 binding and nuclear localization. Reproduced from Oakley and Cidlowski, 
2013. 
 
The GR is predominantly found in the cytoplasm in its unliganded form, where it is bound to 
chaperone proteins (mainly heat shock proteins) and immunophilins (Pratt and Toft, 1997). 
The association with these proteins is significant as the GR is maintained in a transcriptionally 
inactive form that favours ligand binding. After dissociating from CBG, free cortisol diffuses 
across the plasma membrane and, depending on the expression of 11β-HSD isoforms, is 
available for binding to the GR. After ligand binding, the GR undergoes a conformational 
change and the associated chaperone proteins dissociate from the GR-ligand complex. The 
conformational change exposes NL1 and NL2, which results in the GR-ligand complex 
translocating to the nucleus. The GR-ligand complex subsequently binds to the GRE in the 
nucleus and influences the expression of target genes (Beato, 1989) (Fig 3.19). The GRE, 
consisting of two 6-base pair half sites, is an imperfect palindrome (GGAACAnnnTGTTCT) 
and each half site is occupied by one homodimer GR subunit. The three nucleotides located 
between the two 6-base pair DNA binding sites, is essential for GR dimerization on the GRE. 
This GRE, often referred to as an activating or positive GRE, has always been associated with 
transactivation of gene transcription, although recent studies have shown that target gene 
transcription can also be repressed via a GRE (Uhlenhaut et al., 2013). The latter suggests that 
parameters outside of the GRE sequence could regulate whether a GRE is positive or negative 
(nGRE) (Surjit et al., 2011). The palindromic nGRE sequence CTCC(n)0-2GGAGA was found 
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to differ from that of the positive or classic GRE and does not result in the dimerization of two 
GR monomer subunits (Hudson et al., 2013). Although this motif was shown to elicit repressive 
effects and is abundant throughout the human genome, the extent to which this motif is utilized 
by the GR for repression requires further investigation. In addition, a recent study found that 
helix 8 is critical for ligand binding and receptor function (Deng et al., 2015). 
 
Fig. 3.19. GR signalling mechanisms. Glucocorticoids bind to the cytoplasmic GR which 
induces a conformational change in the GR, leading to its hyperphosphorylation (P) and 
subsequent dissociation from accessory proteins, - translocation into the nucleus. In the 
nucleus, GR-signalling occurs through simple, tethering and composite mechanisms, whereas 
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the non-genomic effects of glucocorticoids are mediated through cytoplasmic or membrane 
bound GR. Reproduced from Kadmiel and Cidlowski, 2013. 
 
Typically two mechanisms of GR signalling exist — non-genomic and genomic (which 
includes simple, tethering and composite mechanisms) (Fig 3.19). Simple GREs, as discussed 
above, consist of imperfect palindromes with two 6-base pair DNA binding sites which are 
separated by three nucleotides. Sixty percent of these DNA sequences within simple GREs are 
highly variable and thus determine the GR mediated transcriptional activity (Meijsing et al., 
2009).  Liganded GR binding to simple GREs is usually associated with transactivation, which 
involves the recruitment of coactivators (Lonard and O’Malley, 2007). Composite GREs, 
consisting of binding sites that accommodate the binding of the GR and other transcription 
factors, allow the GR to modulate gene transcription in a similar manner as above. The 
tethering mechanism, however, has been mostly associated with transrepression of gene 
transcription. The suppression of inflammatory gene transcription in diseases such as asthma 
or chronic obstructive pulmonary disease (COPD), relies on the tethering of the GR to 
transcription factors such as activator protein-1 (AP-1), NF-kB and signal transducer and 
activator of transcription 3 (STAT3) (Kassel and Herrlich, 2007).  
In addition to GR binding occurring in a tissue specific manner as a result of chromatin 
accessibility and sufficient accessibility of the GRE, evidence suggests that only a small 
percentage of GREs are occupied by the GR (John et al., 2011).  Although it is known that the 
tissue-specific effects of glucocorticoids are influenced by GR levels and the differential 
expression of cofactors (Oakley and Cidlowski, 2013), it has been  proposed that the tissue-
specific effects of glucocorticoids may be due to the type of GRE available for binding by the 
GR (Reddy et al., 2012). This may offer an explanation for the hypersensitivity of some tissues 
towards glucocorticoids and the difference in glucocorticoid concentrations required to elicit 
their effects.  
The non-genomic effects of glucocorticoids occur within minutes and may affect membrane 
fluidity, interactions with cytoplasmic and membrane proteins or lipids and neurotransmission 
(Haller et al., 2008). Although these effects can be mediated through glucocorticoids binding 
to cytoplasmic or membrane GRs, glucocorticoids may also exert non-genomic effects by 
binding directly to other receptors such as GABAA receptors (Strömberg et al., 2005).   
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Selective Glucocorticoid Receptor Agonists and Modulators (SEGRAMs) 
For many years the dimer-mediated transactivation of gene transcription by the GR was 
associated with the side effects associated with glucocorticoid treatments, whereas the 
monomer-mediated transrepression of gene transcription was associated with the beneficial 
side effect profile. In theory, this concept allowed for a distinction between the two 
transcriptional processes and a potential drug target for the treatment of glucocorticoid excess 
disorders that elicits an anti-inflammatory effect without the side effects (although not all pro-
inflammatory effects are deemed unfavourable and not all anti-inflammatory effects are 
deemed favourable). This concept led to the discovery of selective GR agonists (SEGRAs) or 
modulators (SEGRAMs), previously known as dissociated glucocorticoids, that could cause 
GR mediated transrepression of transcription, without transactivation of gene transcription. 
Compound A is a well-known example of a SEGRA, and is known to mediate transcriptional 
repression via the GR, but display no transactivation activity (de Bosscher et al., 2008, 2005). 
The study concluded that the effects of Compound A would be anti-inflammatory with no side 
effects. 
However, the recent discovery that transactivation via the GR can also lead to anti-
inflammatory effects through binding to a nGRE, together with the fact that GR activity may 
be selectively modulated by a ligand inducing a specific GR conformation (Vandevyver et al., 
2013), has led to the reassessment of the SEGRAM concept. The concepts of selective 
monomerizing GR agonists and modulators (SEMOGRAM), eliciting effects via GR 
monomers, and selective dimerizing glucocorticoid receptor  agonists or modulator 
(SEDIGRAMs), eliciting effect via GR dimers, was subsequently proposed (de Bosscher et al., 
2016). Thus, the current evidence in the literature suggests the pro- and anti-inflammatory 
effects elicited via the transcriptional activities of the GR may be due to different ratios of GR-
complex conformations, i.e. monomers versus dimers, rather than the classical transactivation 
versus transrepression approach (de Bosscher et al., 2016; Sundahl et al., 2015). 
Mechanisms of MR signalling  
The MR has been shown to bind to various steroids with high affinity, most notably to ALDO, 
DOC, CORT (in rodents), cortisol (in humans) and PROG (Sutanto and de Kloet, 1991). ALDO 
is considered to be the primary MR ligand (Bledsoe et al., 2005), although studies have shown 
that cortisol acts as the primary MR ligand (agonist) in some target tissues, while PROG is 
mostly associated with antagonistic effects (Fagart et al., 1998). 
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The MR is structurally similar to the GR and Fig. 3.20 shows the basic domains and activation 
factors involved in the regulation of gene transcription by mineralocorticoids via the MR. The 
LBD and N-terminal domains are of great importance with regard to regulation and the MR 
LBD has been found to be involved in binding of ligands, transport to the nucleus, interactions 
with heat shock proteins and transactivation of target gene expression through cofactors and 
ligand dependent mechanisms (Farman and Rafestin-Oblin, 2001; Pippal and Fuller, 2008). 
ALDO binds to a fully enclosed pocket of the LBD, which causes the repositioning of helix 12 
to form the hydrophobic cleft which allows for cofactor binding and subsequent activation of 
MR mediated gene transcription (Bledsoe et al., 2005). AF-2 comprises of not only helix 12, 
but requires other areas of the LBD to part take in the activation function. In the N-terminal 
domain, AF-1 plays a significant role in activating gene transcription. AF-1, other than AF-2,  
is not ligand dependent and has been localized to amino acid residues 328 – 382 (Fuse et al., 
2000). Studies have suggested that AF-1 comprises two distinct activation factors, although 
not all results are in agreement (Govindan and Warriar, 1998). 
 
Fig. 3.20:  Representations of structural domains of the human MR and cofactor interactions. 
Reproduced from Yang and Young, 2009. 
 
The unliganded MR is found in the cytoplasm and, similar to the GR, is maintained in an 
inactive form bound to chaperone proteins (Gomez-Sanchez et al., 2006,) which dissociate 
when the MR undergoes a conformational change due to ligand binding to the MR. The ligand 
bound MR, mono- or heterodimer,  translocates to the nucleus where it binds to a specific DNA 
target, called a mineralocorticoid response element (MRE), influencing the transcription of 
target genes (Hellal-Levy et al., 2000) (Fig. 3.21). Rapid, non-genomic effects have also been 
associated with MR signalling and the most renowned of these are the activation of protein 
kinase C, activation of Na+/H+ exchange and elevated intracellular calcium (Funder, 2005). 
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Fig. 3.21: Transactivation mechanism via the MR. The heat shock proteins dissociate from the 
liganded MR in the cytoplasm and nuclear translocation is induced. In the nucleus the MR-
ligand complex binds to the hormone response element (HRE) where after cofactors, such as 
SRC-1 and p300/CBP, are recruited to the MR to accommodate the acetylation of histones and 
for gene transcription to take place. Reproduced from Yang and Young, 2009. 
 
Gene transcription via the MR can be activated by cortisol and ALDO binding as the MR has 
equal affinity for these ligands (Arriza et al., 1987), however the differential activation of the 
MR by these ligands is associated with varying effects at different target sites. The differential 
activation via the MR may take place on three levels — pre-receptor, receptor and post-
receptor. The inactivation of cortisol by 11β-HSD2 represents the pre-receptor regulatory 
mechanism. As cortisone cannot bind to the MR, no activation of gene transcription via the 
MR would occur (Funder et al., 1988). It is thus unlikely that the MR mediated gene 
transcription will be activated by either cortisol or cortisone and will occur though the binding 
of ALDO to the MR. The pre-receptor intervention is only applicable in epithelial cells in the 
kidney, blood vessel walls, colon and sweat glands as 11β-HSD2 is expressed minimally in 
other tissues (Galigniana et al., 2004). At receptor level, the differential activity of the MR is 
linked to the conformational changes induced by the binding of either cortisol or ALDO. 
ALDO induces greater transcriptional activation than cortisol and dissociates at a much slower 
rate (at any cortisol concentration) (Li et al., 2005). Furthermore, the stabilization of ligand 
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binding to the MR through exchanges between the MR N-terminal and hinge region on the 
LBD are much greater in the presence of ALDO, suggesting further ligand specificity by the 
MR (Li et al., 2005).  
Post-receptor effects that contribute to MR ligand selectivity refers to the transcription of 
different MR isoforms that differ in their ligand specificity which may further contribute to 
MR ligand selectivity. Human MR transcription can be regulated by two promotors (P1 and 
P2) that result in the hMRα and hMRβ transcripts, respectively. These isoforms differ in their 
5’ untranslated regions and are expressed in different tissues. Transcription by P1 can be 
induced by the presence of glucocorticoids, however P2 is sensitive to induction by 
mineralocorticoids, which adds to MR specificity (Zennaro et al., 1997). 
Physiological effects of corticosteroids 
The physiological effects elicited by corticosteroids depend on many factors as described 
above. The main effect of these hormones is to maintain a homeostatic state in the body, 
however for the purposes of this study we will focus on the psychiatric and cognitive, 
immunomodulatory and cardiovascular effects. 
Psychiatric and cognitive effects 
Psychiatric side effects that are associated with corticosteroid treatment have been reported and 
appear to be dose dependent — the higher the dose, the greater the probability of developing 
psychiatric complications (Goldstein and Preskorn, 1989). These side effects have been 
observed in spite of the different methods of administration (Berthelot et al., 2013). Although 
it has been shown that women and young children are more prone to develop psychiatric related 
side effects when receiving corticosteroid treatment (George et al., 2004), a direct link between 
age and gender has not been established. Although an exact pattern of the onset of psychiatric 
side effects after the initiation of corticosteroid treatment has not been established, research 
suggest that it is most probable that side effects start within the first five days of treatment 
(Drozdowicz and Bostwick, 2014; Ling et al., 1981). 
The hydrophobic nature of corticosteroids allows them to permeate across the plasma 
membrane, as well as the blood brain barrier, and influence gene transcription by binding to 
the GR and/or MR. In addition to their endocrinological effects, corticosteroids affect the 
feeling of hunger, the processes of learning and memory, as well as the sleep-wake cycle. 
Behavioral disorders resulting from corticosteroid treatment includes restlessness, weight gain 
associated with increased appetite (70 % of cases) and insomnia (73 % of cases) (Da Silva et 
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al., 2006). Prolonged corticosteroid exposure has also been associated with a sense of well-
being labelled “steroid euphoria” as well as muscle stiffness and catatonia related behaviours 
(Benyamin et al., 2008). 
These effects are mediated through interactions with specific receptors located in the 
basolateral amygdala, hippocampus and prefrontal cortex (Lewis and Smith, 1983). 
Glucocorticoids in the brain regulate their effects through neurotransmission with particular 
focus on serotonin and dopamine neurotransmission. Previous studies have observed a strong 
link between high endogenous cortisol concentrations and hippocampal atrophy associated 
with cognitive dysfunction (Fardet et al., 2012; Hall et al., 1978). In a healthy subject, the 
damage caused by high cortisol concentrations would be inhibited by the feedback inhibition 
of the HPA-axis and the resulting decrease in plasma steroid concentrations. 
The susceptibility of individuals to stress-related psychopathology appears to vary 
considerably and has been linked to variations in the sensitivities and functionalities of the 
HPA-axis, which is greatly determined by GR sensitivity (Harris et al., 2013). The latter may 
impact on the effect of a stressor on the brain, HPA-axis feedback actions and the ultimate 
development of depression. The transcription of GR mediated genes are additionally regulated 
by factors such as FK506 binding protein (FKBP5), which activates a short negative feedback 
loop after binding to the liganded GR and decreases GR signalling (Binder, 2009). The MR, 
however, regulates the initiation of the stress response through transcriptional activities of 
genes associated with HPA-axis activation. The functional role of MRs in the maintenance of 
basal steroid levels has been suggested to occur through inhibitory actions mediated through 
GABAergic neurons that act on the PVN of the hypothalamus (Berardelli et al., 2013). In 
addition, the MR contributes to the exertion of rapid non-genomic effects though 
neurotransmission and the synaptic signalling strength in the brain (de Kloet et al., 2016, 2005; 
Hauer et al., 2011).  
In addition to the effect elicited by the conventional genomic signalling pathways, GR and MR 
have been shown to adapt to stressors within minutes. These rapid effects have been associated 
with non-genomic effects of the GR and MR, and it has been shown that membrane bound GR 
and MR exists within the brain tissues and are responsible for eliciting rapid effects through 
signalling pathways that mirror the conventional signalling strategies (Groeneweg et al., 2012). 
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Immunomodulating effects 
In spite of the well-documented side effects of glucocorticoids, they remain the gold standard 
for the treatment of inflammatory disorders and immune suppression after organ transplants. 
Beneficial and adverse effects are elicited through the ability of glucocorticoids to act on nearly 
every cell type within the immune system (Zen et al., 2011). In dendritic cells, cell maturation 
is suppressed by glucocorticoids resulting in cells with weak T-cell stimulating activities. In 
addition to inducing apoptosis and migration of dendritic cells, glucocorticoids also elicit 
varied effects depending on the GR isoform expressed in these cells (Cao et al., 2013). 
Glucocorticoids have also been shown to increase the pro-inflammatory response initiated by 
macrophages. Typically, macrophages contain Toll-like receptors that detect harmful stimuli, 
such as infectious agents, resulting in the activation of the pro-inflammatory response through 
the inflammasome complex (Guo et al., 2015). Also, Toll-like receptor-2 is activated by a 
glucocorticoid-TNF-α complex which results in the stimulation of innate immunity (Hermoso 
et al., 2004). Contrary to the pro-inflammatory effects, glucocorticoids have been shown to 
suppress the inflammatory response by augmenting the phagocytosis of macrophages as well 
as neutrophils (Baschant and Tuckermann, 2010). Neutrophil migration into the inflammatory 
site is also suppressed by glucocorticoids by inhibiting adhesion molecule expression (Busillo 
and Cidlowski, 2013). The effects of glucocorticoids on T-cells may vary considerably and 
depend on the type of T-cell. Glucocorticoids induce apoptosis in pro-inflammatory T-cells, 
whereas the survival of regulatory T-cells is augmented by the actions of glucocorticoids 
(Baschant and Tuckermann, 2010). In auto immune disorders and B-cell tumors, 
glucocorticoids inhibit the production of B-cell antibodies with additional inhibitory effects on 
the activation, proliferation and differentiation of B-cells (Zen et al., 2011).  
The anti-inflammatory and anti-proliferative effects of glucocorticoids render them popular 
treatment choices for cutaneous inflammatory disorders such as psoriasis or eczema (Goldminz 
et al., 2012), although the beneficial effects may be accompanied by skin atrophy and delayed 
wound healing. The identification of skin specific GRs showed that the anti-proliferative 
effects of glucocorticoid treatments are associated with transrepression via the GR in 
keratinocytes, with delayed wound healing being associated with both transactivation and 
transrepression (Sevilla et al., 2013). Cutaneous therapies could thus be enhanced by utilizing 
treatments that augment transcriptional activities linked to transrepression via the GR instead 
of transactivation. 
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Cardiovascular effects 
Corticosteroids have been linked to the initiation and progression of cardiovascular diseases 
with hypertension and heart failure being the most common clinical conditions. One of the first 
studies suggesting that ALDO may play a significant role in heart failure showed that increased 
plasma ALDO levels resulted in a predictive index of morbidity and mortality (Swedberg et 
al., 1990). In a more recent investigation it was found that both plasma ALDO and cortisol are 
complementary predictors of mortality (Güder et al., 2007). Further investigations showed that 
ALDO was able to induce cardiac fibrosis without affecting blood pressure significantly, which 
was prevented following treatment with spironolactone (SPL), a well-known MR antagonist 
(Robert et al., 1994; Young et al., 1994). The latter discovery prompted investigations into MR 
antagonists in the treatment of cardiovascular disease. The increased interest in the MR as drug 
target led to the discovery that the MR is expressed not only in the well-known ALDO target 
tissues, but in the blood vessels (Meyer and Nichols, 1981), heart (Funder et al., 1988; Lombès 
et al., 1992) and brain (Yu et al., 2002). During chronic heart failure, the elevated 
concentrations of AngII, a potent stimulator of ALDO biosynthesis, and ALDO may have 
damaging effects on cardiovascular structure and although ACE inhibitors may decrease the 
plasma concentrations of ALDO and AngII (Pitt, 1995), this effect is dissipated after a few 
months of treatment. The mechanism though which ALDO and AngII elicit the latter “escape” 
effect is still largely unknown. 
The ligand responsible for the activation of the MR in cardiomyocytes has been a point of 
debate in recent years as it is known that the MR binds to ALDO, cortisol, CORT and DOC 
with high affinity. In the distal colon, distal nephron, sweat glands and other MR classical 
target tissues, the MR is co-expressed with 11β-HSD2 that encourages ligand specificity of the 
MR as this enzyme converts cortisol to cortisone. In vascular smooth muscle cells and 
cardiomyocytes, very little or no 11β-HSD2 activity has been reported, suggesting that 
glucocorticoids, which are present approximately 1000-fold more than ALDO (Rickard et al., 
2009), can interact with the MR.  
In addition to the effects of the glucocorticoids, ALDO acts as an agonist for MR mediated 
gene transcription in cardiomyocytes and vascular smooth muscle cells. ALDO was shown to 
increase Ca2+ channel activity through the redistribution of Ca2+ ions across the membrane in 
the cardiomyocytes (Gomez et al., 2009; Ouvrard-Pascaud et al., 2005). The beating frequency 
of cardiomyocytes was significantly affected by the presence of ALDO, however the treatment 
of the cardiomyocytes with CORT or dexamethasone (Dex), a potent synthetic glucocorticoid, 
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in an environment favouring MR-glucocorticoid binding, had no significant effect on the 
increased beating response elicited by ALDO (Rossier et al., 2008). In addition, ALDO and 
CORT resulted in a similar size in myocardial infarction and in both cases the effects were 
ablated by the addition of SPL (Latouche et al., 2010; Mihailidou et al., 2009).  
Although the MR displays similar affinities for corticosteroid ligands, it has been reported that 
the activation efficiencies of the MR:ALDO and MR:cortisol complexes differ, with the 
MR:ALDO being more stable and more efficient in transactivating gene transcription 
compared to the MR:cortisol complex. Hetero- and homodimerization of MR and GR isoforms 
that bind to the same HREs, expressed in a tissue specific manner, further add to the cell 
specific transcriptional activities of these receptors. Cell specific expression of cofactors, as 
well as phosphorylation sites in the LBD of the MR that influence ligand binding (Shibata et 
al., 2013), further add to the tissue specific transcriptional activities of these receptors (Gomez-
Sanchez and Gomez-Sanchez, 2012; Savory et al., 2001; Tsugita et al., 2009). The N/C 
interaction, an interaction between the N-terminus and the LBD first identified for the AR (Li 
et al., 2006), has been identified as an important interaction in terms of MR activity and is 
antagonized by SPL and eplerenone (Pippal and Fuller, 2008). In terms of MR agonists, cortisol 
and DOC, unlike ALDO, do not mediate the N/C interaction and antagonized the N/C 
interaction mediated by ALDO. The latter adds to the discrimination between ALDO and 
cortisol binding to the MR and confirms that different ligands induce different conformational 
states (Fuller, 2015). 
Studies have investigated the role of the MR in the progression of heart failure using MR 
antagonists, such as SPL and eplerenone (Grossmann and Gekle, 2009; Kimura et al., 2011). 
Although MR antagonists have been shown to be efficient treatments for heart failure and 
hypertension in clinical trials, the use of these antagonists have not been implemented to the 
extent that would be expected (Albert et al., 2009). SPL, marketed since the 1960’s as an anti-
hypertensive and diuretic drug, exerts useful clinical effects through the antagonism of the 
effects of ALDO on the MR (Piotrowski, 2012). However, this drug has been associated with 
painful menstrual disturbances in premenopausal women (Hughes and Cunliffe, 1988) which 
has been accredited to androgen-like and PROG-like effects. These side effects resulted in 
limited investigations into SPL as an anti-hypertensive treatment, however, the fairly recent 
increase in heart failure has contributed to renewed interest in SPL and other steroidal MR 
antagonists such as eplerenone (Piotrowski, 2012). It was however shown that SPL also exerts 
anti-glucocorticoid effects through interactions with the GR and androgenic effects through 
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interactions with the AR (de Gasparo et al., 1987). The affinity of these receptors for SPL is 
however lower than that of the MR and thus the associated effects via the GR and AR are often 
negligible when compared to effects via the MR  (Couette et al., 1992). Generally speaking, 
eplerenone has been shown to elicit fewer endocrine disrupting effects than SPL (Stier, 2003). 
In addition to steroidal MR antagonists, several nonsteroidal MR antagonists, such as 
finerenone (Liu et al., 2015), have been identified displaying reduced side effect profiles 
(Piotrowski, 2012). 
Conclusion 
Taken together, this chapter outlines the complex mechanisms that are involved in maintaining 
homeostasis. The influence of hormones, cytokines, neurotransmitters, receptors and delivery 
systems all play crucial roles in maintaining homeostasis during every-day or stress-like 
perturbations. The complexity of these processes and mechanisms further lends itself to being 
susceptible to disturbances between processes in such a way that if a disease state would affect 
one system, other systems would inevitably be affected, with a cascade of potentially 
detrimental effects.  Chronic exposure to corticosteroids has been shown to elicit such 
responses as is evident through their psychological, immunomodulatory and cardiovascular 
effects as discussed in this chapter.  
The studies discussed in this chapter also suggest several mechanisms through which 
corticosteroid actions can be manipulated, whether as a therapy or as a result of a disease state. 
The inhibition of steroidogenesis, the modulation of the HPA-axis and the transcriptional 
activities of the GR and the MR in target tissues may all be valid targets for the development 
of anti-depressive, anti-inflammatory and/or anti-hypertensive treatments. For example, the 
role of the HPA-axis, glucocorticoids and GR signalling in the inflammatory response and 
immunomodulation is well established and as such these three aspects of the inflammatory 
response have been identified as drug targets for the treatment of clinical conditions related to 
immune dysfunction (Edwards, 2012; Kadmiel and Cidlowski, 2013). In addition, the 
observation that hypersensitive GREs exist may suggest that lowered concentrations of 
glucocorticoids could be employed as therapies to treat specific disorders, avoiding the typical 
side effects associated with high concentrations of free glucocorticoids. Furthermore, targeting 
protective functions such as the co-expression of the MR and 11β-HSD2 in mineralocorticoid 
sensitive tissues, as well as cofactor recruitment, might also be a valuable target for drug 
development for diseases linked to excessive corticosteroids.  
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Although these processes and mechanisms are valuable targets for the pharmaceutical industry 
for the treatment of corticosteroid-related diseases, it has been suggested that some botanicals 
exert their medicinal properties by influencing these processes and mechanisms.  Extracts made 
from Aspalathus linearis (Schloms et al., 2012) and Sceletium tortuosum (Swart and Smith, 
2015) have been shown to influence steroid output in adrenal cell models, with Aspalathus 
linearis also inhibiting individual steroidogenic enzymes. S. frutescens has been shown to elicit 
anti-anxiety effects in stressed rats by lowering serum CORT and influencing the expression 
of the GABAA receptor and the GR in the hippocampus (Smith and Myburgh, 2004b; Smith 
and van Vuuren, 2014). Specific compounds, that have been isolated from plant extracts, like 
triterpenoids, have also shown anti-anxiety and anti-inflammatory effects. Furthermore, 
various plant extracts have been shown to inhibit the catalytic activities of hepatic P450 
enzymes. 
In the next chapter we thus investigated the effect of a methanolic S. frutescens extract, as well 
as compounds isolated from the extract, on the catalytic activity of steroidogenic enzymes, 
adrenal steroidogenesis and the transcriptional activities of the extract and SUB via the MR 
and GR.  
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Chapter 4: The influence of S. frutescens on adrenal steroidogenesis and 
downstream receptor-ligand interaction  
Introduction 
S. frutescens is generally used as a herbal remedy to treat disorders that are associated with 
inflammation and stress (van Wyk and Wink, 2004). The application of this herbal remedy as 
anti-stress and anti-inflammatory tonic may be rooted in the effect of S. frutescens on steroid 
hormone production, specifically cortisol biosynthesis.   
Inflammation is initially a favourable defensive response to a stressor, which results in the 
production of pro-inflammatory agents with the objective to repair cellular damage or eliminate 
effects of an extracellular stressor.  However, the re-establishment of homeostasis after a pro-
inflammatory response is of utmost importance in avoiding chronic inflammation (Pascual and 
Glass, 2006). Inflammation is managed by the stress-induced release of glucocorticoids which, 
in addition to the stress response, play important regulatory roles in lipid, carbohydrate and 
protein metabolism, reproductive and growth processes and brain functions such as behaviour 
and memory (Chrousos and Kino, 2009). The physiological stress response is initiated when 
the brain detects a homeostatic challenge, be it physical, physiological or emotional, and results 
in the activation of the SNS. The release of epinephrine and NE by the SNS is followed by the 
activation of the HPA-axis. Stressors stimulate the secretion of ACTH from the pituitary within 
the HPA-axis to increase glucocorticoid production in adrenal steroidogenesis, resulting in 
increased active glucocorticoids in circulation. Chronic stress could thus result in the 
dysfunction of the HPA response and the disrupted adrenal steroidogenic output, resulting in 
glucocorticoid resistance and an inability to down regulate the inflammatory response (Cohen 
et al., 2012; Kanczkowski et al., 2013).  
Previous studies have shown that a methanolic extract of S. frutescens significantly inhibited 
DOC (59 %) and PROG (17 %) binding in adrenal P450-containing mitochondrial and 
microsomal preparations. It was shown that the extract did not inhibit PREG binding to 
microsomal enzymes, however, a chloroform extract significantly inhibited PREG binding 
while an aqueous extract inhibited the conversion of PREG and PROG by ovine CYP17A1 
(Prevoo et al., 2008, 2004). Furthermore, we have shown that deoxycortisol and DOC binding 
to P450 enzymes in adrenal mitochondrial preparations is inhibited in the presence of the 
methanol extract as well as cortisol and CORT production by CYP11B1, expressed in COS-1 
cells (Sergeant, 2009).  
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The therapeutic effects of S. frutescens have been attributed to the presence of a wide variety 
of compounds. The most renowned compounds identified in the extract are GABA, pinitol, L-
canavanine together with flavonoid and triterpenoid compounds. The triterpenoids or SU 
compounds in S. frutescens extracts include four complex cycloartane glycosides –SU A, B, C 
and D with SUB being the major triterpenoid present in plant material (Fu et al., 2008), 
confirmed by liquid chromatography-mass spectrometry (LC-MS) (Albrecht et al., 2012; 
Avula et al., 2010). Recently, additional cycloartane glucosides were identified using novel 
chromatographic techniques (Zaki et al., 2016), however, limited information regarding these 
compounds is available. 
Triterpenoid compounds in plant extracts have been linked to a variety of pharmacological 
effects which include lowering serum cholesterol levels, anti-inflammatory, cardiovascular and 
hypoglycaemic effects (Desai et al., 2009; Lockyer et al., 2012; Wu et al., 2011). The 
mechanisms by which these compounds elicit biological effects are mostly unknown, however, 
it has been suggested that these compounds are able to elicit steroid-like effects due to structural 
similarities with endogenous steroid ligands. Studies have shown that triterpenoids exhibit anti-
cancer and anti-inflammatory properties with data indicating that many of these compounds 
target and downregulate NF-κB. Triterpenoids are furthermore widely used in Asian medicine 
in the treatment of chronic diseases which include amongst others, diabetes, obesity, 
cardiovascular atherosclerosis, arthritis and depression (Sanna et al., 2015; Venkatesha et al., 
2016; Yadav et al., 2010). The aforementioned conditions are closely associated with an 
impaired endocrine system and, as such, triterpenoids may also interact with the steroidogenic 
P450 enzymes which catalyze steroid biosynthesis due to the structures of the compounds being 
closely related to the cyclopentanoperhydrophenanthrene structure of steroid hormones. 
Studies investigating the effect of S. frutescens extracts on hepatic P450 enzymes showed 
nevirapine metabolism by CYP3A4 to be inhibited in rats (Minocha et al., 2011), while the 
catalytic activity of CYP2D6 and CYP2E1 were not affected (Fasinu et al., 2013). As 
mentioned above, we have reported that S. frutescens extracts inhibit substrate conversion by 
steroidogenic P450 enzymes such as CYP17A1 and CYP21A2. It was suggested that the 
inhibition of P450 enzymes by the extract may be elicited by compounds within the extract that 
are structurally similar to natural steroid substrates (Prevoo et al. 2008; Prevoo et al. 2004). 
Besides interfering with the catalytic activity of the P450 enzymes, the triterpenoids may also 
mimic or antagonize the downstream actions of endogenous steroid hormones. 
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We hypothesized that the anecdotal anti-inflammatory effects of S. frutescens, when used as a 
treatment in inflammatory disorders, could be attributed to the influence of the extract on 
steroidogenesis and downstream, on the activation of steroid receptors. We further 
hypothesized that the presence of triterpenoids, specifically SUB, in S. frutescens extract may 
contribute to its anecdotal effects. We therefore investigated the following: 
 The effect of a methanolic extract of S. frutescens on single adrenal steroidogenic 
enzymes and steroid production. 
 SUB levels in the extract used in this study.  
 The effects of SUB on single adrenal steroidogenic enzymes and steroid production. 
 The effect of the methanolic S. frutescens extract and SUB on downstream 
transcriptional activities elicited by the GR and MR. 
Materials and Methods 
Reagents 
Phorbol 12-myristate 13-acetate (PMA), (9-α-fluoro-16-α-methylprednisilone (dexamethasone 
(Dex)), SPL, gamma aminobutyric acid (GABA) and Dulbecco’s modified Eagle’s medium 
(DMEM) were purchased from Sigma-Aldrich (RSA). Steroids were purchased from 
Steraloids (Wilton, USA). COS-1 cells were purchased from the American Type Culture 
Collection (Manassas, VA, USA). Dulbecco’s phosphate buffered saline, together with 
penicillin-streptomycin and trypsin-ethylenediaminetetraacetic acid (EDTA) were sourced 
from Gibco-BRL (Gaithersburg, MD, USA). Mirus TransIT®- LT1 transfection reagent was 
purchased from Mirus Bio Corporation (Madison, WI, USA). Fetal calf serum was supplied by 
Highveld Biological (Lyndhurst, RSA), while cosmic calf serum was purchased from 
HyClone®,Thermo Scientific (RSA). S. frutescens subspecies (L.) R. Br. were supplied by 
Professor Ben-Erik van Wyk, Department of Botany of Rand Afrikaans University (Voucher 
specimen from Mrs. Grobler: C. Albrecht s.n sub B.-E. van Wyk 4126 (JRAU)). Triterpenoids 
were supplied by Prof J. Syce (University of Western Cape, Cape Town, South Africa) and 
Prof WR Folk (University of Missouri, Missouri, USA). All chemicals used were of high 
analytical grade and obtained from reputable suppliers.  
S. frutescens extraction and isolation of SUB  
S. frutescens was subjected to organic extraction using a glass soxhlet extractor coupled to a 
double wall condenser. Dried plant material, 18.5 g, was extracted with chloroform, 250 mL, 
for 8 hours, after which the solvent was replaced with methanol, 250 mL, and extracted for a 
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further 8 hours (Swart et al., 1993). The methanol extract was dried at room temperature at 
reduced pressure on a rotary evaporator. The residue was redissolved in 35 mL de-ionized 
water and centrifuged at 6 000 × g for 5 minutes. The supernatant, with a final concentration 
of 53.43 mg/mL, was stored at -18 °C in aliquots until use. LC–MS/MS analysis of the extract 
was conducted on a Waters Synapt G2 quadrupole time-of-flight mass spectrometer (Milford, 
MA, USA) using a Waters BEH C18 column (2.1 x 50 mm, 1.7 μm). Solvent A consisted of 
0.1 % formic acid in water and solvent B consisted of acetonitrile. A linear gradient from 100 
% A to 78 % A in 3 min, followed by linear gradient from 78 % A to 55 % A in 7 min and a 
linear gradient from 55 % A to 0 % A in 2 min was applied. The column was returned to 100 
% A in 1 min, after an isocratic elution at 100 % B for 2 min. The samples, 5 µl, were analysed 
at a flow rate of 0.35 mL/min with a total run time of 15 minutes for each sample. Ionization 
was achieved with an electrospray source with the cone voltage set at 15 V and capillary voltage 
at 3 kV. Analysis was carried out utilizing positive and negative modes. 
S. frutescens triterpenoids were fractionated on a semi-preparative Novapak HR C18 high 
pressure liquid chromatography (HPLC) column (6 μm spherical particles, 300 mm×7.8 mm; 
Millipore-Waters, La Jolla, USA) utilizing an elution gradient from 80% solvent A (0.1% 
trifluoroacetic acid in analytical quality water, v/v) and 20% solvent B to 70% solvent B (90% 
acetonitrile and 10% A, v/v) and eluted over 23 minutes. The major fractions (fractions 1 and 
3) were collected and subjected to further analysis by LC-MS/MS to determine the total ion 
count in positive and negative electron spray ionization (ESI) modes. The fractions were 
subjected to the same LC-MS/MS method as described for the methanolic extract above. SUB 
was collected, lyophilized and dissolved in ethanol, 2 mg/mL, prior to storage at -18 °C.  
Preparation of adrenal mitochondrial and microsomal fractions  
Microsomal and mitochondrial fractions were prepared by differential centrifugation as 
described by Yang & Cederbaum (Yang and Cederbaum, 1997). Fresh sheep adrenals were 
washed with a 15 mM KCl solution after decapsulation and the adrenal tissue (51.36 g) was 
homogenized in three parts of 10 mM Tris–HCl buffer (pH 7.4) containing 1.0 mM EDTA and 
0.25 M sucrose. The homogenate was centrifuged for 15 minutes at 12 000 x g to pellet the 
mitochondrial fraction. The post-mitochondrial supernatant was centrifuged at 12 000 x g for 
15 minutes. To prepare the microsomes, a 50 % (w/v) PEG 8000 solution was added slowly 
with stirring to the supernatant to a final concentration of 8.5 % and the mixture was stirred for 
10 minutes and subsequently centrifuged at 13 000 x g for 20 minutes. The microsomal pellets 
were homogenized in 10 mM Tris-HCl buffer (pH 7.4) containing 150 mM KCl and 1 mM 
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EDTA. PEG (50 % w/v) was again added to the solution to a final concentration of 8.5 % and 
the mixture was stirred and centrifuged at 13 000 x g for 20 minutes. This procedure was 
repeated until the supernatant was clear. The final microsomal pellet was resuspended in 80 
mL of 10 mM Tris-HCl buffer (pH7.4) containing 1 mM EDTA and 0.25 M sucrose and stored 
at -80 ºC until further use. The cytochrome P450 concentrations were determined and protein 
determination was carried out by using the BCA method (Pierce Biotechnology, USA) as 
instructed by the manufacturer.  
Determination of the mitochondrial cytochrome P450 concentration 
The cytochrome P450 concentration of the mitochondrial and microsomal fractions were 
determined using a method previously described by Omura and Sato (Omura and Sato, 1964). 
The dried mitochondrial fraction was resuspended in 0.1 M phosphate buffer (pH7.4, 10 % 
ethylene glycol) to a final concentration of 2 mg/mL. The solution was placed on ice and 
sonicated with 1 minute intervals for a total of 5 minutes and subsequently saturated with 
carbon monoxide. The microsomal solution was diluted using 0.1 M phosphate buffer (pH7.4, 
10 % ethylene glycol) where after it was saturated with carbon monoxide. One millilitre of 
either microsomal suspension or mitochondrial sonicate was added to each of two optically 
matched cuvettes (representative of the sample and reference). After recording a baseline 
between 400 and 500 nm, an initial spectrum was recorded after the addition of approximately 
2 µg of sodium dithionate to the sample cuvette. The spectrum was allowed to develop for 
approximately 10 minutes, where after a final reading was taken.  
The Beer-Lambert law (Equation 1) was used to calculate the P450 concentration using the 
molar extinction coefficient previously determined by Omura and Sato (Omura and Sato, 
1964).  
∆A = εcl                       Equation 4.1 
Where ∆ = change in absorbance; ε = Molar extinction coefficient; c = concentration of the 
solution and l = path length (1 cm) 
Spectral binding assays 
Spectra were recorded between 385 and 500 nm using a Cary 100 Conc UV/Visible 
Spectrophotometer (Varian). Type 1 substrate-induced difference spectra were obtained with 
PROG (3.2 µM) in the microsomal preparations (P450, 0.35 µM) (Prevoo et al 2008) and DOC 
or deoxycortisol (3.2 µM)  in the mitochondrial preparations (P450, 0.8 µM). SUA and B were 
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assayed at a final concentration of 10 µM with inhibition being indicated by a reduction in 
amplitude of the difference spectra. The percentage inhibition was calculated by: 
% inhibition = {(A – B)/ A} x 100   Equation 4.2 
A = the amplitude between the absorbance at 390 nm and 420 nm without test compound. 
B = the amplitude between the absorbance at 390 nm and 420 nm with test compound. 
Steroid conversion assays in COS-1 cells 
The influence of the methanolic S. frutescens extract and SUB on recombinant enzymes, 3β-
HSD2, CYP17A1, CYP21A2, CYP11B1 and CYP11B2, was assayed in non-steroidogenic 
COS-1 cells as described previously (Schloms et al., 2012). Confluent cells were seeded into 
12 well plates, 1 × 105 cells/mL/well, 24 hours prior to transfection. Cells were transiently 
transfected with 0.5 μg DNA and 1.5 µl Mirus TransIT®- LT1 transfection reagent according 
to the manufacturer’s instructions. Cells were incubated for 72 hours after which the 
appropriate steroid substrate, at a final concentration of 1 µM, was added to the culture 
medium. PREG was added to cells expressing the baboon 3β-HSD2 and CYP17A1, PROG 
was added to cells expressing CYP17A1 and CYP21A2, deoxycortisol was added to cells 
expressing CYP11B1 and DOC was added to the cells expressing CYP11B1 and CYP11B2. 
The influence of the methanol S. frutescens extract was determined by adding 2.66 mg/mL 
extract to the medium. A pCIneo vector containing no insert DNA was used to perform control 
transfections. Aliquots, 500 µl, were removed after 4 hours (3β-HSD2, CYP17A1 and 
CYP21A2) and 8 hours (CYP11B1 and CYP11B2) and the steroids extracted using a 10:1 
volume of dichloromethane to culture medium. The mixture was vortexed for 30 seconds, 
centrifuged at 500 × g for 5 minutes and the medium aspirated. The dichloromethane phase 
containing the steroids was dried under N2, resuspended in 120 μl methanol and stored at 4 °C 
prior to steroid analysis by ultra performance liquid chromatography coupled with tandem mass 
spectrometry (UPLC–MS/MS). Metabolites were separated by UPLC (ACQUITY UPLC, 
Waters, Milford, USA) using a Waters UPLC BEH C18 column as previously described 
(Schloms et al., 2012) and a Xevo triple quadrupole mass spectrometer (Waters, Milford, USA) 
was used for quantitative mass spectrometric detection. Calibration curves were constructed by 
using weighted (1/x2) linear least squares regression. Data was collected with the MassLynx 
4.0 software program and steroid analyses presented as the mean, n=6.  
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Steroid metabolism in H295R cells 
The influence of a methanolic S. frutescens extract and SUB was assayed on steroid metabolism 
in H295R cells as previously described (Schloms et al., 2012). The extract was assayed under 
basal, forskolin and AngII stimulation, whereas SUB and GABA were assayed under basal 
conditions only. Briefly, confluent cells were seeded into 12 well plates, 4x105 cells/mL/well, 
and allowed to attach for 48 hours after which the medium was replaced with growth medium 
containing 0.1 % cosmic calf serum. Cells were incubated for 12 hours after which extract (1 
mg/mL), SUB (10 or 30 µM), SU mixture (10 or 30 µM) or GABA (10 µM) was added, with 
and without forskolin or AngII in the case of the extract, to determine effects on basal and 
stimulated steroid production. Aliquots, 500 µl, were collected after 48 hours and the steroids 
extracted as described in the previous section. The steroid residue was resuspended in 150 µl 
methanol for analysis by UPLC-LC-MS. Steroids were separated using a Phenomenex UPLC 
Kinetex PFP (2.1 mm × 100 mm, 2.6 µm) column and analysed and quantified by UPLC-APCI-
MS (Schloms et al., 2012) as described above. All experiments were performed either two or 
three times and tabulated data are representative of at least two experiments. Each experiment 
was conducted in triplicate and results are presented as means ± SEM.  
Transactivation and transrepression assays  
The effects of the extract and SUB on the transcriptional activities of the GR were assayed in 
COS-1 cells which were plated in complete medium (DMEM containing 10% fetal calf serum 
and 1% penicillin- streptomycin) at a density of 2x106 cells/mL in 10 cm culture dishes. After 
24 hours the cells were transiently transfected with the appropriate expression vectors, using a 
TransIT®-LT1 transfection reagent (Mirus, USA) according to the manufacturer’s 
instructions. For transactivation assays, 900 ng pRS-hGR and 9 μg pTAT-2xGRE-Elb-
luciferase, driven by the E1b promoter containing two copies of the rat TAT-GRE (Sui, 1999) 
were used, while for transrepression assays 1.5 µg pRS-hGR and 3 µg of the IL6-luc-promoter 
reporter construct (p(IL6κB)350hu.IL6Pluc+) were used. After 24 hours, the transfected cells 
were seeded into 24 well plates at a density of 5 x 104 cells/well and incubated for 24 hours. 
The cells were washed with phosphate buffered saline (PBS) and incubated for 24 hours with 
serum-free medium containing dexamethasone (Dex) (10 µM), S. frutescens (0.5 or 0.75 
mg/mL) and SUB (10 or 30 µM) (for transactivation) or serum-free medium containing PMA 
in the absence and presence of Dex (10 µM), extract (0.5 or 0.75 mg/mL) and SUB (10 or 30 
µM) (for transrepression).  
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The effects of the extract and SUB on the MR were assayed in CHO cells stably transfected 
with the rat MR, 11β-HSD2 and a pTAT3-gLuc reporter gene (Morita et al., 1996). Cells were 
seeded at a density of 2.5 x 104 cells/mL/well in 12 well plates in complete growth media 
(DMEM/F-12 containing 10% cosmic calf serum, 1% penicillin- streptomycin and 0.1 % 
gentamicin) and incubated for 48 hours. The cells were incubated for 24 hours in experimental 
medium (DMEM/F-12 containing 0.1 % charcoal stripped cosmic calf serum, 1% penicillin-
streptomycin and 0.1 % gentamicin) containing ALDO (10 nM), S. frutescens (0.5 and 0.75 
mg/mL) and SUB (10 and 30 µM) to investigate agonist activity, and containing 10 nM ALDO 
in the absence and presence of S. frutescens (0.5 or 0.75 mg/mL), SUB (10 or 30 µM) or SPL 
(1 µM) to investigate antagonist activity. 
Lysed cells were analysed as previously described (Africander et al., 2011) for all the reporter 
assays. The luciferase activity, measured in relative light units (RLUs), was normalized to 
protein concentration as determined using a Pierce® BCA Protein Assay Kit (Rockford, IL, 
USA) to correct for plating efficiency.  
Cell viability assays 
The viability of the COS-1, H295R and CHO cells in the presence of S. frutescens extract and 
SUB was determined using an in vitro cytotoxicity assay kit based on an 3-(4,5-dimethythiazol- 
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Sigma-Aldrich) according to the 
manufacturer’s instructions. The concentrations of cells used for these assays were 1x105 
cells/mL for COS-1 cells, 4x105 cells/mL for H295R cells and 2.5x104 cells/mL for CHO cells. 
SUB was assayed at 10 and 30 µM and the extract was assayed at 0.5, 0.75, 1 and 2.6 mg/mL. 
Cell viability was not affected at these concentrations and no detrimental or stimulatory effects 
were observed. In addition, the 17-dehydrogenase activity endogenous to COS1 cells was not 
affected by S. frutescens with the conversion of testosterone to A4 being ± 90% in the presence 
of the extract (2.5mg/mL) as previously reported (Sergeant, 2009).  
Statistical analysis 
Experiments were repeated in duplicate with three replicates within each experiment (unless 
stated otherwise). Mean values of data obtained in each experiment were analyzed using one-
way ANOVA and appropriate post-tests (as indicated in figure legends). The error bars 
represent the standard error of the mean (SEM) and a value of P<0.05 was considered 
statistically significant. All data manipulations, graphical representations and statistical 
analysis were performed using Graph Pad Prism 5 (GraphPad Software, Inc, CA, USA). 
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Results 
The effect of a methanolic extract of S. frutescens on adrenal steroidogenic enzymes. 
As previous investigations have shown the effects of an aqueous extract on CYP17A1, 
CYP21A2 and CYP11B1, we investigated a methanolic extract on steroid conversion by 
CYP17A1, CYP21A2, CYP11B1, 3β-HSD2 and CYP11B2. In addition, we investigated 
whether the methanolic extract of S. frutescens would influence steroid production in H295R 
cells. These cells were chosen as an experimental model as they mimic steroid production in 
in the  adrenal gland and produce glucocorticoids, mineralocorticoids and adrenal androgens 
(Rainey et al., 1994; Wang and Rainey, 2012). The effects of the extract on steroid production 
were thus investigated under both basal and stimulated conditions. 
S. frutescens methanolic extracts influence steroid conversion assays in COS-1 
cells 
Steroid substrate conversion by 3β-HSD2, CYP17A1, CYP21A2, CYP11B1 and CYP11B2 
was assayed in the presence of the extract to assess the effect of S. frutescens on the catalytic 
activity of individual recombinant steroidogenic enzymes, in the absence of competing 
enzymes, in a simple cell model. COS-1 cells were transiently transfected with either baboon 
3β-HSD2, baboon CYP17A1, bovine CYP21A2 or co-transfected with either human CYP11B1 
and Fedx or CYP11B2 and Fedx. As discussed in chapter 3, Fedx is required for effective 
electron transfer between FeRed and CYP11B1 or CYP11B2 (Grinberg et al., 2000). Since 3β-
HSD2 catalyses the conversion of PREG to PROG, 17OH-PREG to 17OH-PROG and DHEA 
to A4, the three steroid substrates were added at a final concentration of 1 µM, to cells 
transiently expressing the enzyme and assayed in the absence and presence of extract (2.66 
mg/mL). Figure 4.1 shows that the presence of the methanol extract had no effect on the 
conversion of PREG to PROG (Fig.4.1A) or the conversion of DHEA to A4 (Fig.4.1C). 
However, the conversion of 17OH-PREG to 17OH-PROG was inhibited significantly 
(P<0.001), resulting in ± 20 % lower 17OH-PROG levels (Fig.4.1B).  
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Fig. 4.1: Effect of the methanolic extract of S. frutescens on steroid conversion in COS-1 cells 
expressing baboon 3β-HSD2. A) PREG conversion to PROG, B) 17OH-PREG conversion to 
17OH-PROG and C) DHEA conversion to A4, after 4 hours. Steroid substrates, 1 µM; S. 
frutescens extract, 2.66 mg/mL. The data represents the mean of two independent experiments 
conducted in triplicate (n=6) and statistical analysis was performed using a one-way ANOVA 
with Dunnett’s post-test (***, P<0.001; ns, non-significant). 
 
The effect of the extract on PREG and PROG conversion by CYP17A1 was subsequently 
assessed. PREG is hydroxylated by CYP17A1 to produce 17OH-PREG, which, in turn, 
undergoes a lyase reaction to produce DHEA. Similarly, CYP17A1 hydroxylates PROG to 
produce 17OH-PROG which, since CYP17A1 does not exhibit 20, 21-lyase activity towards 
17OH-PROG, is not converted to A4. The presence of the extract appeared to have no 
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significant inhibitory effect on either the hydroxylase or lyase catalysed reactions in the 
conversion of PREG to 17OH-PREG and subsequently to DHEA (Fig. 4.2A), however the 
conversion of PROG to 17OH-PROG by CYP17A1 was significantly inhibited (± 50 % 
inhibition), while A4 was not detected after 4 hours as expected (Fig. 4.2B).   
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Fig. 4.2: Effect of the methanolic extract of S. frutescens on steroid conversion in COS-1 cells 
expressing baboon CYP17A1. A) PREG conversion to 17OH-PREG and DHEA and B) PROG 
conversion to 17OH-PROG, after 4 hours. Steroid substrates, 1 µM; S. frutescens extract, 2.66 
mg/mL. The data represents the mean of two independent experiments conducted in triplicate 
(n=6) and statistical analysis was performed using a one-way ANOVA with Dunnett’s post-
test (***, P<0.001; ns, non-significant). 
 
As CYP17A1 is not the only P450 enzyme that metabolises PROG, with CYP21A2 also 
catalysing the conversion of the steroid, the effect of the extract on the catalytic activity of 
CYP21A2 was also investigated. S. frutescens inhibited the conversion of PROG to DOC 
significantly with ± 87 % substrate remaining after 4 hours (Fig. 4.3).  
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Fig. 4.3: Effect of the methanol extract of S. frutescens on steroid conversion in COS-1 cells 
expressing bovine CYP21A2. The figure shows PROG conversion to DOC by CYP21A2 after 
4 hours in the absence and presence of the extract. PROG, 1 µM; S. frutescens extract, 2.66 
mg/mL. The data represents the mean of two independent experiments conducted in triplicate 
(n=6) and statistical analysis was performed using a one-way ANOVA with Dunnett’s post-
test (***, P<0.001). 
 
The effect of S. frutescens on the catalytic activity of CYP11B1 and CYP11B2, the enzymes 
catalysing the final steps in adrenal glucocorticoid and mineralocorticoid biosynthesis, was 
subsequently assessed. The conversion of both DOC and deoxycortisol by CYP11B1 (Fig. 4.4) 
and DOC by CYP11B2 (Fig. 4.5) were determined in the absence and presence of the extract. 
Both enzymes were co-transfected with Fedx as it is required for effective electron transfer 
between the endogenous reductase and CYP11B1 or CYP11B2. The conversion of DOC and 
deoxycortisol to CORT (Fig. 4.4 A) and cortisol (Fig. 4.4 B) was significantly inhibited in the 
presence of the extract, with the inhibition being similar for both substrates. A greater 
inhibitory effect was observed in the conversion of DOC by CYP11B2 in the presence of S. 
frutescens (Fig 4.5).  The conversion of DOC to CORT in the initial hydroxylation at C11 in 
the production of ALDO was inhibited significantly. The inhibitory effect of S. frutescens on 
the subsequent 18-hydroxylase and 18-oxidase activities in the production of 18OH-CORT and 
ALDO was non-significant. This can be ascribed to more than 50% DOC remaining after 8 
hours and, together with CORT levels being reduced 1.9-fold, resulted in a 1.3-fold decrease 
in the 18OH-CORT intermediate and a 1.6-fold decrease in ALDO production. 
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Fig. 4.4: Effect of the methanol extract of S. frutescens on steroid conversion in COS-1 cells 
expressing bovine human CYP11B1 and human Fedx. The figure shows A) DOC conversion 
to CORT and B) deoxycortisol conversion to cortisol, after 8 hours. Steroid substrates, 1 µM; 
S. frutescens extract, 2.66 mg/mL. The data represents the mean of two independent 
experiments conducted in triplicate (n=6) and statistical analysis was performed using a one-
way ANOVA with Dunnett’s post-test (**, P<0.01). 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
  
81 
 
D
O
C
C
O
R
T
18
O
H
-C
O
R
T
A
LD
O
0
20
40
60
Control
S. frutescens
**
ns
ns
ns
%
 S
te
ro
id
 
Fig. 4.5: Effect of the methanol extract of S. frutescens on steroid conversion in COS-1 cells 
expressing human CYP11B2 and Fedx after 8 hours. DOC, 1 µM; S. frutescens extract, 2.66 
mg/mL. The data represents the mean of two independent experiments conducted in triplicate 
(n=6) and statistical analysis was performed using a one-way ANOVA with Dunnett’s post-
test (**, P<0.01; ns, non-significant). 
 
In summary, S. frutescens inhibited 3β-HSD2 activity in a substrate specific manner in which 
the conversion of 17OH-PREG was affected, the hydroxylation of PROG by both CYP17A1 
and CYP21A1 was inhibited, while the conversion of PREG by CYP17A1 was not. Both 
CYP11B1 and CYP11B2 were affected by S. frutescens with data suggesting a greater 
inhibition of CYP11B2.  
Steroid metabolism in H295R cells 
The results obtained in the experiments in COS-1 cell model and in previous investigations 
clearly show that the methanolic extract of S. frutescens does affect substrate conversion by 
individual steroidogenic enzymes. The effect of the S. frutescens extract on steroidogenesis 
was subsequently assayed in a more complex cell model expressing adrenal steroidogenic 
enzymes to determine the manner in which steroid production in the glucocorticoid, 
mineralocorticoid and androgen pathways would be affected.  
Methanolic S. frutescens extracts alter basal steroid production in H295R cells  
H295R cells were incubated in the absence and presence of the extract to firstly determine the 
effect on basal steroid production (Table 4.1). The production of CORT (± 250 to 125 nM), 
16OH-PROG (± 50 to 35 nM), deoxycortisol (± 1440 to 1070 nM) and cortisol (± 930 to 510 
nM) were significantly decreased by the presence of the extract, while DOC (± 6 to 15 nM) 
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and DHEAS (± 10 to 25 nM) production increased. Although not statistically significant, total 
steroid production in the presence of the extract showed a decreasing trend. 
The detection limits for both PREG and DHEA, which could not be accurately detected in these 
experiments, was 100 ng/mL as was previously shown (Schloms et al., 2012). 
Table 4.1: Steroid production in H295R cells in the presence of S. frutescens extract after 48 
hours. The data represents the average of two independent experiments conducted in triplicate 
(n=6). 
Steroid metabolite 
Basal 
S. frutescens 
1 mg/mL 
% of Total ± SEM % of Total ± SEM  
PREG ND ND  
PROG 0.00 ± 0.00 0.00 ± 0.00 ns 
DOC 0.15 ± 0.00 0.50 ± 0.05 ↑ P<0.01 
CORT 6.30 ± 0.60 4.30 ± 0.60 ↓ P<0.001 
18OH-CORT 0.35 ± 0.10 0.40 ± 0.10 ns 
ALDO 0.05 ± 0.05 0.05 ± 0.00 ns 
11-DHC 0.70 ± 0.05    1.00 ± 0.15 ns 
17OH-PREG 0.00 ± 0.00 0.00 ± 0.00 ns 
17OH-PROG 1.15 ± 0.05 1.65 ± 0.10 ns 
16OH-PROG 1.20 ± 0.00 1.20 ± 0.05 ↓ P<0.01 
Deoxycortisol 35.80 ± 1.76 37.00 ± 1.10 ↓ P<0.01 
Cortisol 23.10 ± 0.75 17.60 ± 6.00 ↓ P<0.001 
Cortisone 0.20 ± 0.05 0.25 ± 0.05 ns 
DHEA ND ND  
DHEAS 0.25 ± 0.00 0.85 ± 0.15 ↑ P<0.01 
A4 24.60 ± 0.40 28.80 ± 0.70 ns 
11OH-A4 4.85 ± 0.30 5.50 ± 0.50 ns 
Testosterone 1.30 ± 0.5 1.25 ± 0.10 ns 
Total steroid (nM) 4020.00 ± 90.00 2900.00 ± 135.5 ns 
 
Forskolin-stimulated steroid production in H295R cells is influenced by S. 
frutescens 
The effect of the extract was subsequently investigated in H295R cells under forskolin- 
stimulated conditions. Shown in Table 4.2 are the effects of forskolin on basal steroid 
production in the cell model, corroborating findings from previous studies (Schloms et al., 
2012; Xing et al., 2011). Results showed that the glucocorticoids and glucocorticoid precursors 
were significantly increased in the presence of forskolin. The levels of CORT (± 250 to 1800 
nM), 18OH-CORT (± 15 to 105 nM), ALDO (± 2 to 30 nM), 11-DHC (± 30 to 60 nM), cortisol 
(± 930 to 4480 nM), A4 (± 990 to 1100 nM) and 11OHA4 (± 195 to 960 nM) were significantly 
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increased after forskolin stimulation. 17OH-PREG and DHEA were not detected under basal 
conditions, however, the concentrations of these metabolites were increased after forskolin 
stimulation to ± 95 nM and ± 135 nM, respectively. In addition, steroid output increased 
significantly with forskolin stimulation with total steroid production (± 11 µM) being greater 
than that produced under basal conditions (± 4 µM).  
Table 4.2: Steroid production in H295R cells in the presence of forskolin after 48 hours. The 
data represents the average of two independent experiments conducted in triplicate (n=6). 
Steroid metabolite Basal 10 µM Forskolin  
 % of Total ± SEM % of Total ± SEM 
PREG ND ND ns 
PROG 0.02 ± 0.00 0.01 ± 0.00 ns 
DOC 0.17 ± 0.02 0.10 ± 0.01 ns 
CORT 6.31 ± 0.60 16.73 ± 0.41 ↑ P<0.001 
18OH-CORT 0.33 ± 0.11 0.96 ± 0.03 ↑ P<0.001 
ALDO 0.07 ± 0.04 0.29 ± 0.10 ↑ P<0.01 
11-DHC 0.69 ± 0.03 0.54 ± 0.14 ↑ P<0.001 
17OH-PREG ND 0.87 ± 0.20 ↑ P<0.001 
17OH-PROG 1.13 ± 0.06 0.24 ± 0.03 ns 
16OH-PROG 1.19 ± 0.02 0.39 ± 0.01 ns 
Deoxycortisol 35.79 ± 1.76 10.86 ± 2.02 ns 
Cortisol 23.12 ± 0.75 41.54 ± 3.42 ↑ P<0.001 
Cortisone 0.18 ± 0.03 0.11 ± 0.01 ns 
DHEA ND 1.24 ± 0.46 ↑ P<0.001 
DHEAS 0.23 ± 0.02 0.11 ± 0.01 ns 
A4 24.61 ± 0.40 10.25 ± 1.62 ↑ P<0.001 
11OHA4 4.84 ± 0.30 8.92 ± 1.07 ↑ P<0.001 
Testosterone 1.31 ± 0.06 0.38 ± 0.07 ns 
Total steroid (nM) 4020 ± 90 10790 ± 720 ↑ P<0.001 
 
As forskolin represents the stress response in the adrenal cell, the data generated were firstly 
compared to basal steroid production to allow comparative analyses of the effects of S. 
frutescens on steroid production under stimulated conditions with basal levels (Table 4.3). 
Most of the steroid metabolites in the three pathways were significantly increased — DOC (± 
6 to 10 nM), CORT (± 250 to 750 nM), 18OH-CORT (± 15 to 65 nM), ALDO (± 2 to 18 nM), 
11-DHC (± 30 to 85 nM), cortisol (± 930 to 2050 nM) and 11OHA4 (± 195 to 395 nM). Under 
basal conditions 17OH-PREG and DHEA were not detected, however after foskolin 
stimulation in the presence of the extract these metabolites were detected at ± 90 nM and 130 
nM, respectively. Evident from these analyses is that the extract did not attenuate the effects of 
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forskolin back to basal steroid levels. Steroid production in stimulated cells in the presence of 
extract was significantly greater than in unstimulated cells (± 6.6 µM vs 4 µM). In addition, 
while deoxycortisol and A4 levels were comparable to the basal levels, 17OH-PROG and 
16OH-PROG were lower than basal levels, 2-fold and 1.5-fold, respectively. It is interesting to 
note that testosterone was also lower (± 50 to 35 nM) than basal levels.  
Table 4.3: Steroid production in H295R cells in the presence and absence of forskolin and 1 
mg/mL S. frutescens extract after 48 hours. The data represents the average of two independent 
experiments conducted in triplicate (n=6). 
Steroid metabolite Basal 10 µM Forskolin+ S. frutescens 
 % of Total ± SEM   % of Total ± SEM 
PREG ND ND    ns 
PROG 0.02 ± 0.00 0.03 ± 0.01 ns 
DOC 0.17 ± 0.02 0.17 ± 0.03 ↑ P<0.001 
CORT 6.31 ± 0.60 11.32 ± 0.30 ↑ P<0.001 
18OH-CORT 0.33 ± 0.11 1.02 ± 0.07 ↑ P<0.001 
ALDO 0.07 ± 0.04 0.28 ± 0.04 ↑ P<0.05 
11-DHC 0.69 ± 0.03 1.28 ± 0.25 ↑ P<0.001 
17OH-PREG ND 1.36 ± 0.06 ↑ P<0.001 
17OH-PROG 1.13 ± 0.06 0.34 ± 0.02 ns 
16OH-PROG 1.19 ± 0.02 0.49 ± 0.01 ns 
Deoxycortisol 35.79 ± 1.76 20.70 ± 2.23 ns 
Cortisol 23.12 ± 0.75 31.05 ± 2.07 ↑ P<0.001 
Cortisone 0.18 ± 0.03 0.07 ± 0.01 ns 
DHEA ND 1.95 ± 0.74 ↑ P<0.001 
DHEAS 0.23 ± 0.02 0.50 ± 0.11 ↑ P<0.001 
A4 24.61 ± 0.40 14.49 ± 0.80 ns 
11OHA4 4.84 ± 0.30 5.96 ± 0.61 ↑ P<0.001 
Testosterone 1.31 ± 0.06 0.54 ± 0.03 ns 
Total steroid  (nM) 4020 ± 90 6600 ± 226 ↑ P<0.001 
 
When comparing the steroid metabolites produced under forskolin stimulated conditions and 
in the presence of the extract and forskolin (Table 4.4), it is apparent that the extract inhibited 
the stimulatory effects of forskolin significantly with steroid production in the presence of the 
extract decreasing from 10.8 to 6.6 µM. The presence of the extract under stimulated conditions 
significantly decreased CORT (± 1800 to 750 nM), 17OH-PREG (± 95 to 90 nM), 16OH-
PROG (± 40 to 30 nM), cortisol (± 4480 to 2050 nM), A4 (± 1105 to 955 nM) and 11OHA4 
(± 960 to 395 nM).  However, 11-DHC (± 60 to 85 nM), deoxycortisol (± 1170 to 1370 nM) 
and DHEAS (± 10 to 30 nM) production was significantly increased in the presence of the 
extract. These results show that the addition of the extract under forskolin stimulation results 
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in a similar inhibitory trend as was observed when basal steroid metabolism was assayed in the 
presence of the extract — steroid production in the mineralocorticoid pathway is decreased the 
most (± 2010 to 930 nM), followed by the steroid production in the glucocorticoid (± 5830 to 
3565 nM) and androgen pathways (± 2120 to 1410 nM). 
Table 4.4: Steroid production in H295R cells in the presence of forskolin and 1 mg/mL S. 
frutescens extract after 48 hours. The data represents the average of two independent 
experiments conducted in triplicate (n=6). 
Steroid metabolite 
10 µM Forskolin 10 µM Forskolin + S. frutescens 
% of Total ± SEM % of Total ± SEM 
PREG ND ND ns  
PROG 0.01 ± 0.00 0.03 ± 0.01 ns 
DOC 0.10 ± 0.01 0.17 ± 0.03 ns 
CORT 16.73 ± 0.41 11.32 ± 0.30 ↓ P<0.001 
18OH-CORT 0.96 ± 0.03 1.02 ± 0.07 ns 
ALDO 0.29 ± 0.10 0.28 ± 0.04 ns 
11-DHC 0.54 ± 0.14 1.28 ± 0.25 ↑ P<0.05 
17OH-PREG 0.87 ± 0.20 1.36 ± 0.06 ↓ P<0.05 
17OH-PROG 0.24 ± 0.03 0.34 ± 0.02 ns 
16OH-PROG 0.39 ± 0.01 0.49 ± 0.01 ↓ P<0.01 
Deoxycortisol 10.86 ± 2.02 20.70 ± 2.23 ↑ P<0.01 
Cortisol 41.54 ± 3.42 31.05 ± 2.07 ↓ P<0.05 
Cortisone 0.11 ± 0.01 0.07 ± 0.01 ns 
DHEA 1.24 ± 0.46 1.95 ± 0.74 ns 
DHEAS 0.11 ± 0.01 0.50 ± 0.11 ↑ P<0.01 
A4 10.25 ± 1.62 14.49 ± 0.80 ↓ P<0.05 
11OHA4 8.92 ± 1.07 5.96 ± 0.61 ↓ P<0.05 
Testosterone 0.38 ± 0.07 0.54 ± 0.03 ns  
Total steroid (nM) 10790 ± 720 6600 ± 226 ↓ P<0.001 
 
AngII-stimulated steroid production is altered in the presence of S. frutescens 
extracts 
The data obtained when investigating the effect of S. frutescens on basal steroid production 
showed possible modulatory effects of the mineralocorticoid pathway in that DOC levels were 
significantly increased while CORT were significantly decreased which may possibly indicate 
that ALDO production may be affected by S. frutescens. Therefore, with the focus thus on the 
mineralocorticoid pathway, the effect of S. frutescens on the stimulation of mineralocorticoid 
production by AngII was investigated. Table 4.5 shows that even though total steroid 
production was marginally higher and 18OH-CORT and ALDO levels did not change 
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significantly after stimulation, the precursor steroid, CORT, increased significantly (± 55 to 
100 nM) after 48 hours in the presence of 10 nM AngII, while basal and AngII-stimulated DOC 
levels remained comparable. This finding therefore enabled the subsequent analyses of the 
effects of the extract on steroid flux in the mineralocorticoid pathway, and specifically on the 
production of DOC and CORT, as ALDO levels remained low, even upon stimulation. In 
addition, the investigation allowed the assessment of the effects of S. frutescens on the 
stimulatory physiological function that AngII has on an adrenal cell. 
Table 4.5: Steroid production in H295R cells in the presence of Ang II after 48 hours. The data 
represents the average of two independent experiments conducted in triplicate (n=6). 
Steroid metabolite 
Basal 10 nM AngII 
% of Total ± SEM % of Total ± SEM 
PREG ND ND  ns 
PROG 0.00 ± 0.00 0.01 ± 0.01 ns 
DOC 0.53 ± 0.05 0.48 ± 0.03 ns 
CORT 1.30 ± 0.16 2.26 ± 0.27 ↑ P<0.01 
18OH-CORT 0.06 ± 0.02 0.01 ± 0.01 ns 
ALDO 0.04 ± 0.02 0.04 ± 0.01 ns 
11-DHC 0.14 ± 0.04 0.14 ± 0.03 ns 
17OH-PREG 0.55 ± 0.38 1.65 ± 0.07 ns 
17OH-PROG 0.65 ± 0.01 0.63 ± 0.08 ns 
16OH-PROG 1.06 ± 0.04 1.07 ± 0.10 ns 
Deoxycortisol 52.44 ± 0.82 49.27 ± 0.44 ns 
Cortisol 12.93 ± 0.30 14.28 ± 0.68 ns 
Cortisone 0.27 ± 0.04 0.21 ± 0.06 ns 
DHEA ND ND ns 
DHEAS 0.28 ± 0.04 0.31 ± 0.05 ns 
A4 26.72 ± 0.52 25.82 ± 0.34 ns 
11OHA4 1.79 ± 0.09 2.22 ± 0.09 ns 
Testosterone 1.16 ± 0.08 1.12 ± 0.02 ns 
Total steroid (nM) 4365 ± 724 4528 ± 533 ns  
 
The addition of S. frutescens to the AngII stimulated H295R cells (Table 4.6) resulted in a 
reduction of CORT (± 60 to 15 nM), 16OH-PROG (± 45 to 20 nM), deoxycortisol (± 2290 to 
640 nM), cortisol (± 565 to 80 nM), A4 (± 1170 to 415 nM), DHEAS (± 12 to 3 nM) and 
testosterone (± 50 to 10 nM) production when compared to basal steroid production. However, 
DOC (± 25 to 66 nM), 17OH-PROG (± 30 to 80 nM) and PROG (not detected at first, but 
increased to 13 nM) levels were significantly higher in the presence of the extract. In the 
mineralocorticoid pathway, although not significant, 18OH-CORT (66%) and ALDO (50%) 
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appeared to be decreased in the presence of S. frutescens. However, the upstream 4.4-fold 
reduction in CORT together with the increased DOC (2.8-fold) and PROG is indicative of a 
decreased flux in the pathway. 
Table 4.6: Steroid production in H295R cells in the presence and absence of AngII and 1 
mg/mL S. frutescens extract after 48 hours. The data represents the average of two independent 
experiments conducted in triplicate (n=6). 
Steroid metabolite 
Basal 10 nM Ang II + S. frutescens 
% of Total ± SEM % of Total ± SEM 
PREG ND ND ns  
PROG 0.00 ± 0.00 0.92 ± 0.19 ↑ P<0.05 
DOC 0.53 ± 0.05 4.64 ± 0.61 ↑ P<0.05 
CORT  1.30 ± 0.16 0.90 ± 0.04 ↓ P<0.01 
18OH-CORT 0.06 ± 0.02 0.04 ± 0.04 ns  
ALDO 0.04 ± 0.02 0.08 ± 0.05 ns  
11-DHC 0.14 ± 0.04 0.63 ± 0.08 ns  
17OH-PREG 0.55 ± 0.38 2.40 ± 1.28 ns  
17OH-PROG 0.65 ± 0.01 5.39 ± 0.30 ↑ P<0.01 
16OH-PROG 1.06 ± 0.04 1.33 ± 0.09 ↓ P<0.05 
Deoxycortisol 52.44 ± 0.82 44.90 ± 0.97 ↓ P<0.05 
Cortisol 12.93 ± 0.30 5.46 ± 1.20 ↓ P<0.01 
Cortisone 0.27 ± 0.04 0.37 ± 0.05 ns  
DHEA ND ND ns  
DHEAS 0.28 ± 0.04 0.23 ± 0.02 ↓ P<0.05 
A4 26.72 ± 0.52 29.13 ± 0.87 ↓ P<0.05 
11OHA4 1.79 ± 0.09 2.22 ± 0.29  ns  
Testosterone 1.16 ± 0.08 0.60 ± 0.15 ↓ P<0.05 
Total steroid (nM) 4365 ± 724 1426 ± 141 ↓ P<0.05 
 
 
The effect of the extract on AngII stimulated steroid production was investigated (Table 4.7) 
and the results showed that the extract significantly decreased total steroid production after 
AngII stimulation (± 4.5 to 1.4 µM). In the presence of the extract, the concentrations of PROG 
(± 1 to 13 nM), DOC (± 25 to 65 nM) and 17OH-PROG (± 30 to 75 nM) were significantly 
increased in the AngII stimulated cells. Conversely, CORT (± 100 to 15 nM), 16OH-PROG 
(50 to 20 nM), deoxycortisol (± 230 to 640 nM), cortisol (± 650 to 80 nM), A4 (± 1170 to 415 
nM), 11OHA4 (± 100 to 30 nM) and testosterone (50 to 10 nM) concentrations were 
significantly decreased in stimulated cells in the presence of the extract. Interestingly, the 
steroid flux through the glucocorticoid pathway was inhibited to the greatest extent (± 70%), 
followed by the steroid production in the androgen (± 66%) and mineralocorticoid pathway (± 
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30%). The extract had no significant effect on DHEAS production in the AngII stimulated 
cells, however, DHEAS levels appeared to be reduced. 
Table 4.7: Steroid production in H295R cells in the presence of AngII and 1mg/mL S. 
frutescens extract after 48 hours. The data represents the average of two independent 
experiments conducted in triplicate (n=6). 
Steroid metabolite 
10 nM AngII 10 nM AngII + S. frutescens 
% of Total ± SEM % of Total ± SEM 
PREG ND ND 
PROG 0.01 ± 0.01 0.92 ± 0.19 ↑ P<0.05 
DOC 0.48 ± 0.03 4.64 ± 0.62 ↑ P<0.05 
CORT 2.26 ± 0.27 0.90 ± 0.04 ↓ P<0.001 
18OH-CORT 0.01 ± 0.01 0.04 ± 0.04 ns 
ALDO 0.04 ± 0.01 0.08 ± 0.05 ns 
11-DHC 0.14 ± 0.03 0.63 ± 0.08 ns 
17OH-PREG 1.65 ± 0.07 2.40 ± 1.28 ns 
17OH-PROG 0.63 ± 0.08 5.39 ± 0.30 ↑ P<0.01 
16OH-PROG 1.07 ± 0.10 1.33 ± 0.09 ↓ P<0.05 
Deoxycortisol 49.27 ± 0.44 44.90 ± 0.93 ↓ P<0.05 
Cortisol 14.28 ± 0.68 5.46 ± 1.18 ↓ P<0.001 
Cortisone 0.21 ± 0.06 0.37 ± 0.05 ns 
DHEA ND ND 
DHEAS 0.31 ± 0.05 0.23 ± 0.02 ns 
A4 25.82 ± 0.34 29.13 ± 0.75 ↓ P<0.05 
11OHA4 2.22 ± 0.09 2.22 ± 0.29 ↓ P<0.05 
Testosterone 1.12 ± 0.02 0.60 ± 0.15 ↓ P<0.05 
Total steroid (nM) 4528 ± 533 1426 ± 141 ↓ P<0.05 
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The effect of SUB, one of the major triterpenoid in S. frutescens extracts, on adrenal 
steroidogenic enzymes and overall steroidogenesis. 
The results in the previous experiments showed that the methanolic extract of S. frutescens 
influences glucocorticoid and mineralocorticoid production under basal and stimulated 
conditions. We hypothesized that SUB may be one of the compounds within the extract that 
contributes significantly to these effects and subsequently investigated the effects of SUB on 
steroidogenesis in a single enzyme expression system and the influence of SUB on adrenal 
steroid production in H295R cells. The effect of SUB on steroid substrate binding was also 
considered in this study, together with SUA. However, studies using SUA were hampered as 
limited amounts were purified, sufficient for binding assays only.  
Analysis of the methanolic extract of S. frutescens and SU compounds  
The S. frutescens extract was analysed in both ESI negative and positive modes, with a clearer 
visualization of the sutherlandins and SU compounds being obtained in ESI negative mode 
(Fig. 4.6), depicted in the total ion chromatogram (TIC).  
 
Fig. 4.6. Total ion chromatogram of the LC-MS analysis of a methanolic extract of S. frutescens 
in A) ESI+ and B) ESI- modes. The major peaks visible in B) are representative of the 
sutherlandins and sutherlandiosides. 
 
A crude mixture of SUs was obtained and fractionated using semi-preparative HPLC. The SU 
compounds exhibited a similar profile as previously reported, eluting in the order of SUB, 
SUC, SUA and SUD (Fig.4.7). 
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Fig. 4.7: A representative semi-preparative HPLC chromatogram of the crude 
sutherlandiosides mixture chromatographed on a C18 matrix. The collection window in terms 
of HPLC retention times of the two major fractions (fractions 1 and 3) and minor fractions 
(fractions 2 and 4) are given above the relevant high absorbing peaks. 
 
Fraction 1 and 3 were collected upon fractionation of the mixture of SU compounds and 
analysed by LC-MS/MS in ESI negative and positive modes with the resulting ions correlating 
to that previously described (Albrecht et al., 2012). Fraction 1 was identified as SUB and 
fraction 3 was identified as SUA (structures shown in Fig. 4.8).  
 
Fig 4.8. Chemical structures of SUA (A) and SUB (B) as determined by Fu et al. (Fu et al., 
2008). 
Stellenbosch University  https://scholar.sun.ac.za
  
91 
 
Both compounds have the same exact mass, 652.41, and similar structures, and the 
fragmentation patterns of SUA and SUB (Fig. 4.9) are also identical with the following 
extracted ions being identified in ESI positive mode m/z 653.4281 [M+H]+; m/z 635.4281 
[M+H-H2O]+; m/z 491.3741 [M+H-glu]+; m/z 473.3635 [M+H-glu-H2O]+; m/z 455.3532 
[M+H-glu-2H2O]+; m/z 437.3417 [M+H-glu-3H2O]+ and m/z 419.3275 [M+H-glu- 4H2O]+. 
In ESI negative mode the major ions previously reported for SUA and B were m/z 651.4080 
[M-H]− and m/z 697.4161 [M+formate]−, respectively (Albrecht et al., 2012). However, in our 
study m/z 697.4161 [M+formate]− was detected, but not m/z 651.4080 [M-H]−. Quantification 
of the major SU compounds in the methanol extract showed SUB was present at 3 mg/g S. 
frutescens dried plant material and SUA, SUC and SUD at 2.33, 1.86 and 2.60 mg/g, 
respectively. We subsequently focused our bioactivity studies on SUA and SUB and 
determined their effects on the substrate binding activity of the steroidogenic enzymes in 
microsomal and mitochondrial preparation.
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Fig. 4.9. LC-MS chromatogram of SUB in (A) ESI+ mode and (B) ESI- mode and SUB structure (insert). In ESI+ mode m/z 635.4281 [M+H-
H2O]
+; m/z 491.3741 [M+H-glu]+; m/z 473.3635 [M+H-glu-H2O]
+; m/z 455.3532 [M+H-glu-2H2O]
+; m/z 437.3417 [M+H-glu-3H2O]
+ and m/z 
419.3275 [M+H-glu- 4H2O]
+ were detected. In ESI- mode the major ions detected was m/z 697.4161 [M+formate]− 653.4281 [M+H]+. 
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Substrate binding to P450 enzymes is inhibited by SUB 
Previous studies have shown that a triterpenoid fraction isolated from S. frutescens inhibited 
substrate binding and conversion in adrenal microsomal preparations (Prevoo et al. 2008). The 
biological activity of SUA and B was therefore determined by investigating the ability of these 
compounds to interact with steroidogenic P450 enzymes. Microsomal preparations which 
contain both CYP17A1 and CYP21A2 were incubated with the compounds and PROG. The 
typical type 1 substrate-induced difference spectra obtained upon addition of PROG to the 
enzymes is shown in Fig. 4.10. Although the inhibition of the binding of PROG by both SUA 
and SUB, at 10 µM was significant (P<0.05), it was not as prominent as the inhibition of the 
binding of glucocorticoid precursors to CYP11B1 and CYP11B2. Interestingly, in 
mitochondrial preparations, which contain CYP11A1, CYP11B1 and CYP11B2, the binding 
of DOC to the enzymes was inhibited to a greater degree by SUB (70 %) than by SUA (40 %) 
(Fig. 4.11). In contrast, neither SUB nor SUA inhibited the binding of deoxycortisol to P450 
enzymes significantly (Fig. 4.12). As SUB appeared to be the more biologically active SU and 
due to limited availability of SUA, we conducted further investigations with SUB only.  
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Fig. 4.10: Inhibition of PROG binding in ovine adrenal microsomes in the presence of 10 µM 
SUB or SUA. [P450 microsomes], 0.35 µM; [PROG], 3.2 µM. Results are presented as the 
mean, error bars represent SEM and n=3. Inhibition was compared for each concentration using 
one-way analysis of variance followed by Tukey comparison test (***, P<0.001). 
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Fig. 4.11: Inhibition of DOC binding in ovine adrenal mitochondria in the presence of 10 µM 
SUB or SUA. [P450 mitochondria], 0.80 µM; [DOC], 3.2 µM. Results are presented as the 
mean, error bars represent SEM and n=3. Inhibition was compared for each concentration using 
one-way analysis of variance followed by Tukey comparison test (***, P<0.001). 
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Fig. 4.12: Inhibition of deoxycortisol binding in ovine adrenal mitochondria in the presence of 
10 µM SUB or SUA. [P450 mitochondria], 0.80 µM; [Deoxycortisol], 3.2 µM. Results are 
presented as the mean, error bars represent SEM and n=3. Inhibition was compared for each 
concentration using one-way analysis of variance followed by Tukey comparison test (ns, non-
significant). 
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We previously showed (Prevoo et al. 2008), using a mixture of triterpenoids at higher 
concentrations, that PROG binding was inhibited, while lower concentrations had no 
significant effect on PREG binding. It is possible that SUC and SUD, also present in the 
mixture, may have contributed to the inhibition previously observed. Nevertheless, the 
inhibition of substrate binding to P450 enzymes observed in the presence of the 
sutherlandiosides reflects the inhibition of substrate binding observed in the presence of S. 
frutescens.  
Conversion assays in COS-1 cells 
We investigated the influence of SUB on the catalytic activity of CYP17A1 and 3β-HSD2, 
branch point enzymes in adrenal steroidogenesis, towards PREG, and on that of CYP17A1 and 
CYP21A2 towards PROG. While the conversion of both PREG and PROG by CYP17A1 was 
inhibited significantly (P<0.01) in the presence of 30 µM SUB (Fig. 4.13A and B), it was only 
the catalytic activity towards PROG that was significantly inhibited at the lower concentration 
(P<0.05). The catalytic activity of CYP21A2 towards PROG (Fig. 4.13C) was not influenced 
by SUB. In contrast, 3β-HSD2 was inhibited significantly (P<0.01) at both concentrations of 
SUB (Fig. 4.13D). In addition, the catalytic activity of CYP11B1 towards DOC (Fig 4.13E) 
and deoxycortisol (Fig. 4.13F) was not influenced by the presence of SUB, whereas DOC 
conversion by CYP11B2 (Fig. 4.13G) was significantly (P<0.05) inhibited.
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Fig. 4.13: Inhibition of substrate (1 µM) conversion by SUB in transiently transfected COS-1 
cells. Percentage inhibition of (A) PREG and (B) PROG conversion by CYP17A1; (C) PROG 
conversion by CYP21A2 and (D) PREG conversion by 3β-HSD2; (E) DOC and (F) 
deoxycortisol conversion by CYP11B1 and (G) DOC conversion by CYP11B2 in the presence 
of 10 and 30 µM SUB. 
The data show that the enzymes most sensitive to SUB, at the lower and higher concentrations, 
were CYP11B2 and 3β-HSD2 with a 40-50% inhibition being observed. It was only at the 
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higher concentration of SUB that the catalytic activity of CYP17A1 was affected with the 
inhibition of PREG’s conversion being marginally greater than that of PROG. 
Steroid production in H295R cells is influenced by SUB 
In the experiments described above SUB was shown to inhibit the catalytic activities of branch 
point steroidogenic enzymes, CYP17A1 and 3β-HSD2, and as such may thus affect 
steroidogenesis. Due to limited availability, the effect of SUB was not assayed under forskolin 
or AngII stimulated conditions. However, the effect of 30 µM SUB on adrenal steroidogenesis 
was compared to the effect of a mixture of SU compounds at the same concentration in the 
adrenal H295R cell model.  
The effects of SUB on steroid hormone production was first assayed under basal conditions to 
determine whether the compounds could modulate the steroid flux due to their inhibitory 
effects on the catalytic activity of CYP17A1 and 3β-HSD2. Although the reduction of total 
steroid production was not significant at both concentrations, steroid production appeared to 
decrease by ± 20% in the presence SUB (Table 4.8). The reduced levels of 16OH-PROG, which 
were significant at 30 µM, reflect the inhibition of CYP17A1 and, together with the 
significantly decreased A4 and 11OHA4 levels which suggest a reduced flux in the androgen 
pathway, indicates a potential additive effect of the inhibition of 3β-HSD2. In the presence of 
30 µM SUB, A4 (± 990 to 670 nM), 11OHA4 (± 195 to 110 nM), 16OH-PROG (± 50 to 30 
nM) and cortisol (930 to 685 nM) were significantly decreased, while 11-DHC was 
significantly increased (± 30 to 65 nM). The data also showed that, at the higher concentration, 
SUB resulted in a ± 20% and 40% decrease in the steroids in the glucocorticoid and androgen 
pathways, respectively. Interestingly the production of 11-DHC increased significantly 
indicating increased inactivation of CORT metabolism.
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Table 4.8: Steroid production in H295R cells in the absence and presence of SUB after 48 hours. The data represents the average of two 
independent experiments conducted in triplicate (n=6). 
Steroid metabolite 
Basal 10 µM SUB 30 µM SUB 
% of Total ± SEM % of Total ± SEM % of Total ± SEM 
PREG ND ND ns ND ns 
PROG 0.00 ± 0.00 0.05 ± 0.00 ns 0.05 ± 0.00 ns 
DOC          0.15 ± 0.00           0.20 ± 0.00 ns         0.30 ± 0.00 ns 
CORT 6.30 ± 0.50 6.85 ± 1.15 ns 7.40 ± 1.55 ns 
18OH-CORT 0.35 ± 0.10 0.45 ± 0.1 ns 0.50 ± 0.15 ns 
ALDO 0.05 ± 0.05 0.05 ± 0.05 ns 0.15 ± 0.15 ns 
11-DHC 0.70 ± 0.05 1.40 ± 0.30 ns 2.05 ± 0.55 ↑ P<0.05  
17OH-PREG 0.00 ± 0.00 0.00 ± 0.00 ns 0.00 ± 0.00 ns 
17OH-PROG 1.15 ± 0.05 1.10 ± 0.05 ns 1.15 ± 0.05 ns 
16OH-PROG 1.20 ± 0.00 1.10 ± 0.05 ns 0.90 ± 0.1 ↓ P<0.05 
Deoxycortisol     35.80 ± 1.75 39.30 ± 1.5 ns 40.60 ± 1.50 ns 
Cortisol 23.10 ± 0.75 22.40 ± 0.4 ns 21.35 ± 0.80 ↓ P<0.05  
Cortisone       0.20 ± 0.05         0.15 ± 0.05 ns         0.15 ± 0.00 ns 
DHEA ND ND ND  
DHEAS 0.25 ± 0.00 0.14 ± 0.05 ns 0.15 ± 0.05 ns 
A4      24.60 ± 0.50       21.1 ± 0.5 ↓ P<0.05       21.00 ± 1.00 ↓ P<0.05 
11OHA4 4.85 ± 0.50 4.25 ± 0.20 ↓ P<0.01  3.40 ± 0.15 ↓ P<0.001  
Testosterone 1.30 ± 0.05 1.05 ± 0.15 ns   0.90 ± 0.20 ns 
Total steroid (nM)  4020.00 ± 90.00 3200.00 ± 650 ns 3300 ± 1235 ns 
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These results prompted the investigation into the effects of the triterpenoid mixture which 
contained SUA as well as SUC and SUD. Two concentrations were assayed in which the 
sutherlandiosides, SUA, SUB, SUC and SUD were present as follows: at 2.38, 3.06, 1.90 and 
2.66 µM in the 10 µM SU mixture and 7.1, 9.2, 5.7, and 8 µM in the 30 µM mixture, 
respectively. It is possible that the triterpenoids may act either synergistically or competitively 
as our data showed that SUA and SUB interact differently with the P450 enzymes in terms of 
binding (Figs 4.10 -4.12). Table 4.9 shows that the steroid production in H295R cells when 
exposed to the SU mixture at either concentration, was not reduced significantly, with only 
cortisol (± 930 to 640 nM) concentrations decreasing significantly in the presence of both 10 
and 30 µM SU mixture. The data show that the triterpenoids were not able to elicit the same 
effects as SUB suggesting that the compounds do not act synergistically. 
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Table 4.9: Steroids produced by H295R cells in the absence and presence of SU mixture (SU) after 48 hours. The data represents the average of 
two independent experiments conducted in triplicate (n=6). 
Steroid metabolite 
Basal 10 µM SU  30 µM SU  
% of Total ± SEM % of Total ± SEM % of Total ± SEM 
PREG ND ND     ns ND ns 
PROG 0.02 ± 0.00 0.03 ± 0.01 ns 0.04 ± 0.01 ns 
DOC 0.17 ± 0.02 0.24 ± 0.03 ns 0.27 ± 0.02 ns 
CORT 6.31 ± 0.60 7.23 ± 1.36 ns 7.38 ± 1.54 ns 
18OH-CORT 0.33 ± 0.11 0.44 ± 0.12 ns 0.49 ± 0.13 ns 
ALDO 0.07 ± 0.04 0.05 ± 0.03 ns 0.14 ± 0.14 ns 
11-DHC 0.69 ± 0.03 1.94 ± 0.90 ns 2.04 ± 0.57 ns 
17OH-PREG 0.00 ± 0.00 0.00 ± 0.00 ns 0.00 ± 0.00 ns 
17OH-PROG 1.13 ± 0.06 1.07 ± 0.08 ns 1.16 ± 0.06 ns 
16OH-PROG 1.19 ± 0.02 1.10 ± 0.06 ns 0.89 ± 0.08 ns 
Deoxycortisol 35.79 ± 1.76 38.10 ± 1.35 ns 40.59 ± 1.51 ns 
Cortisol 23.12 ± 0.75 21.78 ± 0.91 ↓ P<0.05  21.35 ± 0.79 ↓ P<0.05   
Cortisone 0.18 ± 0.03 0.16 ± 0.04 ns 0.13 ± 0.02 ns 
DHEA ND ND ns ND ns 
DHEAS 0.23 ± 0.02 0.17 ± 0.03 ns 0.16 ± 0.03 ns 
A4 24.61 ± 0.40 21.66 ± 1.97 ns 21.03 ± 1.07 ns 
11OH-A4 4.84 ± 0.30 4.13 ± 0.38 ns 3.41 ± 0.15 ns 
Testosterone 1.31 ± 0.06 1.06 ± 0.17 ns 0.91 ± 0.18 ns 
Total steroid (nM) 4130 ± 132 2970 ± 1000.00 ns 3200 ± 900.00 ns 
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The effect of the S. frutescens extract and SUB on downstream steroidogenic effects, 
specifically GR and MR mediated gene transcription. 
The ability of the extract and SUB to influence adrenal glucocorticoid and mineralocorticoid 
production, as shown in the previous results, may suggest that the extract and SUB could be 
used as a herbal remedy in aiding the treatment of inflammation, hypertension and/or chronic 
disease. These results prompted the investigation into the methanolic extract and SUB eliciting 
genomic effects mediated via the GR and MR. 
S. frutescens and SUB are GR agonists for transrepression but not transactivation. 
The GR and MR are ligand-dependent transcription factors that exhibit significant similarity 
in both their structures and mechanism of action. Like all steroid receptors, the GR and MR 
regulate gene expression by activating (transactivation) or repressing (transrepression) 
transcription of target genes (Nicolaides et al., 2010; Nixon et al., 2013). Transactivation occurs 
when the ligand-activated GR or MR binds to GREs or MREs in the promoters of specific 
genes, while transrepression occurs via protein-protein interactions with other transcription 
factors such as NF-κB, which drives the expression of many genes involved in the 
inflammatory response (Silverman and Sternberg, 2012).  
The relative glucocorticoid properties of the S. frutescens extract and SUB for transactivation 
of a synthetic GRE and transrepression of an IL-6 promoter-reporter gene were assayed in 
COS-1 cells. For transactivation, the cells transiently expressing hGR and GRE-driven rat 
TAT-GRE-luciferase were treated with the synthetic glucocorticoid, Dex (10 µM), extract (0.5 
and 0.75 mg/mL) and SUB (10 and 30 µM). Results show that, unlike Dex, neither the extract 
(Fig. 4.14A) nor SUB (Fig. 4.14B) display glucocorticoid agonist activity via the GRE at either 
concentration tested. 
To compare the relative glucocorticoid properties of the extract and SUB for transrepression, 
COS-1 cells were transiently transfected with the hGR expression vector and the IL-6-NF-κB 
luciferase promoter reporter construct. After stimulation with 10 ng/mL PMA cells were 
exposed to Dex (10 µM), extract (0.5 and 0.75 mg/mL) and SUB (10 and 30 µM). The results 
in Fig. 4.15A and 4.15B showed that Dex, S. frutescens extract and SUB significantly repressed 
the IL-6 promoter (P<0.001) with Dex, as expected, displaying the greatest transrepression. In 
addition, the results show that the extract elicited a greater effect on the transrepression of gene 
transcription by the GR than SUB. 
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Fig. 4.14: S. frutescens and SUB exhibit no GR agonist activity for transactivation. Induction 
was assayed after 24 hours in COS-1 cells transiently transfected with pRShGR and pTAT-
GRE-E1b-luc reporter constructs exposed to vehicle (EtOH) and DEX (10 µM), (A) S. 
frutescens extract (0.5 and 0.75 mg/mL) and (B) SUB (10 and 30 µM). Results are shown as 
fold induction relative to EtOH set as 1 and results are representative of two independent 
experiments performed in triplicate. One-way ANOVA with Dunnett’s post-test was used for 
statistical significance (***, P<0.001; ns, non-significant). 
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Fig. 4.15: S. frutescens and SUB exhibit GR agonist activity for transrepression. COS-1 cells 
transiently expressing the pRShGR and IL-6-NFκB-luc promoter-reporter construct were 
stimulated with PMA (10 ng/mL) and exposed to DEX (10 µM) and (A) S. frutescens extract 
(0.5 and 0.75 mg/mL) and (B) SUB (10 and 30 µM) for 24 hours. Results are shown as the % 
repression of the extract and SUB expressed as a % relative to the DEX response set as 100%. 
Results are representative of two independent experiments each performed in triplicate. One-
way ANOVA with Dunnett’s post-test was used for statistical significance (***, P<0.001; ns, 
non-significant). 
 
S. frutescens and SUB exhibit MR antagonist activity for transactivation. 
We subsequently assayed the putative MR antagonist activity of the extract and SUB in CHO 
cells stably expressing the rat MR, 11β-HSD2 and a pTAT3-gLuc reporter gene (Morita et al., 
1996). Cells were incubated with ALDO (10 nM), extract (0.5 and 0.75 mg/mL) and SUB (10 
and 30 µM) or with 10 nM ALDO in the presence of extract (0.5 and 0.75 mg/mL), SUB (10 
and 30 µM), or SPL (1 µM). The results in Fig. 4.16A and B show that neither the extract nor 
SUB display significant agonist activity for the MR at the concentrations assayed. However, 
Stellenbosch University  https://scholar.sun.ac.za
  
104 
 
the results in Fig. 4.17A and B show that like SPL, the well-known MR antagonist, the effects 
of ALDO via the MR can be antagonized by both the extract (0.5 and 0.75 mg/mL) and SUB 
(10 and 30 µM). Less antagonism is observed in the case of SUB (P<0.05) (Fig. 4.17B) than 
with the S. frutescens extract (Fig. 4.17A), which antagonized the effect of ALDO, comparable 
to that achieved by SPL (P<0.001).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.16: S. frutescens and SUB exhibit no MR agonist activity for transactivation. CHO-
11BHSD2 cells stably expressing rat MR and the pTAT3-gLuc reporter gene were incubated 
with vehicle (EtOH) and ALDO (10 nM) and (A) S. frutescens extract (0.5 and 0.75 mg/mL) 
and (B) SUB (10 and 30 µM) for 24 hours. Results shown are representative of two independent 
experiments performed in triplicate. Fold induction relative to EtOH set as 1 is plotted. One-
way ANOVA with Dunnett’s pos-ttest was used for statistical significance (***, P<0.001; ns, 
non-significant). 
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Fig. 4.17: S. frutescens and SUB exhibit MR antagonist activity for transactivation. CHO-
11BHSD2 cells stably expressing rat MR and pTAT3-gLuc reporter gene were incubated with 
ALDO (10 nM), set at 100%, or (A) ALDO in the presence of S. frutescens extract (0.5 and 
0.75 mg/mL) or SPL (1 µM), and (B) ALDO in the presence of SUB (10 and 30 µM) or SPL 
(1 µM) for 24 hours. Results shown are representative of two independent experiments 
performed in triplicate. One-way ANOVA with Dunnett’s post-test was used for statistical 
significance (***, P<0.001; **, P<0.01). 
 
Since the MR is also susceptible to activation by deoxycortisol and DOC, we investigated 
whether the extract would have a similar antagonizing effect in the presence of these 
glucocorticoids. Cortisol and CORT were not considered in this investigation as CHO cells 
stably express 11β-HSD2 which converts cortisol and CORT to their inactive metabolites 
cortisone and 11-DHC, respectively. Figure 4.18 and 4.19 show that the S. frutescens extract 
antagonized the effects of both DOC (P<0.001) and deoxycortisol (P<0.001) via the MR and 
Stellenbosch University  https://scholar.sun.ac.za
  
106 
 
the antagonist activity observed for the extract is comparable to that of SPL in both cases. The 
effect of SUB was not assessed due to limited availability of SUB. 
 
 
 
 
 
 
 
 
Fig. 4.18: S. frutescens MR antagonist activity for transactivation in the presence of 
deoxycortisol. CHO-11BHSD2 cells stably expressing rat MR and the pTAT3-gLuc reporter 
gene were incubated with deoxycortisol (10 nM) set at 100% or deoxycortisol in the presence 
of S. frutescens extract (0.5 and 0.75 mg/mL) or SPL (1 µM) for 24 hours. Results are 
representative of two independent experiments performed in triplicate (SEM). One-way 
ANOVA with Dunnett’s post-test was used for statistical significance (***, P< 0.001). 
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Fig. 4.19: S. frutescens MR antagonist activity for transactivation in the presence of DOC. 
CHO-11BHSD2 cells stably expressing rat MR and the pTAT3-gLuc reporter gene were 
incubated with DOC (10 nM) set at 100% or DOC in the presence of S. frutescens extract (0.5 
and 0.75 mg/mL) or SPL (1 µM) for 24 hours. Results are representative of two independent 
experiments performed in triplicate (SEM). One-way ANOVA with Dunnett’s post-test was 
used for statistical significance (***, P< 0.001). 
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Cell viability assays 
The cell viability of the COS-1, H295R and stably transfected CHO cells were assessed using 
the MTT assay. The MTT assay is based on the difference in absorbance observed in the 
absence and presence of the test compound as a measure of mitochondrial succinate 
dehydrogenase activity. MTT is reduced from its yellow form to a dark purple formazan 
product, which is dissolved using an organic solvent and the solution is measured 
spectrophotometrically.  This reaction can only occur in cells that are metabolically active and 
is therefore a measure of cell viability. Our results show that there was no significant difference 
between the control reactions and the reactions in the presence of the extract or SUB (all cell 
lines) (Fig 4.20A-C) or GABA (H295R cells only) (Fig 4.20B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.20: S. frutescens extracts (S.f), GABA, SU mixtures or SUB did not affect cell viability. 
The cell concentrations used were (A) 1x105 cells/mL for COS-1 cells, (B) 4x105 cells/mL for 
H295R cells and (C) 2.5x104 cells/mL for CHO cells. The concentrations of extract and 
compounds added to the cells are indicated on the graphs. A one-way ANOVA, followed by a 
Dunnett’s comparison test was used to determine significant differences (ns, non-significant).  
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Discussion 
As disorders such as stress, inflammation and anxiety for which S. frutescens commonly serves 
as a tonic are generally associated with adrenal dysfunction, we assessed the influence of S. 
frutescens and SUB on adrenal steroidogenesis in order to establish a potential link. Data show 
that the methanolic extract of S. frutescens as well as SUB influence adrenal steroid production 
through influencing the catalytic activity of specific P450 enzymes as well as steroid 
production in the H295R adrenal cell model affecting steroidogenic pathways. Furthermore, 
potential downstream effects were investigated in which the extract and SUB were shown to 
influence the transcriptional activities of the GR and MR. Both the extract and SUB repressed 
NF-κB driven transcription via the GR without influencing transactivational activities and were 
able to antagonize the effects of ALDO via the MR. 
Although the inhibitory effect of S. frutescens on CYP17A1 and CYP21A2 was previously 
investigated (Prevoo et al., 2008, 2004), an aqueous extract was utilized whereas a methanolic 
extract was used in this study. Due to the differences in the extraction methods employed, we 
could not assume that the methanol extract would have similar effects on the catalytic activities 
of the enzymes. Our study confirmed the inhibitory effect of S. frutescens on steroid conversion 
catalysed by CYP17A1 and CYP21A2, as was also shown with the aqueous S. frutescens 
extract, although there were differences in the results obtained. Although the inhibition of 
PROG conversion by both CYP17A1 and CYP21A2 was confirmed, the methanolic extract 
appeared to have no inhibitory effect on PREG conversion by CYP17A1. As expected, no A4 
was detected when the conversion of PROG by CYP17A1 was investigated, which can be 
attributed to species specific differences in the CYP17A1 lyase activity. Prevoo et al. utilized 
ovine adrenal microsomes and recombinant ovine CYP17A1, whereas we utilized baboon 
CYP17A1. Hough et al. has shown that numerous ovine CYP17A1 isoforms, which differ with 
regard to lyase activity, exist naturally and therefore influence the conversion of PREG and 
PROG as well as downstream cortisol production to different degrees (Hough et al., 2015, 
2012).  
In addition to the inhibition of the catalytic activity of CYP17A1 and CYP21A2, this study 
also found that 3β-HSD2 was partially inhibited by the presence of the methanolic extract (Fig. 
4.1). Although the conversion of PREG and DHEA catalysed by 3β-HSD2 was not inhibited, 
the conversion of 17OH-PREG to 17OH-PROG was. The impaired production of 17OH-PROG 
by 3β-HSD2 in Angora goats has been linked to hypocortisolism (Goosen et al., 2010) and thus 
the inhibition of 17OH-PROG formation in the presence of the methanolic extract may also 
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indicate that adrenal cortisol output may be reduced by the extract. Taken together with the 
observed inhibition of CYP17A1 and CYP21A2, the results suggest that the extract may inhibit 
the production of glucocorticoids and mineralocorticoids. The collective inhibitory effect of 
both 3β-HSD2 and CYP17A1 would be associated with reduced cortisol production, whereas 
the collective inhibitory effect of both 3β-HSD2 and CYP21A2 would also be associated with 
reduced mineralocorticoid production. 
The final step in adrenal glucocorticoid production is the conversion of DOC and deoxycortisol 
to CORT and cortisol, respectively. DOC plays an integral role in glucocorticoid and 
mineralocorticoid production as this steroid metabolite can either be converted to CORT (a 
glucocorticoid) by CYP11B1 or ALDO (the major mineralocorticoid) by CYP11B2. In 
addition to acting like a glucocorticoid in many functions such as the stress response, DOC has 
also been shown to act as a significant mineralocorticoid in downstream signalling events 
(Vinson, 2011). DOC and deoxycortisol have also been shown to play a significant role in 
hypertension and via the MR (Sugimoto et al., 2016). The inhibitory effect of the methanol 
extract on cortisol and CORT production by CYP11B1 may thus have substantial implications 
in disorders concerning both glucocorticoid and mineralocorticoid abnormalities. 
The results shown in Table 4.1 show that glucocorticoid production in H295R cells was 
affected to the greatest degree in the presence of the methanol extract as the most significant 
decreases in steroid concentration were observed for CORT (2.7-fold), deoxycortisol (1.3-fold) 
and cortisol (1.9-fold), while DOC concentrations were increased (1.6-fold). However, when 
taking into account the steroid shunt in the mineralocorticoid, glucocorticoid and androgen 
pathway, the results show that the greatest inhibitory effect was observed for mineralocorticoid 
production with the extract decreasing the total mineralocorticoids present by 1.7-fold together 
with glucocorticoid production which decreased 1.5-fold (± 2470 nM to 1670 nM), while 
androgen production, which was the least affected, decreased 1.2-fold (1245 nM to 1055 nM). 
The results also confirmed the aforementioned findings which showed that DOC production 
by CYP21A2 and DOC conversion by CYP11B1 were inhibited by the extract as the DOC 
levels in the presence of S. frutescens was ± 2.4-fold higher than that of basal DOC levels. 
Furthermore, SULT2A1 appears to be stimulated by the presence of the extract as DHEAS 
production was shown to be ± 2.5-fold greater than levels at basal production.  
The inhibition of CYP21A2 and CYP11B2 are effects that reflect data obtained in the catalytic 
assays conducted in COS-1 cells (Fig. 4.3 and 4.5) in which PROG and DOC levels were 
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increased. In addition, the increased 17OH-PROG and the decreased deoxycortisol and cortisol 
in the H295R cell assay also indicated the inhibition of CYP21A2 and CYP11B1, respectively. 
It should be noted that the decreased 16OH-PROG levels suggest the inhibition of CYP17A1 
which was also shown in COS-1 cells in which the 17-hydroxylation of PROG was inhibited 
significantly (Fig. 4.2). 
The effect of S. frutescens on adrenal steroid production during chronic stress was mimicked 
by adding the extract to forskolin stimulated cells. Forskolin mimics ACTH stimulation in 
H295R cells and as expected increased glucocorticoid (2.4-fold), mineralocorticoid (6.6-fold) 
and androgen production (1.7-fold) in these cells (Table 4.2). Overall steroid production was 
increased 2.7-fold with the results obtained in this study being similar to those previously 
reported (Mangelis et al., 2016; Schloms et al., 2012; Xing et al., 2010). In the presence of the 
methanolic extract, overall steroid production decreased when compared to forskolin 
stimulation only (1.7-fold), however, the overall steroid production in the presence of the 
extract after forskolin stimulation remained 1.6-fold greater than steroid production under basal 
conditions.  
The greatest inhibitory effect observed under forskolin stimulatory conditions in the presence 
of the extract was the decrease in mineralocorticoid production (2.2-fold), followed by 
decreased glucocorticoid (1.6-fold) and androgen production (1.5-fold). As in the previous 
experiment, the presence of the extract appeared to favour the sulfonation of DHEA, even 
under forskolin stimulated conditions, as DHEAS concentrations increased 2.8-fold. In 
addition, basal testosterone levels were decreased 1.2-fold by the extract under stimulated 
conditions and this apparent decrease could point to a potential inhibitory effect elicited by the 
extract on 17β-HSD with this enzyme belonging to the family of oxidoreductases, in the same 
steroid family as 3β-HSD2. The extract was shown to partially inhibit the catalytic activity of 
3β-HSD2 in the conversion assays (Fig. 4.1). It is due to this theory that the MTT assay was 
employed for determining cell viability during this study as the potential inhibitory effect of 
the extract on the catalytic activity of 17β-HSD may have resulted in ambiguous results. In the 
scope of this study, the measure of reductive capacity of the mitochondria, as measured by the 
MTT assay, was considered be a superior indicator of cell viability compared to steroid 
conversion by 17β-HSD. However, it has been shown that the activity of 17β-HSD towards A4 
was not inhibited significantly with approximately 90% of the A4 being converted to 
testosterone (Sergeant, 2009). 
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Also belonging to the hydroxysteroid dehydrogenase family are the 11-βHSD isozymes, both 
of which are expressed in the adrenal at low levels (Rege et al., 2013), accounting for the 
production of cortisone and 11-DHC, albeit at low levels. In the presence of forskolin both 
cortisone and 11-DHC levels increased (1.5-fold and 2.1–fold, respectively), with only 11-
DHC significantly increased by the extract (P<0.001). While AngII did not increase 11-DHC 
levels significantly, even though precursor CORT levels were elevated, the addition of the 
extract to the cells had no effect on the inactivation of cortisol or CORT. However, considering 
the active:inactive glucocorticoid ratios, the addition of the extract to basal and to both 
forskolin- and AngII-stimulated H295R cells resulted in decreased cortisol:cortisone and 
CORT:11-DHC ratios. These data suggest an interaction between the extract, and/or 
compounds within the extract, and 11-βHSD2 which could likely result in decreased 
circulatory active glucocorticoids, further reducing glucocorticoid-elicited effects at target 
tissues which would, in turn, affect the stress or inflammatory response.   
It is possible that more marked effects on 11-βHSD2 may have been observed had the 
stimulation by AngII been more significant than that reflected by the significant increase in 
CORT alone together with the marginal increases in certain metabolites and in total steroid 
production. Previous studies have shown that the addition of AngII to H295R cells resulted in 
significant stimulation of adrenal steroid production, specifically the mineralocorticoids and 
mineralocorticoid precursors (Mangelis et al., 2016; Yarimizu et al., 2015). The steroid profile 
in these studies differ from the results depicted in Table 4.5 and the differences could be 
attributed to the AngII concentrations. In the studies by Yarimisu et al. (2015) and Mangelis et 
al. (2016) 100 nM AngII was used, whereas our study used a concentration closer to that used 
in the study by Lichtenauer et al. (2012) (20 nM) (Lichtenauer et al., 2012; Mangelis et al., 
2016; Yarimizu et al., 2015). The latter study also showed that a greater mineralocorticoid 
response was observed after forskolin stimulation, rather than after AngII stimulation, a result 
similar to that which was obtained in this study. Forskolin increased mineralocorticoid 
production in the H295R cells 6.6-fold, whereas stimulation by AngII resulted in a 1.5-fold 
increase. The only steroid metabolite that was significantly increased by AngII stimulation was 
CORT (1.8-fold). The increase in CORT production is significant with regard to 
mineralocorticoid production with a 1.5-fold increase in metabolites in the mineralocorticoid 
pathway after AngII stimulation, whereas glucocorticoid production remained unchanged 
(basal, 2965 nM and AngII stimulation, 3040 nM). Basal androgen metabolite (C19 steroids) 
levels did not change significantly in the presence of AngII (1307 nM vs 1335 nM). Previous 
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studies have shown that AngII stimulates the expression of CYP11B2  (Razak et al., 2015) and 
3β-HSD2 mRNA in H295R cells (Ota et al., 2014), and although the increase in 
mineralocorticoids detected in this study after AngII stimulation may reflect this, the 
concentrations of AngII used in this study is approximately 10-fold less than that used in the 
previously reported studies. In addition, it has been reported that the expression of StAR 
mRNA was also upregulated after AngII stimulation (Olala et al., 2014) which would impact 
on cholesterol’s availability for PREG production.  
The therapeutic effects associated with the traditional use of S. frutescens could be attributed 
to specific compounds or compounds acting synergistically. Several compounds, such as L-
canavanine, D-pinitol, and GABA have been identified in methanolic extracts of S. frutescens, 
however, these compounds have not been shown to interfere with steroidogenic P450 enzyme 
activity. As our previous results have shown, the methanolic extract of S. frutescens influenced 
glucocorticoid and mineralocorticoid production by altering the catalytic activities of the 
steroidogenic enzymes. These results prompted us to investigate the effects of the cycloartanes 
on steroidogenesis, with our primary focus on SUB, to determine whether the therapeutic 
effects associated with the use of S. frutescens could be attributed to the presence of these 
compounds. Initial investigations included SUA however, due to insufficient amount of the 
compound, studies could not be completed with SUA. 
Our study confirmed the presence of SU A, B, C and D in the methanolic extract by LC-MS/MS 
and confirmed SU A and B to be the major triterpenoids in S. frutescens extracts. Although the 
SU compounds have similar cycloartane glycoside structures, they do however, differ markedly 
in their aglycone backbone specifically in terms of hydroxyl and ketone moieties at C1, C3, C7 
and C11. In addition, SUA has a C9/C11 double bond and an epoxy spanning C7/C10 over a 
7-carbon ring structure while SUB, C and D have a methylene bridge between C9 and C10 
(Avula et al., 2010; Fu et al., 2008). These structural differences permit these compounds to 
retain defined three dimensional structures which may contribute to different bioactive 
properties. In this study we turned our attention to SUB as the compound was also present at 
concentrations marginally higher than the other SU compounds in our extract. While extraction 
methods would contribute to the SU yields, studies have shown that secondary metabolites 
present in S. frutescens vary according to geographical location of plants, harvesting seasons 
and processing methods (Albrecht et al., 2012; Shaik et al., 2011). SUB specifically, has been 
shown to vary 0 to 1 % (of dry mass) of S. frutescens plants grown in different geographical 
locations (Albrecht et al., 2012). Plants grown in vitro showed different secondary metabolite 
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profiles which may be caused by the pH differences and soil that field specimens were 
cultivated in (Shaik et al., 2010). Our results are in agreement with the expected range and the 
SUB yield constituted 0.3% of the extracted dry mass of S. frutescens.  
Since the SUs have structures similar to those of steroid hormones, it is plausible to assume 
that these compounds may interact with the adrenal P450 enzymes catalysing hormone 
biosynthesis. The P450 enzyme family, comprising of hepatic and steroidal P450 enzymes, are 
structurally conserved and studies suggest that herbal remedies which interact with hepatic 
P450 enzymes could interact with the steroidal P450 enzymes due to the structural homology 
between these enzymes. These interactions are well documented and it has been demonstrated 
that adverse events associated with herb-drug interactions may be attributed to the inhibition 
of hepatic P450 enzymes by bioactive compounds (Mrozikiewicz et al., 2010; Shi and Klotz, 
2012; Zhou et al., 2003). Triterpenoid compounds in plant extracts have been linked to 
pharmacological effects which include the lowering of serum cholesterol levels as well as anti-
inflammatory, cardiovascular and hypoglycemic effects (Desai et al., 2009; Han and Bakovic, 
2015; Lockyer et al., 2012; Wu et al., 2011). The mechanisms through which these compounds 
elicit the aforementioned biological effects remain mostly unknown. While we have reported 
the modulation of adrenal P450 enzymes (Prevoo et al., 2004, 2008), a more recent study 
reported on S. frutescens extracts modulating P450 enzymes in human liver microsomal 
preparations, inhibiting the catalytic activities of CYP1A2, CYP2A6, CYP2B6, CYP2C8, 
CYP2C9 and CYP2C19 towards their known substrates in a dose dependent manner (Fasinu 
et al., 2013). An earlier study reported that SUB could influence drug metabolism by inhibiting 
CYP3A4, however no significant effect on CYP2D6 activity was reported (Madgula et al., 
2008). In addition, it has been shown that the ginsenosides present in ginseng are not only 
metabolized by hepatic P450 enzymes (Qi et al., 2011), but that they also inhibit the 
aforementioned enzymes. Results have shown that the glycosyl moiety of the compounds 
influences bioactivity and has, as such been shown to contribute to the resistance of ginsenoside 
to its metabolism by CYP3A4 when compared to the metabolism of its aglycone. These data 
suggest that steric hindrances caused by the location of the glycosyl groups may prevent the 
ginsenosides from binding to the active pocket of CYP3A4 and from being metabolised (Hao 
et al., 2010). However, ginsenosides may bind sites other than the active site and may thus 
nevertheless hamper the catalytic activity of the P450 enzymes. We have shown that both SUA 
and SUB inhibited the binding of PROG to microsomal P450 enzymes comparable to the 
extract as reported by Prevoo et al., suggesting that these compounds may contribute 
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significantly to the inhibitory effect elicited by the extract. The data does however show that 
the effect of SUA was markedly lower that the inhibitory effect of SUB. The inhibition of the 
binding of PROG could account for the increased PROG production observed in the presence 
of SUB in the H295R cells. This effect is most likely due to the inhibitory effect of SUB on 
CYP17A1, rather than CYP21A2, as the results show that SUB inhibits PROG conversion by 
CYP17A1 without affecting the catalytic activity of CYP21A2 significantly. In addition, the 
inhibition of DOC binding specifically by SUA and SUB may indicate that SUA and SUB have 
inhibitory effects on substrate binding to CYP11B2 and not CYP11B1 binding, as both 
CYP11B isoforms are present in adrenal mitochondria, while deoxycortisol is the major 
substrate for CYP11B1 and DOC is the major substrate for CYP11B 2 (Mornets et al., 1989). 
This effect is further mirrored in the conversion assays where SUB significantly inhibited DOC 
conversion by CYP11B2 while not inhibiting the catalytic activity of CYP11B1.  
Although both CYP17A1 and 3β-HSD2 were inhibited by SUB when expressed in isolation, 
these modulatory effects are not always obvious in a complex model system endogenously 
expressing all the steroidogenic enzymes. Steroid conversion would, in the H295R model 
system, also be dependent on competition between enzymes for the same substrates, together 
with the availability of precursors. However, analyses indicated inhibition of CYP17A1 by 
SUB which would impact on the availability of substrates for the downstream conversion by 
3β-HSD2 and CYP21A2. 
As with SUB, mineralocorticoid production remained relatively unchanged in the presence of 
the SU mixture. However, the SUs decreased glucocorticoid and androgen production with the 
greatest inhibitory effect on androgen production (1.6-fold decrease). The only steroid 
metabolite that was significantly affected by the presence of the SU mixture was cortisol (1.4-
fold decrease) (Table 4.9). Furthermore, the total steroid produced in the presence of the SUs 
was similar for both concentrations assayed and, although not significant, displayed a 
decreasing trend (± 1.3-fold). 
Interestingly cortisol production was also decreased significantly by SUB and in the case of 
both the SU mixture and SUB, the cortisol:cortisone ratio increased while the CORT:11-DHC 
ratio decreased. Although one would expect the production of inactivated glucocorticoids to be 
decreased as well, it would appear that SUB affects 11β-HSD2 catalytic activity in a substrate 
specific manner. However, confirmation of the latter would require further investigations.  
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Further analyses of steroid metabolite ratios showed that the cortisol:testosterone ratio 
increased, as both cortisol and testosterone levels decreased,  in the presence of the SU mixture 
and SUB. Analyses of cortisol:testosterone ratios have enabled clinicians to establish a link 
with type 2 diabetes, hypertension and cardiovascular disease (Rosmond et al., 2003), as 
elevated ratios are also characteristic of ischemic heart disease associated with insulin 
resistance (Smith, 2005). In addition, decreased cortisol:testosterone ratios have also been 
associated with adverse behavioural changes in stressed individuals (Romero-Martínez et al., 
2013). Although these effects are in conflict with the anti-inflammatory, anti-stress and anti-
diabetic effects associated with the use of S. frutescens, the effects elicited in an animal model 
may be different to that observed in the cell model system as bioavailability of compounds 
would play a significant role in compounds reaching their target sites.  
The differences in steroid metabolite production and the inhibitory effects on the catalytic 
activity of the steroidogenic enzymes between the SU compounds and the extracts may be 
attributed to the presence of other complex compounds in the extract. Several flavonoids have 
been identified in and isolated from S. frutescens extracts, with the sutherlandins constituting 
the greater part thereof (Avula et al., 2010; Fu et al., 2010), while rutin, vitexin and orientin 
have also been isolated from methanolic S. frutescens extracts (Sergeant, 2009). As was 
previously reported for flavonoids (Schloms and Swart, 2014), SUB inhibited the catalytic 
activity of 3β-HSD2 and CYP17A1 without affecting the activity of CYP21A2 and therefore 
could contribute towards the inhibitory effect of the extract towards these enzymes and steroid 
production in H295R cells. In addition, the SU compounds and sutherlandins could be acting 
synergistically in inhibiting 3β-HSD2 and CYP17A1 activity which could account for the 
greater inhibitory effect observed in the presence of the extract. Furthermore, rutin, vitexin and 
orientin were shown to inhibit the catalytic activity of CYP11B1 towards deoxycortisol to a 
greater degree than DOC, although rutin showed no inhibitory effect on DOC conversion by 
CYP11B1 (Schloms and Swart, 2014). Similar effects have been observed for flavonoids such 
as daidzein and genistein with earlier studies showing that these flavonoids inhibited the 
catalytic activity of 3β-HSD2 competitively with DHEA as substrate (Ohno et al., 2004) and 
to reduce cortisol production through influencing steroidogenic enzymes in H295R cells (Ohno 
et al., 2002). 
Typically, the downstream effects of glucocorticoids and mineralocorticoids, specifically the 
effects associated with the inflammatory response, inflammatory mediated hypertension and 
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cardio-protective effects, involve the induction of transcriptional activity mediated by the 
steroid receptor family, specifically the GR and MR. We thus next investigated the effect of 
the methanolic extract of S. frutescens and SUB on transcriptional activities of nuclear 
receptors, with specific focus on the glucocorticoid and mineralocorticoid receptors. Neither 
the extract nor SUB resulted in activation of transcription via the GR or MR, while both the 
extract and SUB efficiently repressed NF-κB-driven gene expression via the GR. The data 
furthermore showed that the extract and SUB antagonized the MR-mediated transactivation 
effects of ALDO, deoxycortisol or DOC.  
Exogenous glucocorticoids acting via the GR are widely used to treat inflammatory disorders. 
The clinical usage of glucocorticoids is however limited, due to multiple adverse side effects 
associated with prolonged use which include, amongst others, mood and behavioural changes, 
adiposity and steroid-induced diabetes (Whitehouse, 2011). These side effects are generally 
reported to be due to their capacity to transactivate gene transcription (Baschant et al., 2013) 
while the therapeutic anti-inflammatory properties are generally considered to be due to the 
transrepression  mechanism (Nixon et al., 2013). The latter concept was recently been called 
into question as it was shown that the negative side effects associated with anti-inflammatory 
treatments may in fact result from both transactivation as well as transrepression mechanisms 
of the GR (Coutinho and Chapman, 2011; Sundahl et al., 2015). However, potential anti-
inflammatory treatments with fewer side effects which stimulate and ultimately modify GR-
mediated gene expression profiles, are still actively being sought (Vandevyver et al., 2013). 
These compounds are referred to as dissociated compounds or SEGRAs (discussed in Chapter 
3). One of the first SEGRAs to be described was Compound A, a non-steroidal compound 
isolated from Salsola tuberculatiformis (Swart et al., 1993), displaying no transactivation of 
GRE-mediated gene transcription while repressing NF-κB-driven gene expression (de 
Bosscher et al., 2005; Gossye et al., 2010). Collectively, our transactivation and transrepression 
results show that the S. frutescens extract and SUB can efficiently repress NF-κB-driven gene 
expression, without activating GRE-driven gene expression suggesting that the extract and 
SUB display SEGRA-like properties which may have anti-inflammatory applications. In 
addition to the SEGRA-like properties, it is also likely that the extract and SUB could influence 
the transcriptional activities of the PR and AR as these receptors share similarities in their 
mechanisms of action and are often able to bind to the same DNA sequence and in so doing 
regulate gene transcription. However, no conclusive remarks can be made regarding the effect 
of the extract and SUB on the PR and AR until further investigations have been conducted. 
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Circulating glucocorticoids have been found to induce hypertension and although it was 
originally proposed that essential hypertension was mediated by sodium imbalances, recent 
data have suggested that the pathogenesis and maintenance of glucocorticoid-induced 
hypertension is mediated by the activation of the MR by glucocorticoids (Whitworth et al., 
2000). Typical hypertension treatments include the administration of MR antagonists such as 
SPL, however research has shown a strong association between inflammation and congestive 
heart failure (Messaoudi et al., 2012). Although the release of pro-inflammatory cytokines are 
major contributing factors to the onset of inflammation-induced congestive heart failure (Dick 
and Epelman, 2016), glucocorticoids, the GR and the MR have also been shown to play 
significant roles (Fuller, 2015; Messaoudi et al., 2012). Compared to ALDO, circulating 
glucocorticoid concentrations are significantly higher (±1000-fold), but the binding of 
glucocorticoids to the MR is regulated by the presence of 11β-HSD2. As previously mentioned, 
11β-HSD2 converts cortisol and CORT to their inactive forms, cortisone and 11-DHC 
respectively, which have no affinity for the MR (Edwards, 1988). Our results showed that 
neither the S. frutescens extract nor SUB activated MR mediated gene transcription, but instead 
antagonized the effects of ALDO, DOC and deoxycortisol via the MR comparable to the known 
MR antagonist, SPL. This result strongly suggests that the extract could be used as an anti-
hypertensive treatment. The finding that S. frutescens also contains cardenolides, naturally 
occurring cardiac glycosides, also suggests a potential application as a herbal remedy in the 
treatment of congestive heart failure in addition to its traditional use in treating inflammation 
(Shaik et al., 2011).  
The anti-inflammatory properties of S. frutescens have traditionally been regarded as a 
favourable effect elicited by the extract. However, recent studies have suggested that this effect 
may further compromise the immune system of compromised individuals as the anti-
inflammatory effect may be beneficial under basal conditions, but may add to exacerbating 
neuro-inflammation in HIV patients (Africa and Smith, 2015). Furthermore, it is not 
uncommon for drug-herb interactions to affect the efficacy of drugs that require further 
metabolism to activate drug compounds. Although data with specific reference to the effect of 
S. frutescens in drug-herb interactions is limited, the effect of the extract on hepatic P450 
enzymes (Fasinu et al., 2013) and a recent study showing reduced host reaction to conventional 
tuberculosis treatments after S. frutescens administration (Folk et al., 2016), suggest that the 
topic on drug-herb interactions by S. frutescens requires urgent attention.  
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In addition to the anti-inflammatory and anti-hypertensive effects shown in this chapter, S. 
frutescens has been anecdotally linked to anti-stress and anti-anxiety and its vernacular names 
reflect this — musapelo (Sesotho: to turn the heart around), insiswa (Zulu: to dispel darkness) 
and phetola (Setswana: it changes) (van Wyk and Albrecht, 2008). In many cases the 
therapeutic effects of herbal medicines in the treatment of mental health disorders have been 
associated with the placebo effect rather than an actual medicinal effect. In the case of S. 
frutescens however, the inhibitory effect of the extract on the P450 enzymes and the resulting 
reduction in glucocorticoids together with the repression of NF-κB-driven gene expression, 
may add scientific merit to the anecdotal use of S. frutescens as an anti-stress and anti-anxiety 
therapy. Furthermore, previous studies have shown that the ingestion of S. frutescens resulted 
in reduced hippocampal GR and GABAA receptor expression (Smith and van Vuuren, 2014). 
As S. frutescens has been shown to contain GABA (Shaik et al., 2010), it is plausible that the 
extract may exert anxiolytic effects in a GABAergic manner. We thus next investigated the 
influence of GABA on steroid production in H295R cells in the next chapter. 
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Chapter 5: Influence of GABA on steroidogenesis in H295R cells 
Introduction 
GABA, a non-protein amino acid, is found in the leaves and seed pods of many plant species 
and is essential for nitrogen storage. Although GABA serves as a nitrogen source in plants 
especially important during the germination process (Wink, 2013), in vertebrates it acts as an 
inhibitory neurotransmitter and has been reported to act as a non-sedative anxiolytic, mild 
anaesthetic and memory enhancer (Rudolph and Möhler, 2006a). These effects have been 
linked to its ability to inhibit glucocorticoid production via the HPA-axis (Herman et al., 2004), 
as well as influencing catecholamine secretion from the adrenal gland (Parramón et al., 1995). 
The presence of GABA receptors in the human adrenal (Metzeler et al., 2004) suggest that it 
may affect adrenal steroid production, however there is little data to confirm a direct influence 
of GABA on adrenal steroidogenic enzymes or hormone production in the adrenal gland.  The 
use of herbal remedies containing GABA has been linked to potential anti-cancer properties, 
as well as effects on platelet aggregation and the migration and metastasis in colon carcinoma 
(Ortega, 2003).  
The presence of GABA, L-canavanine, as well as all of the 20 naturally occurring amino acids, 
and D-pinitol has been confirmed in S. frutescens extracts by LC-MS (Mncwangi and Viljoen, 
2012; Shaik et al., 2010). Collectively, the amino acids represented between 10 and 15% (w/w) 
of the dried plant material, of which proline, alanine and asparagine contributed approximately 
60% of the total amino acid content. However, the amino acid content varies considerably 
between populations with not all samples containing these amino acids (Mncwangi and 
Viljoen, 2012). Nevertheless, GABA concentrations in the leaves of S. frutescens were found 
to be relatively high compared to other plant species as GABA is naturally low in most plants 
(Shelp et al., 1999). Ojewole et al. showed that S. frutescens extracts elicited anti-convulsant 
properties when seizures were induced in mice (Ojewole, 2004). Although the results were 
inconsistent and conclusions regarding anti-convulsant properties could not be made, the 
aqueous shoot extract did delay the onset of some induced seizures to a similar extent as 
diazepam (a well-established anti-seizure drug). The study showed that the extract acted in a 
GABA-like manner eliciting anti-convulsant properties (Ojewole, 2004). In addition, Tai et al. 
(2004) showed that the S. frutescens extract elicited anti-proliferative effects in several human 
tumour cell lines (Tai et al., 2004). The studies by Ojewole (2004) and Tai et al. (2004) 
attributed the effects of the extract to the presence of GABA. 
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GABA typically exerts a neuro-inhibitory effect through binding to the GABAA receptor in the 
brain. GABAA receptors are benzodiazepine-like receptors which are functionally closely 
related to peripheral benzodiazepine receptors (Rudolph and Möhler, 2006b). Upon GABA or 
GABA agonists binding to the GABAA receptors, chloride ions are released resulting in 
hyperpolarization and subsequently reduced neuronal activity (Zorumski et al., 2013). The 
inhibitory role of GABAA receptors in the central nervous system is well documented and many 
compounds, including barbiturates, neurosteroids, benzodiazepines and ethanol have been 
shown to bind to these receptors resulting in anxiolytic effects. Adrenal steroids, specifically 
the neuro-active metabolites of PREG, have been shown to act as neurosteroids and influence 
mood, anxiety and stress responses by binding to the GABAA receptor and exerting GABA-
like effects (Belelli and Lambert, 2005; Gunn et al., 2015). Although GABA generally exerts 
its central effects through interactions with both the GABAA (ligand-gated ion channels) and 
GABAB (G-protein-linked) receptors, GABAA receptors have been shown to be of greater 
significance with regard to the activation of the HPA-axis and stress-related effects (Brickley 
and Mody, 2012).  The neuro-inhibitory properties of GABA allows it to influence the HPA-
axis, the feedback inhibition by glucocorticoids and ultimately the stress response. These 
effects are mostly regulated at the PVN level enabling control of neuroendocrine activation 
during the stress response (Cullinan et al., 2008).  
In addition to its role in neurotransmission, it has been shown that GABA exerts 
neuromodulatory effects in the autonomic nervous system as well as eliciting hormone-like 
effects in peripheral tissues. The compound has been linked to the development of endocrine 
disorders such as diabetes mellitus and adrenal gland diseases (Gladkevich et al., 2006). 
Although the expression of GABAA receptors has been observed in the bovine and rat adrenal 
medulla, the influence of GABA at these sites has been associated mostly with catecholamine 
secretion (Inoue et al., 2010; Matsuoka et al., 2008). Studies have also shown that GABAA 
receptors are expressed in the adrenal cortex and in H295R cells (Metzeler et al., 2004), but to 
our knowledge, no studies have reported the effects of GABA on steroid production in the 
adrenal gland (Mishunina and Kononenko, 2002). Although it is well known that GABA 
influences steroid output by influencing the HPA–axis (Crowley and Girdler, 2014), there is 
little data that suggest a local effect of GABA on steroid production. 
We hypothesized that the effect of GABA on reducing anxiety and stress could be due to a 
localised effect on adrenal steroid production, since GABAA receptors are expressed in the 
adrenal gland (Metzeler et al., 2004), thus reducing elevated glucocorticoid output leading to 
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reduced anxiety. We subsequently investigated the influence of GABA on steroid production 
by P450 enzymes in H295R cells.  
Materials and methods 
General 
GABA, L-canavanine and DMEM was purchased from Sigma-Aldrich (RSA) while the 
steroids were sourced from Steraloids (Wilton, USA). Cosmic calf serum was supplied by 
HyClone®, Thermo Scientific (RSA). S frutescens subspecies were supplied by Professor Ben-
Erik van Wyk, Department of Botany of Rand Afrikaans University (Voucher specimen from 
Mrs. Grobler: C. Albrecht s.n sub B.-E. van Wyk 4126 (JRAU)). All chemicals used were of 
high analytical grade and obtained from reputable suppliers. 
Derivatization of GABA from S. frutescens extracts  
The derivatization protocol was previously reported by Colling et al. and used to determine the 
concentration of amino acids in S. frutescens (Colling et al., 2010). A 50 µL aliquot of an 
extract (53.43 mg/mL) was transferred to a glass hydrolysis tube and dried under reduced 
pressure for approximately one hour. The sample was dried under reduced pressure for another 
hour after the addition of 20 µL methanol:water:thriethylamine (2:2:1) and the adjustment of 
the pH. After adding the derivatization solution, 
methanol:water:thriethylamine:phenylisocyanate (PITC) (7:1:1:1), the sample was incubated 
at room temperature for 10 minutes and then subjected to drying under reduced pressure for an 
hour. The sample was diluted in 200 µL 50 % methanol (v/v) solution and subjected to LC-
MS/MS (Alliance HPLC coupled to a API Quatro Micro triple quadrupole mass spectrometer 
(Waters, Millford, MA, USA). The sample was separated using 0.1% (v/v) formic acid (solvent 
A) and acetonitrile (solvent B) on a Waters Xbridge C18, 2.1mm×50mm, 3.5µm column. The 
isocratic gradient, 1 minute at 96% solvent A, was followed by a 7 minute linear gradient, 60% 
solvent B to 40% solvent A, whereafter the system was returned to 96% solvent A for 7 
minutes. Linear standard curves, produced using 4 concentrations of GABA, asparagine, 
arginine and canavanine, were used to calibrate the samples. 
Inhibition of steroid metabolism in H295R cells 
Basal steroid metabolism in H295R cells was assessed in the presence of 10 µM GABA with 
and without the extract (1 mg/mL) as previously described (Schloms et al., 2012). Confluent 
cells were seeded into 12 well plates at 4x105 cells/mL/well, and allowed to settle for 48 hours 
before the medium was replaced with growth medium containing 0.1 % cosmic calf serum. 
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Cells were incubated for 12 hours before the addition of GABA and S. frutescens to the cells. 
Aliquots, 500 µL, were collected after 48 hours and the steroids extracted as previously 
described in Chapter 4. The steroid residue was resuspended in 150 µL methanol for analysis 
by UPLC-LCMS. Steroids were separated using a Phenomenex UPLC Kinetex PFP (2.1 mm 
× 100 mm, 2.6 um) column and analyzed and quantified by UPLC-APCI-MS (Schloms et al., 
2012). 
Cell viability assays 
The viability of the H295R cells in the presence of the extract was determined using an in vitro 
cytotoxicity assay kit based on an MTT assay (Sigma-Aldrich, RSA) according to the 
manufacturer’s instructions. Viability was assayed using 4x105 cells/mL in the presence of 1 
mg/mL extract or 10 µM GABA. Cell viability was not affected at these concentrations and no 
detrimental or stimulatory effects were observed.  
Statistical analysis 
Experiments were repeated in duplicate with three replicates within each experiment (unless 
stated otherwise). Mean values of data obtained in each experiment were analyzed using one-
way ANOVA and appropriate post-tests as indicated in figure legends. The error bars represent 
the standard error of the mean (SEM). All data manipulations, graphical representations and 
statistical analysis were performed using Graph Pad Prism 5 (GraphPad Software, Inc, CA, 
USA). 
Results 
Quantification of GABA in the methanolic S. frutescens extract. 
A sample of the methanolic extract was subjected to derivatization and separation by LC-
MS/MS as described by Colling et al. (2010). The samples were analysed for amino acid 
content, specifically GABA, asparagine, arginine and canavanine. Although the aim of the 
study was to determine the concentration of GABA in the extract, the concentrations of 
asparagine, arginine and canavanine were also quantified (Fig 5.1) as the derivatization method 
has not been validated and results may vary between plant samples. The concentrations of these 
amino acids were subsequently used for the relative comparison to the amount of GABA 
present. GABA, asparagine, arginine and canavanine were quantified at ± 0.8, 1, 0.4 and 0.5 
µg/µL, respectively.  
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Fig. 5.1:  Total ion chromatograms (ESI + mode) of the derivatised amino acids present in a methanolic S. frutescens extract.
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The influence of GABA on steroid production in H295R cells 
The influence of GABA on adrenal steroidogenesis was investigated to determine whether the 
compound would ultimately affect glucocorticoid, mineralocorticoid and androgen production 
in H295R cells. The results in Table 5.1 show the steroid metabolites produced in H295R cells 
in the presence of GABA and/or a methanolic S. frutescens extract as compared to steroid 
production under basal conditions.  
The presence of GABA resulted in an increase in 11-DHC (± 30 to 60 nM) levels, and 
decreased levels of cortisol (± 930 to 655 nM) and adrenal androgens, A4 (± 995 to 700 nM), 
11OHA4 (± 195 to 125 nM), testosterone (± 50 to 30 nM), while total steroid production was 
reduced, ± 4040 to 3200 nM. The presence of GABA reduced total steroid production 1.3-fold, 
however the addition of extract together with GABA resulted in a greater reduction, 1.7-fold. 
In the presence of GABA, only DOC (± 7 to 13 nM) levels increased significantly, while 
decreased levels were detected for CORT (± 255 to 140 nM), 17OH-PROG (± 45 to 20 nM), 
16OH-PROG (± 50 to 25 nM), deoxycortisol (± 1445 to 940 nM), cortisol (± 930 to 440 nM), 
A4 (± 995 to 575 nM), 11OHA4 (± 195 to 124 nM),  and testosterone (± 50 to 20 nM). 
The influence of GABA and the extract on total steroid production was similar with a decrease 
of 1.26- and 1.4-fold, respectively. Both conditions decreased CORT levels with the extract 
having a greater effect (± 236 nM vs ± 124 nM). Interestingly, while GABA did not lower 
DHEAS levels significantly (± 9 nM vs ± 6.5 nM), DHEAS levels were significantly increased 
in the presence of the extract (± 24 nM). When the effects of GABA in the absence and presence 
of extract were compared, the results showed that the presence of the extract further decreased 
total steroid production (± 3200 to 2400 nM) as well as  CORT (± 235 to 143 nM) levels, while 
DHEAS levels decreased from 24 nM to 18 nM.  
Stellenbosch University  https://scholar.sun.ac.za
  
125 
 
Table 5.1: Steroid levels in H295R cells in the presence of GABA and GABA with S. frutescens analysed after 48 hours. The data represents the 
average of two experiments conducted in triplicate (n=6). 
Steroid metabolite 
Basal 1 mg/mL S. frutescens 10 µM GABA GABA + S. frutescens 
% Total ± SEM % Total ± SEM % Total ± SEM % Total ± SEM 
PREG ND    ND ND ND  
PROG 0.02 ± 0 0.02 ± 0.01 ns 0.04 ± 0.01 ns 0.03 ± 0.01 ns 
DOC 0.17 ± 0.02 0.47 ± 0.03 ns 0.23 ± 0.04 ns 0.55 ± 0.06 ↑ P<0.05 
CORT 6.31 ± 0.6 4.3 ± 0.58 ↓ P<0.05  7.35 ± 0.95 ns 5.95 ± 1.27 ↓ P<0.01 
18OH-CORT 0.33 ± 0.11 0.38 ± 0.1 ns 0.45 ± 0.1 ns 0.57 ± 0.14 ns 
ALDO 0.07 ± 0.04 0.03 ± 0.02 ns 0 ± 0 ns 0 ± 0 ns 
11-DHC 0.69 ± 0.03 0.9 ± 0.13 ns 1.78 ± 0.35 ↑ P<0.01 1.95 ± 0.6 ↑ P<0.01 
17OH-PREG ND ND   ND ND 
17OH-PROG 1.13 ± 0.06 1.63 ± 0.11 ns 1.17 ± 0.05 ns 1.3 ± 0.06 ↓ P<0.05 
16OH-PROG 1.19 ± 0.02 1.19 ± 0.06 ns 1.08 ± 0.09 ns 1.1 ± 0.07 ↓ P<0.01 
Deoxycortisol 35.79 ± 1.76 36.89 ± 1.08 ↓ P<0.05  39.67 ± 2.13 ns 39.24 ± 0.75 ↓ P<0.01 
Cortisol 23.12 ± 0.75 17.57 ± 0.58 ns 20.52 ± 0.87 ↓ P<0.001 18.45 ± 0.67 ↓ P<0.001 
Cortisone 0.18 ± 0.03 0.26 ± 0.04 ns 0.16 ± 0.02 ns 0.23 ± 0.05   
DHEA ND    ND ND ND 
DHEAS 0.23 ± 0.02 0.85 ± 0.15 ↑ P<0.001  0.17 ± 0.01 ns 0.76 ± 0.17 ns 
A4 24.61 ± 0.4 28.78 ± 0.71 ns 21.94 ± 0.57 ↓ P<0.05 23.99 ± 2 ↓ P<0.01 
11OHA4 4.84 ± 0.3 5.47 ± 0.3 ns 3.87 ± 0.27 ↓ P<0.01 4.95 ± 0.25 ↓ P<0.01 
Testosterone 1.31 ± 0.06 1.26 ± 0.11 ns 1.02 ± 0.13 ↓ P<0.05 0.93 ± 0.15 ↓ P<0.01 
Total steroid (nM) 4040 ± 78 2900 ± 135 ns 3200 ± 226 ↓ P<0.05 2400 ± 248 ↓ P<0.001 
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Even though GABA in the presence of the extract decreased steroid output, the androgen 
production remained at 27% in the case of GABA, and 30% in the case of GABA in the 
presence of extract. The data suggests that GABA attenuates the effect of the extract on 
androgen output as 36.5% of adrenal steroids are channelled towards androgen production in 
the presence of the extract alone, although levels did not exceed those in basal steroid 
production: Basal = 30% (± 1250 nM); GABA = 27% (± 865nM); GABA + 1 mg/mL S. 
frutescens = 30% (± 732 nM) and S. frutescens = 37% (± 1056 nM). It is interesting to note 
that, as was found in the Chapter 4, the S. frutescens extract decreased glucocorticoid 
biosynthesis, while both CORT and cortisol levels were decreased by GABA which was 
amplified in the presence of S. frutescens.    
Cell viability 
The viability of H295R cells in the presence of GABA was assessed in a MTT cytotoxicity 
assay. Figure 5.2 shows that there is no significant difference in cell viability between the 
control and test (S. frutescens extract or GABA) experiments.  
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Fig. 5.2: S. frutescens extracts (S.f, 1 mg/mL) and GABA (10 µM) did not affect the viability 
of H295R cells. A one-way ANOVA, followed by a Dunnette’s comparison test was used to 
determine significant differences (ns, non significant). 
 
Discussion 
The aim of this investigation was to determine whether GABA would influence adrenal 
steroidogenesis in H295R cells. The results show that the addition of GABA to H295R cells 
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resulted in a significantly different steroid metabolite profile when compared to basal steroid 
production, with the greatest effect on adrenal androgen production. 
The GABA content of the methanolic S. frutescens extract was determined by subjecting an 
aliquot of the extract to derivatization and subsequent separation by LC-MS/MS. As amino 
acids are polar, derivatization is employed to make the amino acids more volatile, less reactive 
and generally improve their chromatographic characteristics (Bidlingmeyer et al., 1984). We 
determined GABA levels to be 1.5 mg GABA/g dried plant material which falls between the 
ranges previously reported. Shaik et al. showed that leaf extracts of S. frutescens contained 
3.48 mg GABA/g dried plant material, whereas van Wyk and Albrecht found 0.23 and 0.85 
mg/g dried plant material  (Shaik et al., 2010; van Wyk and Albrecht, 2008). The difference in 
GABA levels reported could be attributed to pH, light exposure and general growth conditions 
since the specimens used by Shaik et al. were grown in vitro and van Wyk and Albrecht utilized 
field specimens (Shaik et al., 2010; van Wyk and Albrecht, 2008). Shaik et al. showed that L-
arginine, alanine and proline comprised approximately 60% of the total amino acid content of 
S. frutescens extracts (Shaik et al., 2010). However, previous reports indicate that the amino 
acid content of the extracts is highly variable — asparagine: 1.6 – 3.5 mg/g extract, arginine: 
0.5 – 6.7 mg/g extract, and canavanine: 0.42 – 14.5 mg/g extract (Moshe et al., 1998; van Wyk 
and Albrecht, 2008). This variability can be attributed to differences in extraction methods, the 
geographical location of the plants and harvesting methods. Our results showing that 
asparagine, arginine and canavanine were present in the extract at 1.82, 0.68 and 0.90 mg/g 
dried plant material, respectively, are comparable to these previously reported studies. In the 
presence of the S. frutescens extract (1 mg/mL), the final concentration of GABA added to the 
H295R cells was approximately 140 µM. We assayed GABA at 10 µM as this concentration 
was used in previous studies investigating the effects of glucocorticoids on the GABAergic 
system in rat cortical microsacs (Strömberg et al., 2005).  
Several effects elicited by S. frutescens extracts have been attributed to the presence of GABA, 
specifically anti-anxiety, anti-convulsant (Ojewole, 2004), anti-proliferative and pro-apoptotic 
effects (Tai et al., 2004). Recent studies have shown that disrupted endocrine systems play a 
major role in the development of cancers as well as cancer relapses caused by chemotherapy 
induced endocrine resistance (Casco and Soto-Vega, 2016). The anti-cancer effect of the 
extract may be linked to the extract’s ability to reduce glucocorticoid production during 
steroidogenesis and the repression of NF-κB-driven gene transcription mediated by the GR as 
shown in Chapter 4. Although we have identified compounds that could contribute to these 
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effects, the contribution of GABA to the reduction in steroid metabolites could not be assumed 
and was therefore investigated in this study. In addition, the sedative effects of the extract could 
be attributed to the effects of GABA on neurotransmission in the hippocampus as subjects 
receiving GABA orally showed the compound to have anxiolytic effects as the subjects showed 
decreased anxiety (Abdou et al., 2006).  
The inhibitory role of GABAA receptors in the central nervous system is well documented and 
many compounds, including barbiturates, neurosteroids, benzodiazepines and ethanol have 
been shown to bind to these receptors causing anxiolytic effects. Studies have shown that 
PREG and DHEA metabolites exert neural excitatory effects as these neurosteroids antagonize 
the inhibitory effects of GABA on GABAA receptors, whereas PROG metabolites exert 
inhibitory effects by binding as agonists to the GABAA receptors (Falkenstein et al., 2000; 
Vallée et al., 2000). Although the main site of androgen production is the gonads, testosterone 
is also produced in the adrenal cortex (Udhane and Flück, 2016) and adrenal androgens, 
specifically androstanediol — a downstream metabolite of testosterone, has been shown to 
directly affect the GABAA receptor (Reddy and Jian, 2010). In addition, studies have shown 
that the phosphorylation of the GABA receptor’s subunits may influence neurosteroid activity 
adding variability to neurosteroid responses (Comenencia-Ortiz et al., 2014). 
Earlier investigations have confirmed the presence of various GABAA receptor subunits within 
the adrenal gland and H295R cells, however, these studies have not investigated the localized 
effect of GABA on steroid metabolism in H295R cells. Metzeler et al. found mRNA traces for 
α2, α3, β2, β3, γ2, and ε subunits of the GABAA receptor in H295R cells, however no mRNA for 
α1 and β1 was detected (Metzeler et al., 2004). GABAB receptor subunits were also detected in 
these cells. Additionally, it was shown that GAD, an enzyme involved in GABA production, 
is active in H295R cells. The GABA receptor subunits and GAD play a significant role in the 
GABAergic system and the expression of these subunits and enzyme has been found to be 
similar in other endocrine tissues (Metzeler et al., 2004). 
Our results show that GABA significantly influenced steroid production in H295R cells, 
decreasing adrenal androgen production to the greatest extent (1.4-fold). Although 
mineralocorticoid production appeared to be unchanged, the steroid shunt in the glucocorticoid 
pathway was decreased 1.2-fold by GABA. Glucocorticoid and adrenal androgen production 
were decreased by 1.7-fold and mineralocorticoid production was decreased by 1.4-fold when 
the extract was added to the cells incubated with GABA. The cortisol:cortisone ratio was not 
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significantly affected by the presence of GABA, however the CORT:11-DHC ratio decreased. 
After the addition of the extract, both these ratios were decreased significantly (a trend 
observed in previous experiments (Chapter 4) where the extract decreased the CORT:11-DHC 
ratio in H295R cells). This observed trend thus suggests a further lowering effect on active 
glucocorticoid levels which may contribute to the anti-stress and anti-inflammatory effects of 
the extract. In addition, GABA decreased the testosterone:cortisol ratio, reflecting its 
application in mood disorders as increased testosterone:cortisol ratios have been linked to an 
increase in violence (Montoya et al., 2012; Romero-Martínez et al., 2013). The decrease in 
CORT and increase in DHEAS levels by the extract is a consistent result observed in the H295R 
experiments in Chapter 4. The increase in GABA concentration does not seem to alter the 
ability of the extract to stimulate the production of DHEAS. A similar effect was observed in 
Chapter 4, where SUs were unable to stimulate DHEAS production whereas the extract 
appeared to favour the sulfonation reaction, even under forskolin stimulated conditions. 
Increased levels of DHEAS may however counteract the anxiolytic effects associated with the 
extract as this steroid metabolite has been shown to act as an allosteric GABAA receptor 
antagonist (Majewska et al., 1990). The antagonistic effects of DHEAS on the GABAA receptor 
may however be concentration dependent as the effects elicited by this steroid have been shown 
to vary at high and low physiological concentrations (Reddy, 2010).  
In addition to DHEAS, PREGS is also produced from PREG by SULT2A1 (Strott, 2002) and 
although we did not investigate the formation of PREGS in the H295R cells, we could speculate 
that PREGS production would also be increased in the presence of the extract as PREGS and 
DHEAS have both been shown to elicit excitatory effects after binding to the GABAA receptors 
(Paul and Purdy, 1992; Rupprecht and Holsboer, 1999) and act as GABAA receptor antagonists. 
Studies have shown the stress-induced downregulation of GABA1α receptors in hippocampal 
tissues of rats after the ingestion of S. frutescens, suggesting that the effect of the extract in the 
brain may not only be exerted through the inhibitory effect of GABA in the extract, but also 
the downregulation of GABA receptor expression. Previous reports confirmed decreases in 
GABA receptors in response to stress, however these decreases are associated with total 
GABAA receptor decreases and it can therefore not be assumed that the anxiolytic effect of the 
extract would be abolished because of the interaction with only one GABA receptor subunit 
(Smith and van Vuuren, 2014). As a previous report has confirmed the activity of an ethanol 
extract of S. frutescens in the GABA-benzodiazepine receptor binding assay (Stafford et al., 
2005), we cannot exclude the ability of compounds within the extract to potentially bind to the 
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GABAA receptor and eliciting anxiolytic effects. In addition, it has been shown that 
neurosteroids may bind directly to GABA receptors and elicit anxiolytic responses (Wang, 
2011).  
The decreased testosterone production (and perhaps the other C19 steroids in the androgen 
pathway) in H295R cells in the presence of GABA may add scientific merit to the therapeutic 
application of the extract as an anti-convulsant therapy as testosterone has been shown to 
modulate susceptibility to seizures (Reddy and Jian, 2010). Furthermore, the decrease in 
adrenal androgen production, specifically testosterone, in the presence of GABA may have 
implications in the development of prostate cancer. Traditional views that increased circulating 
testosterone levels are directly related to the development of prostate cancers have been 
questioned and there is conflicting evidence suggesting that elevated testosterone levels may 
not be indicative of prostate cancer. Varying results and potentially skewed study designs have 
all contributed to the controversy surrounding testosterone and prostate cancer (Klap et al., 
2015). However, the decrease in glucocorticoids observed may suggest a potential anti-
inflammatory action of GABA, when used for the treatment of inflammatory disorders, and as 
inflammation is associated with many cancers, this anti-inflammatory effect could add to the 
anti-cancer effects of GABA. However, as the present investigation has shown, it is unlikely 
that GABA is the major contributing compound to the anti-inflammatory and anti-cancer 
properties of S. frutescens (Gallo-Payet and Payet, 2003). 
Considering the results obtained by Smith and van Vuuren showing that relatively low dosages 
of S. frutescens resulted in decreased GR expression in the hippocampus and reduced 
expression of the GABAA α1 receptor subunit, it is plausible that compounds within the extract 
facilitate the transport of GABA (and potentially other compounds) across the blood-brain 
barrier. The combinations of compounds present in the extract may thus impact on transport 
and delivery mechanisms to target sites. 
In addition to GABA, the anti-anxiety effects of the extracts could also be elicited through 
flavonoid compounds present in the extract as studies have shown that flavonoid compounds 
bind the GABAA receptor with high affinity (Marder and Paladini, 2002; Medina et al., 1997). 
For example, flavonoid-rich orange juice extracts displayed significant agonist activity on the 
benzodiazepine binding site of GABAA receptors resulting in anti-epileptic and anti-convulsant 
effects (Citraro et al., 2016). Studies have also shown that rutin, identified within S. frutescens 
extracts, exerts anxiolytic effects in rats through interacting with GABAA receptors in the 
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basolateral amygdala while these effects could not be associated with benzodiazepine receptors 
(Hernandez-Leon et al., 2017). Furthermore, it has been shown that flavones bind specifically 
to the benzodiazepine sites of the GABAA receptor with high affinity, inducing effects 
comparable to that of benzodiazepine (Kahnberg et al., 2002).  
The altered local steroid production in the presence of GABA may be explained by the presence 
of GABAA receptors in the adrenal gland as GABA is known to inhibit steroid production via 
the HPA-axis when binding to these receptors (Crowley and Girdler, 2014; Cullinan et al., 
2008). This inhibitory effect has however only been localized to the hippocampus and further 
investigations are required to investigate the local effect of GABA and GABA receptors on 
steroid production in the adrenal. The effects elicited by GABA are unlikely to be due to a 
direct interaction with the steroidogenic and P450 enzymes as Prevoo et al. have shown that 
GABA does not influence PROG and PREG binding in ovine adrenal microsomes (Prevoo et 
al., 2008). Furthermore, GABA requires active transport across the blood-brain barrier, which 
additionally suggests that a transporting mechanism could be involved in the delivery of 
ingested GABA at concentrations high enough to elicit the effects associated with S. frutescens 
administration (Kuriyama and Sze, 1971; Malakoutikhah et al., 2010). Numerous studies have 
shown that GABA is transiently absorbed in the intestine through rapid transepithelial transport 
which is pH-dependent. After oral administration, GABA has also been shown to induce anti-
convulsant and anxiolytic effects as expected (Thwaites et al., 2000). Smith and van Vuuren 
have however shown that rats receiving relatively low dosages of S. frutescens displayed 
decreased GR expression in the hippocampus accompanied by a reduced expression of the 
GABAA α1 receptor subunit, although these effects were independent of each other (Smith and 
van Vuuren, 2014). The GABAA α1is generally associated with a sedative effect (Vinkers et 
al., 2009) and could thus account for the calming effect associated with the use of S. frutescens. 
The effect of GABA on transcriptional activities of the GR was investigated in this study, 
however, due to highly variable data no conclusive results were obtained (data not shown).  
Taken together, the results of this study show that GABA does influence glucocorticoid and 
adrenal androgen production in H295R cells and in doing so may contribute to the anti-
inflammatory, anti-stress and anti-anxiety properties associated with the traditional use of S. 
frutescens for the treatment of disorders associated with excess glucocorticoid production. The 
results suggest that S. frutescens could exert anxiolytic effects through rapid, non-genomic 
(neuro inhibition through GABA and flavonoid compounds) as well as longer term genomic 
effects (downregulation of GR and GABA receptors), however further investigations are 
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required to confirm these mechanisms. Future investigations into the inhibitory effect of GABA 
on individual steroidogenic enzymes and steroid receptors may also shed light on the 
mechanism through which GABA influences adrenal steroid production as previous studies 
have shown that GABA does not bind directly to P450 enzymes. 
  
Stellenbosch University  https://scholar.sun.ac.za
  
133 
 
Chapter 6: Conclusion 
S. frutescens is one of southern Africa’s most popular medicinal plants and is used for a 
plethora of ailments and a wide range of diseases, with acquired immunodeficiency syndrome 
(AIDS) being the most recent addition. While its popular traditional use has been in the 
treatment of cancers, anecdotal evidence does suggests that S. frutescens extracts can be used 
in the treatment of depression and inflammation (van Wyk and Wink, 2004). Some scientific 
studies have been undertaken to investigate the molecular mechanism of action of S. frutescens 
and show that the anti-inflammatory effects of S. frutescens, are associated with the inhibition 
of the COX-2 enzyme (Na et al., 2004) and influences on cytokine activation (Gonyela, 2016; 
Jiang et al., 2014; Lei et al., 2014). However, studies linking the anti-inflammatory or anti-
stress effects to the dysfunction of the endocrine system are limited. A study from our group 
has shown interactions of the extract and P450 enzymes and linked these effects to the anti-
stress, anti-anxiety and anti-depression properties of the extract (Prevoo et al., 2008, 2004). 
The results presented in this thesis have added scientific merit to the use of S. frutescens 
extracts as anti-inflammatory and anti-stress treatments and has shown, for the first time, that 
the extracts may exhibit anti-hypertensive properties. Considering that MR antagonists are used 
in the treatment of patients with heart failure, the results suggest that S. frutescens may also 
exhibit cardioprotective properties. 
The novel finding that the extracts may display anti-hypertensive and cardioprotective 
properties is based on the effects of the extract on mineralocorticoid production and the 
antagonistic effects of the extract on MR mediated transcriptional activity. The current 
treatment strategies for hypertension and related cardiac disorders have relied mainly on the 
manipulation of the production and/or activity of vaso-active hormones such as ALDO and 
AngII. The increase in cardiac disorders over the past decade has renewed interest in MR 
antagonists despite adverse side effect profiles, such as hyperkalemia, observed when steroidal 
MR antagonists, such as SPL and eplerenone, are used (Tamirisa et al., 2004). In contrast, 
clinical data suggests that the use of non-steroidal MR antagonists may reduce the risk of the 
development of hyperkalemia, and generally elicit less severe side effects while maintaining 
anti-hypertensive properties (Piotrowski, 2012).   
The results presented in this thesis have shown that extracts decreased mineralocorticoid 
production in H295R cells, inhibited specific P450 enzymes in the mineralocorticoid pathway 
(most notably CYP11B2) and antagonized the effects of ALDO on MR mediated 
transactivation comparable to SPL. As it cannot be deduced from the results whether specific 
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compounds within the extracts act as steroidal or nonsteroidal MR antagonists, it is difficult to 
speculate whether it would display an improved side effect profile when compared to that of 
SPL side effects. Although SUB elicited similar anti-hypertensive effects by antagonizing the 
effects of ALDO via the MR and was able to inhibit CYP11B2, SUB did not influence 
mineralocorticoid production in H295R cells. The structure of SUB, resembling that of adrenal 
steroids, may suggest that the compound may act as a steroidal MR antagonist potentially 
eliciting similar adverse side effects as those associated with the use of SPL. However, the fact 
that SUB decreases adrenal androgen production in H295R cells may suggest that the side 
effects may not be as severe. This hypothesis does however require further investigation into 
the effects of SUB on the steroidogenic enzymes involved in downstream androgen activation 
and metabolism. Furthermore, as some of the side effects associated with MR antagonists such 
as SPL have been linked to interactions with the AR (Barthelemy et al., 2014; Bonne and 
Raynaud, 1974; Hughes and Cunliffe, 1988), it would be interesting to investigate the effects 
of SUB via the AR . In terms of the cardioprotective effects, it is unlikely that the results 
observed in this study could be attributed, in part, to the presence of the cardenolides in the S. 
frutescens extract as the mechanism of action of these compounds involves sodium and 
potassium pumps (Takahashi et al., 2011). However, studies have not confirmed whether or 
not cardenolides exert local effects on steroid biosynthesis in the adrenal gland.  
Furthermore, this study adds merit to the use of S. frutescens in the treatment of inflammation. 
Previous studies have focussed on the ability of the extract to interfere with cytokine activation, 
however our results show that the extract is able to influence glucocorticoid biosynthesis and 
GR mediated gene transcription. This study investigated the effects of the extract and SUB on 
adrenal glucocorticoid production and the effects of the extract and SUB on transactivation and 
transrepression of gene transcription mediated via the GR. Our results showed that both the 
extract and SUB decreased glucocorticoids produced in H295R cells, inhibit key branch point 
P450 enzymes (CYP17A1 and CYP21A2) and mediate SEGRA-like effects. The novel finding 
that the extract and SUB elicit SEGRA-like effects may provide insight into the mechanism of 
action of the therapeutic application of the extracts to treat inflammation without eliciting the 
damaging side effects associated with long term glucocorticoid use. Although the 
transactivation of inflammatory gene transcription mediated via the GR was first reported to 
be primarily associated with adverse effects of glucocorticoid therapies, while transpression 
mechanisms were associated with favourable ant-inflammatory effects, it has become clear that 
receptor interaction and downstream gene activation is far more complex and as such this 
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simplistic general distinction between the two mechanisms should be interpreted with caution. 
Emerging research has shown that the inflammatory effects elicited via the transcriptional 
activities of the GR may be the result of different ratios of GR-complex conformations, i.e. 
monomers vs dimers, rather than merely transactivation vs transrepression (de Bosscher et al., 
2016; Sundahl et al., 2015). Taking our results together with the recent report that the GR 
expression is downregulated in the presence of the extract (Smith and van Vuuren, 2014), it is 
likely that the extract and SUB could be applied successfully as an anti-inflammatory therapy 
as reduced GR expression together with decreased levels of glucocorticoids available for 
binding to the GR and the SEGRA-like effects of the extract and SUB, will decrease the 
likelihood of a pro-inflammatory response. However, caution should be exercised when 
considering the use of this medicinal plant in the treatment of inflammation as a recent study 
has shown that the extract may exacerbate the inflammatory response when used as a treatment 
in immunocompromised HIV infected patients (Africa and Smith, 2015).  
The more well-known anecdotal application of S. frutescens relates to its ability to reduce 
stress, anxiety and depression. The Zulu name for the S. frutescens, unwele, which translates 
to hair, refers to the use of the plant in preventing people from pulling out their hair in distress 
(van Wyk, 2008). However, in traditional medicine used successfully in the treatment of mental 
illness, positive effects are often attributed to a placebo effect rather than active compounds 
producing the physiological response. It should however be noted that while S. frutescens 
contains compounds that may exhibit neurological effects, the stress response is complex, with 
the release of stress hormones from the adrenal gland regulated via the HPA-axis which, in 
turn, is regulated by many different factors (de Kloet et al., 2008). As the susceptibility of 
individuals to stress-related psychopathology appears to vary considerably, the development 
and progression of stress and depression have been linked to variations in the sensitivities and 
functionalities of the HPA-axis which is associated with GR sensitivity. The latter may impact 
on the effect of a stressor on the brain, HPA-axis feedback actions and the ultimate 
development of depression. The transcription of GR mediated genes are additionally regulated 
by factors, such as chaperone and co-chaperone proteins (Vermeer et al., 2003), which activate 
a short negative feedback loop after binding to the liganded GR and decreases GR signalling 
(Binder, 2009). The MR, however, regulates the initiation of the stress response through 
transcriptional activities and determines the threshold for HPA-axis activation. The functional 
role of MRs in the maintenance of basal steroid levels has been suggested to occur through 
inhibitory actions mediated through GABAergic neurons that act on the PVN of the 
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hypothalamus (Berardelli et al., 2013). In addition, the MR contributes to the exertion of rapid 
non-genomic effects though neurotransmission and the synaptic signalling strength in the brain 
(de Kloet et al., 2016, 2005; Hauer et al., 2011). A recent study has also shown that GABA 
influenced hypertension by antagonizing MR mediated gene transcription (Downey, 2015). 
GABA has been shown to modulate the immune response by affecting the GABAA receptors 
and have been shown to play an important role in autoimmune diseases (Bhat et al., 2010; Jin 
et al., 2013). Although mostly associated with neurotransmission and potential anti-cancer 
effects, GABA may also contribute to the anti-inflammatory effects reported for S. frutescens 
extracts. These effects are mirrored in the results of this study as it was found that GABA 
reduced the glucocorticoid levels in H295R cells. The reduction in glucocorticoids can also be 
linked to the anti-stress and anti-anxiety effects that GABA is associated with as increased 
glucocorticoid levels in the brain result in adverse behavioural and cognitive effects (Frodl and 
O’Keane, 2013). However, the effect of GABA on steroidogenesis has been mostly associated 
with neurotransmission affecting the central regulation of the HPA-axis.  
Our study also showed that GABA significantly influenced the production of adrenal 
androgens. GABA decreased DHEAS production, whereas DHEAS was significantly 
increased in the presence of the S. frutescens extract. This result may be significant as it has 
been shown that sulfonated steroids act on GABA receptors (Paul and Purdy, 1992) and, based 
on our findings, it may suggest that the anxiolytic effect associated with the use of the extract 
may be attributed to other compounds within the extract and not GABA as previously 
suggested  by van Wyk (van Wyk et al., 2008). As DHEA was mostly below the limit of 
quantification in the H295R assays, the increase in DHEAS in the presence of the extract, even 
under stimulated conditions, may suggest that the DHEA:DHEAS ratio is decreased by S. 
frutescens. This could have implications for fertility, potential remodelling of cardiovascular 
tissues and neuronal functions as a decline in DHEA has been associated with the age-related 
decline in DHEA:DHEAS ratios (Prough et al., 2016). The perturbation of the DHEA:DHEAS 
ratio has also been shown to correlate with an increased risk of cancers, especially prostate 
cancer (Nowell and Falany, 2006). 
In addition to the observed effects of the extract and SUB on the production of specific steroid 
metabolites and pathways, the ratios of steroid metabolites may be indicative of other 
interactions and implications with the therapeutic use of the extract. The cortisol:cortisone and 
CORT:11-DHC ratios have been used as indicators of active circulatory glucocorticoids as well 
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as potential interactions with 11βHSD2, as this enzyme inactivates cortisol and CORT to their 
inactive metabolites, cortisone and 11-DHC, respectively (Palermo et al., 1996; Stewart et al., 
1988). 
In studying the effects of S. frutescens on steroidogenesis in the H295R cells, the effects of the 
compounds did not always mimic the effects of the extract, even when considering relative 
concentrations of the compounds in the extracts. Although the adrenal P450 enzymes may 
catalyze the hydroxylation of more than one steroid, these enzymes are reported to be highly 
specific for their natural substrates, and thus compounds inhibiting the binding of steroid 
substrates to their respective enzymes will modulate subsequent hormone biosynthesis. 
However, studies have shown that more than one substrate may bind to the enzymes at a time 
(Korzekwa et al., 1998). Moreover, it has previously been shown that the triterpenoid fraction 
of the S. frutescens extracts did not induce a reverse type I spectra in the presence of PREG or 
PROG in ovine adrenal microsomes (Prevoo et al., 2008), suggesting that these compounds 
may influence the steroidogenic P450 enzymes by binding to sites other than in the active 
pocket. Furthermore, it has been suggested that the binding of the first substrate may increase 
the enzyme’s affinity for the second substrate or, alternatively, faster product generation may 
occur when two substrates are bound to the enzyme (Hlavica and Lewis, 2001; Omura et al., 
1993). Further complicating the interaction of S. frutescens with the P450 enzymes are reports 
showing that the bioavailability of certain compounds may be increased in the presence of 
smaller molecules (Tang et al., 2015). These findings may be applicable to S. frutescens where 
the extract could exhibit relatively high bioavailability and could thus elicit beneficial effects, 
as observed by Fasinu et al., in contrast to the relatively poor bioavailability shown with the 
SU compounds. 
In some cases, compounds that have shown biological activity in simple experimental models 
may not exert biological effects when used in more complicated models (Williamson et al., 
2005). Whether compounds elicit biological effects is highly dependent on whether these 
compounds can reach their intended target. As most herbal remedies are taken orally, the 
effects of digestion and uptake on the potential bioavailability of the compounds should be 
considered. Numerous studies have shown that GABA is transiently absorbed in the intestine 
through rapid transepithelial transport which is pH-dependent (Thwaites et al., 2000). After 
oral administration, GABA has also been shown to induce anti-convulsant and anxiolytic 
effects as expected. A recent study has shown that a single dose of 300 mg of S. frutescens 
could result in a GI concentration of extract markedly greater than the minimum concentration 
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required for the inhibition of hepatic P450 enzymes, with the greatest inhibitory effect observed 
for CYP3A4/5 (Fasinu et al., 2013). The bioavailability, absorption and degradation of SU 
compounds within the extract after oral ingestion will thus affect their overall biological 
activities. Although the data presented suggest that SUB could have potential applications as 
anti-inflammatory and/or anti-hypertensive drugs, these studies were conducted in cell line 
models and the possible metabolism of SUB in the GI tract should thus be considered. It is 
plausible that SU compounds are degraded in the GI tract due to the low pH of the GI 
environment and the O-glycoside bond at C-25 which would be sensitive to degradation in an 
acidic environment. Acid hydrolysis of SUB was shown to produce an aglycone structure and 
D-glucose as a by-product (Fu et al., 2008; Mbamalu et al., 2017). This modification may have 
a significant impact on not only the bioavailability of SUB but also in terms of the effect of 
SUB at target sites. It is possible that cellular effects may be increased due to increased uptake 
into the cell and enhanced interaction at enzyme and/or receptor level. In addition, intestinal 
flora also exhibit glycosidic actions which would yield the aglycone of the SU compounds. 
The aglycones, with greater structural similarity to the steroid hormone backbone, would also 
impact the catalytic activity of the P450 enzymes. It has also been shown that plasma 
triterpenoid levels remain low after oral administration due to extensive metabolism in the GI 
tract, poor membrane permeability and the low solubility of the triterpenoid aglycone (Tawab 
et al., 2003). After ingestion, triterpenoids such as ginsenosides, have been shown to be 
metabolized in the gut by intestinal bacteria, often resulting in the deglycosylation of the 
molecule (Kim et al., 2013). Although the pre-systematic metabolism of ginsenosides may 
result in relatively low plasma levels, it has been shown than these deglycosilated triterpenoids 
are present in hepatic tissues at much higher concentrations than in plasma and other tissues 
(Gu et al., 2009). SU compounds may follow similar degradation and metabolic trends as 
ginsenosides due to the considerable structural similarity between SU compounds and 
ginsenosides. Considering that the bioavailability of some structurally complex compounds are 
increased by the co-administration of smaller molecules (Tang et al., 2015), it is plausible that 
the bioavailablility of the SU compounds in the S. frutescens extracts may likely be increased 
due to the presence of the simpler polyphenols also present in S. frutescens resulting in the 
complexed compounds being more stable and effective when administered in an extract than 
when administered as purified isolates. The smaller molecules within the extract may therefore 
aid the absorption of SU compounds and increase their concentrations in plasma.  
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In recent years Lipinski’s rule of 5 has been used as a guideline for drug development from 
phytochemicals as this guide can be applied to predict the bioavailability of a drug. Molecular 
weight, hydrophilicity and reactive chemical groups are all considered within Lipinski’s theory 
(Lipinski, 2004). This theory would dictate that SUB would not be a good candidate for further 
drug development as it does not adhere to the requirements for low molecular weight, 
hydrophilicity and the reactive chemical groups present on this molecule. However, research 
has shown that many complex molecules, such as Lipitor (Pfizer), are readily available for 
absorption in the GI-tract in spite of scoring “low” with regard to Lipinski’s theory.  Adding to 
this, more than 40% of oral drugs currently commercially available are poorly soluble and 
several measures can be implemented to increase bioavailability, including  crystal 
engineering, micronization, nanosizing and the addition of cyclodextrins (Krishnaiah, 2010). 
Triterpenoids have previously been subjected to chemical modification to increase 
bioavailability and to increase favourable effects associated with these compounds, specifically 
the anti-inflammatory and anti-tumour effects (Parra et al., 2014). These modifications appear 
to be mostly associated with the acylation of the hydroxyl groups at C3 and C28. The biological 
activity of steroid hormones is also very susceptible to modifications at C3 and although the 
manipulation of SUB at C3 may have implications for improved bioavailability as well as 
associated therapeutic effects, it may alter steroidogenic enzyme as well as receptor interaction. 
Since the keto or hydroxyl group of the steroid hormones are of critical importance in the 
orientation and binding in the active pocket of p450 enzymes and thus to enzymatic activity, 
changes at C3 of the triterpenoid may result in loss of inhibitory effects and perhaps receptor 
interaction, particularly if the aglycone SUs bind in the active pocket.  
The commonality between herbal remedies is that these remedies are anecdotally used to treat 
several different disorders with anti-inflammatory, anti-oxidant and anti-cancer properties 
being described most frequently (Na et al., 2004; Skerman et al., 2011; van Wyk and Wink, 
2004; Venkatesha et al., 2016). These disorders are often inter-linked and the complexity of 
the pathogenesis often overlaps due to several factors influencing the disorder. Although 
studies investigating the effects of botanicals on endocrine disruption as a hypothesis for their 
application in the anecdotal treatments have been limited, the studies in this thesis was focussed 
on determining direct effects on steroid production or site-specific actions via steroid receptors. 
As many unbound circulatory steroids, considered to be free and therefore active steroids due 
to their interaction at the target site, are still used as disease indicators, the effects of herbal 
remedies on the binding of active steroids to steroid transporters within the bloodstream could 
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be significant as the compounds may be competing with endogenous active steroids for binding 
sites on the steroid transporters. Studies investigating disease alleviating effects of medicinal 
plants have focussed on either steroid production, steroid receptor binding and downstream 
transcriptional activities, although the latter two have been the more popular topics. To our 
knowledge, no studies have investigated the potential effects of botanicals on steroid 
transporters within the circulatory system. In plasma, active steroids are bound to albumin, 
CBG and SHBG (Siiteri et al., 1982). Albumin is present in greater concentrations than CBG 
or SHBG, however the affinity of albumin for steroids is relatively low. In addition, circulating 
ALDO is mainly bound to albumin, whereas glucocorticoids and PROG are bound primarily 
to CBG and the androgens and estrogens are bound to SHBG (Strel ’chyonok and Avvakumov, 
1990). The effect of herbal remedies, be it whole extracts or specific compounds, on steroids 
binding to their transporters is thus of great importance. In this context, the anti-glucocorticoid 
effect elicited by SUB and S. frutescens, as confirmed in this study, might be abolished if 
compounds displace glucocorticoids from CBG resulting in elevated free glucocorticoid levels 
in circulation. The latter will however be dependent on factors such as the serum levels of the 
glucocorticoids, SUB and S. frutescens, as well as the affinity of the transporters for the ligands. 
However, due to the non-specific nature of albumin binding which allows it to bind to a host 
of phytochemicals thus reducing potential endocrine disruptive effects (Baker, 2002), it is more 
likely for hydrophobic compounds in the extract, such as SUB, to be transported by albumin. 
In the study of therapeutic applications of herbal remedies this aspect has been severely 
neglected and remains to be investigated. 
Although the in vivo biological activity of the extract and SUB was not addressed in this study, 
the in vitro results obtained indicate that S. frutescens extracts display anti-stress, anti-
inflammatory and anti-hypertensive properties and therefore adds merit to the anecdotal use of 
this medicinal plant in the treatment of stress, anxiety and inflammation.  
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Sutherlandia frutescens modulates adrenal hormone biosynthesis, acts as a
selective glucocorticoid receptor agonist (SEGRA) and displays anti-
mineralocorticoid properties
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A B S T R A C T
Ethnopharmacological relevance: Sutherlandia frutescens is a traditional African medicinal plant used in the
treatment of stress and anxiety, while also exhibiting anti-inﬂammatory properties.
Aim of study: The study aimed at linking anti-stress and anti-inﬂammatory properties of S. frutescens to its
inﬂuence on glucocorticoid biosynthesis and the inﬂammatory response via steroid receptor interaction.
Materials and methods: The inﬂuence of S. frutescens extracts and sutherlandioside B (SUB),10 and 30 µM, on
key steroidogenic enzymes was assayed in COS-1 cells. Eﬀects were also assayed on basal and stimulated
hormone levels in the adrenal H295R cell model. Agonist activity for transactivation and transrepression of the
extract and SUB with the glucocorticoid- (GR) and mineralocorticoid receptor (MR) was subsequently
investigated.
Results: Inhibitory eﬀects of the extract towards progesterone conversion by CYP17A1 and CYP21A2 were
signiﬁcant. SUB inhibited CYP17A1 and 3β-HSD2, while not aﬀecting CYP21A2. In H295R cells, SUB decreased
cortisol and androgen precursors signiﬁcantly. The extract decreased total steroid production (basal and
stimulated) with cortisol and its precursor, deoxycortisol, together with mineralocorticoid metabolites
signiﬁcantly decreased under forskolin stimulated conditions. S. frutescens extracts and SUB repressed NF-
κB-driven gene expression without activating GRE-driven gene expression and while neither activated MR
mediated gene transcription, both antagonized the eﬀects of aldosterone via the MR.
Conclusion: Data provide evidence linking anti-stress, anti-inﬂammatory and anti-hypertensive properties of S.
frutescens to inhibition of steroidogenic enzymes and modulation of adrenal hormone biosynthesis. Findings
suggesting S. frutescens and SUB exhibit dissociated glucocorticoid characteristics underline potential
therapeutic applications in the treatment of inﬂammation and hypertension.
1. Introduction
Sutherlandia frutescens (S. frutescens) is a medicinal plant in-
digenous to South Africa and has customarily been used to treat a
broad spectrum of ailments such as cancers, hence the common name
Cancer bush, symptoms of anxiety and stress, inﬂammation as well as
diabetes (van Wyk, 2008; Van Wyk, 2015). A number of secondary
metabolites, including the sutherlandin ﬂavonoids and triterpenoid
compounds, have been isolated from S. frutescens extracts prepared
from leaves (Fu et al., 2008), seed pods (Albrecht et al., 2012) and
commercially available capsules (Avula et al., 2010). The triterpenoids
identiﬁed in S. frutescens extracts include four complex cycloartane
glycosides – sutherlandiosides (SU) A, B, C and D with SUB being the
major triterpenoid present in plant material (Fu et al., 2008). The
presence of the SU compounds were later also conﬁrmed by liquid
chromatography-mass spectrometry (LC-MS) (Albrecht et al., 2012;
Avula et al., 2010). In the isoprenoid biosynthesis pathway of the
triterpenoids, these molecules are oxidized by various cytochrome
P450-dependent (P450) monooxygenases, after which glycosylation
yields compounds containing a β-D-glucopyranose moiety at C24
(Lambert et al., 2011). Studies have shown that triterpenoids exhibit
anti-cancer and anti-inﬂammatory properties with data indicating that
many of these compounds target and downregulate nuclear factor-
kappa B (NF-κB) (Bai et al., 2016; Chen et al., 2015; Yadav et al.,
2010). Triterpenoids are furthermore widely used in Asian medicine in
the treatment of chronic diseases which include amongst others,
diabetes, obesity, cardiovascular atherosclerosis, arthritis and depres-
sion (Sanna et al., 2015; Venkatesha et al., 2016; Yadav et al., 2010).
http://dx.doi.org/10.1016/j.jep.2017.03.019
Received 16 January 2017; Received in revised form 10 March 2017; Accepted 14 March 2017
⁎ Corresponding author.
E-mail address: acswart@sun.ac.za (A.C. Swart).
Journal of Ethnopharmacology 202 (2017) 290–301
Available online 18 March 2017
0378-8741/ © 2017 Elsevier B.V. All rights reserved.
MARK
Stellenbosch University  https://scholar.sun.ac.za
The aforementioned conditions are closely associated with an impaired
endocrine system and as such, the triterpenoids which have molecular
structures closely related to the cyclopentanoperhydrophenanthrene
structure of steroid hormones, may also interact with the steroidogenic
P450 enzymes which catalyze steroid biosynthesis. In addition, the
triterpenoids may mimic or antagonize the downstream actions of
endogenous steroid hormones. While we have shown that S. frutescens
extracts inhibit the catalytic activity of the adrenal steroidogenic P450
enzymes, P450 17α-hydroxylase/17,20-lyase (CYP17A1) and P450 21-
hydroxylase (CYP21A2) (Prevoo et al., 2004, 2008), a more recent in
vivo study by Smith and van Vuuren, 2014, showed that S. frutescens
extracts aﬀected steroidogenesis increasing plasma corticosterone
levels in male Wistar rats (Smith and van Vuuren, 2014). Although
the inhibition of several hepatic P450 enzymes by S. frutescens extracts
has also been shown (Fasinu et al., 2013), reports on the interaction of
the SU compounds with adrenal steroidogenic P450 enzymes are
limited.
Adrenal P450 enzymes catalyze the biosynthesis of the steroid
hormones in the mineralocorticoid, glucocorticoid and androgen path-
ways (Fig. 1). These steroids are all derived from the precursor steroid,
cholesterol, with P450 side-chain cleavage (CYP11A1) catalysing its
conversion to pregnenolone (PREG). In the mineralocorticoid pathway,
limited to the zona glomerulosa of the adrenal cortex, PREG is
converted by 3β-hydroxsteroid dehydrogenase type 2 (3β-HSD2) to
progesterone (PROG) and subsequently to deoxycorticosterone (DOC)
by CYP21A2. DOC is converted to aldosterone (ALDO) via corticoster-
one (CORT) and 18-hydroxycorticosterone (18OH-CORT) by aldoster-
one synthase (CYP11B2). In the glucocorticoid pathway, 17-hydro-
xypregnenolone (17OH-PREG), a product of the CYP17A1 conversion
of PREG, is converted to cortisol via 17-hydroxyprogesterone (17OH-
PROG) and deoxycortisol, catalyzed by 3β-HSD2, CYP21A2 and P450
11β-hydroxylase (CYP11B1) respectively. In the androgen pathway,
dehydroepiandrosterone (DHEA), the product of 17OH-PREG, is
converted to androstenedione (A4) by 3β-HSD2. We recently showed
that A4 is also a substrate for CYP11B1 which catalyzes the formation
of 11-hydroxyandrostenedione (11OHA4) (Swart et al., 2013).
Although the adrenal P450 enzymes may catalyze the hydroxylation
of more than one steroid, these enzymes are reported to be highly
speciﬁc for their natural substrates, and compounds inhibiting the
binding of steroid substrates to their respective enzymes will modulate
subsequent hormone biosynthesis.
In adrenal steroidogenesis CYP17A1, together with 3β-HSD2 and
CYP21A2, play a key role in channeling PREG into the three respective
pathways (Goosen et al., 2013). We have previously reported that an
aqueous extract of S. frutescens inhibited both PREG and PROG
conversion by CYP17A1 signiﬁcantly with the inhibition of PROG
conversion being greater. The extract was also able to bind to
microsomal P450 enzymes eliciting a reverse type I spectrum, suggest-
ing that compounds bind to sites other than the active pocket. In
addition, we showed that a methanolic extract and a mixture of the
triterpenoid compounds inhibited the binding of PREG and PROG to
adrenal microsomal P450 enzymes (Prevoo et al., 2008). Interference
of the binding of PROG and PREG and the modulation of their
metabolism by CYP21A2 and CYP17A1 may thus impact on the
downstream production of glucocorticoids and mineralocorticoids,
and in so doing also impact on the expression of various genes
inﬂuenced by adrenal hormone levels via the glucocorticoid receptor
(GR) and mineralocorticoid receptor (MR) in target tissue. The GR and
MR are generally associated with the regulation of inﬂammatory
(Nixon et al., 2013) and hypertensive processes (Messaoudi et al.,
2012), involving gene transcription which is inﬂuenced by many other
factors such as co-regulators and genetic modiﬁers (Bosscher et al.,
2016; Griekspoor et al., 2007; Harris et al., 2013).
Conventional drugs used in the treatment of inﬂammation and
hypertension target the GR and MR, respectively. Considering that S.
frutescens is used as a traditional medicine to treat an array of
conditions and has been shown to elicit immunomodulating eﬀects
(Zhang et al., 2014), the question arises whether S. frutescens and the
triterpenoids can act via these receptors. Although a previous report
has shown that S. frutescens extracts down-regulate lipopolysacchar-
ide-induced NF-κB activity (Ajit et al., 2016), to our knowledge, no
previous studies have investigated the eﬀects of S. frutescens or the
SUs on any members of the steroid receptor family. Compounds such
as ginsenosides, which are classed as triterpene saponins with an
Fig. 1. Human adrenal steroid biosynthesis. The metabolism of cholesterol by the major steroidogenic enzymes yielding ALDO, cortisol and 11OHA4 in the mineralocorticoid-,
glucocorticoid-, and androgen pathways, respectively.
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aglycone skeleton structure similar to the SUs, have however been
shown to be functional ligands of the GR (Du et al., 2011; Lee et al.,
1997). Similarly, the pentacyclic triterpene, ursolic acid, enables
nuclear translocation of the GR without aﬀecting glucocorticoid
response element (GRE)-driven gene transcription (Kassi et al.,
2009). While the binding of triterpenes to the GR suggests that these
compounds, and possibly other structurally similar triterpenes, may
modulate GR-dependent signalling pathways, studies reporting inter-
action of triterpenoids with the MR are limited. Saireito, a Japanese
herbal medicine currently used clinically in the treatment of water
retention and inﬂammatory edemas, comprises of a range of ginseno-
sides as well as the more complex saikosaponin compounds. These
inhibit ALDO binding to the MR with saikosaponin H being the most
potent inhibitor. The data suggests that the diuretic action of Saireito
may possibly be attributed to the antagonistic eﬀects of saikosaponin H
as well as the eﬀects of other triterpenoid saponin compounds towards
the MR (Hattori et al., 2006).
The aim of this study was to investigate whether the anti-stress and
anti-inﬂammatory properties of S. frutescens could be attributed to the
modulation of adrenal hormone biosynthesis and interaction with the
GR and the MR. We therefore determined the inﬂuence of S. frutescens
on adrenal steroidogenesis by assessing the interaction of a methanolic
extract of S. frutescens and SUB, one of the major SU compounds in S.
frutescens extracts, with the enzymes in the glucocorticoid and
mineralocorticoid pathways, and to investigate the inﬂuence on the
steroid ﬂux in the H295R adrenal cell model. The transcriptional
activation and repression of the extract and SUB via the GR, as well as
its relative agonist and antagonist properties for transactivation via the
MR were also investigated to determine possible downstream eﬀects of
S. frutescens at the cellular level.
2. Materials and methods
2.1. Materials
Phorbol 12-myristate 13-acetate (PMA), 9-α-ﬂuoro-16-α-methyl-
prednisilone (dexamethasone (Dex)), spironolactone and Dulbecco's
modiﬁed Eagle's medium (DMEM) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Steroids were purchased from
Steraloids (Wilton, USA). COS-1 cells were purchased from the
American Type Culture Collection (Manassas, VA, USA). Dulbecco's
phosphate buﬀered saline, along with penicillin-streptomycin and
trypsin-EDTA were sourced from Gibco-BRL (Gaithersburg, MD,
USA). Mirus TransIT®- LT1 transfection reagent was purchased from
Mirus Bio Corporation (Madison, WI, USA). Fetal calf serum was
supplied by Highveld Biological (Lyndhurst, RSA), while cosmic calf
serum was purchased from HyClone®,Thermo Scientiﬁc (South Logan,
Utah, USA). S. frutescens subspecies (L.) R. Br. were supplied by
Professor Ben-Erik van Wyk, Department of Botany of Rand Afrikaans
University (Voucher specimen from Mrs. Grobler: C. Albrecht s.n sub
B.-E. van Wyk 4126 (JRAU)). Triterpenoids were supplied by Prof J.
Syce (University of Western Cape, Cape Town, South Africa) and Prof
WR Folk (University of Missouri, Missouri, USA). All chemicals used
were of high analytical grade and obtained from reputable suppliers.
2.2. Preparation of the methanolic extract of S. frutescens and SUB
S. frutescens was subjected to organic extraction using a glass
soxhlet extractor coupled to a double wall condenser. Dried plant
material, 18.5g, was extracted with chloroform, 250 mL, for 8 h, after
which the solvent was replaced with methanol, 250 mL, and extracted
for a further 8 h (Swart et al., 1993). The methanol extract was dried at
room temperature at reduced pressure on a rotary evaporator. The
residue was resuspended in 35 mL de-ionized water and centrifuged at
6000g for 5 min. The supernatant, at a ﬁnal concentration of
53.43 mg/mL, was stored at −18 °C until use. LC–MS/MS analysis of
the extract was conducted on a Waters Synapt G2 quadrupole time-of-
ﬂight mass spectrometer (Milford, MA, USA) using a Waters BEH C18
column (2.1×50 mm, 1.7 µm). Solvent A consisted of 0.1% formic acid
in water and solvent B consisted of acetonitrile. A linear gradient from
100% A to 78% A in 3 min, followed by linear gradient from 78% A to
55% A in 7 min and a linear gradient from 55% A to 0% A in 2 min was
applied. The column was returned to 100% A in 1 min, after an
isocratic elution at 100% B for 2 min. The samples, 5 µl, were analysed
at a ﬂow rate of 0.35 mL/min with a total run time of 15 min for each
sample. Ionization was achieved with an electrospray source with the
cone voltage set at 15 V and capillary voltage at 3 kV. Analysis was
carried out utilizing positive and negative modes.
S. frutescens triterpenoids were fractionated on a semi-preparative
Novapak HR C18 HPLC column (6 µm spherical particles,
300 mm×7.8 mm; Millipore-Waters, La Jolla, USA) utilizing an elution
gradient from 80% solvent A (0.1% triﬂuoroacetic acid in analytical
quality water, v/v) and 20% solvent B to 70% solvent B (90%
acetonitrile and 10% A, v/v) and eluted over 23 min. SUB was
collected, lyophilized and dissolved in ethanol, 2 mg/mL, prior to
storage at −18 °C.
2.3. Steroid conversion in transiently transfected COS-1 cells
The inﬂuence of S. frutescens extract and SUB on recombinant
enzymes, 3β-HSD2, CYP17A1 and CYP21A2 was determined in non-
steroidogenic COS-1 cells as described previously (Schloms et al.,
2012). Brieﬂy, conﬂuent cells were plated into 12 well plates, 1×105
cells/mL/well, 24 h prior to transfection. Cells were transiently trans-
fected with 0.5 μg DNA and 1.5 µl Mirus TransIT®- LT1 transfection
reagent, used as instructed by the manufacturer. Cells were incubated
for 72 h after which 1 µM of the appropriate steroid substrate was
added to the medium. PREG and PROG were added to cells expressing
the baboon CYP17A1 cDNA construct; PREG was added to cells
expressing the baboon 3β-HSD2 construct; PROG was added to cells
expressing the bovine CYP21A2 construct. The eﬀect of the methanolic
extract of S. frutescens on steroid conversion by these enzymes was
determined by adding 2.6 mg/mL extract to the medium, and the eﬀect
of SUB by adding the compound to a ﬁnal concentration of either 10 or
30 µM. Control transfection reactions were performed using the
pCIneo vector, without insert DNA. Aliquots, 500 µl, were removed
after 4 h and the steroids extracted with dichloromethane (10:1),
vortexed for 30 s and centrifuged at 500g for 5 min. The organic phase
was evaporated using N2, resuspended in 120 µl methanol and stored
at 4 °C prior to steroid analysis. Metabolites were separated by UPLC
(ACQUITY UPLC, Waters Corporation, Milford, USA) using a Waters
UPLC BEH C18 column as previously described and a Xevo triple
quadrupole mass spectrometer (Waters Corporation, Milford, USA)
was used for quantitative mass spectrometric detection. A linear least
squares regression (weighted (1/x2)) was utilized to construct curves
for calibration and the MassLynx 4.0 software program was used for
data collection (Schloms et al., 2012) and steroid analyses presented as
the mean, n=3.
2.4. Steroid metabolism in H295R cells
The inﬂuence of S. frutescens extract and SUB on steroid metabo-
lism was assayed in H295R cells under basal and forskolin stimulated
conditions as previously described (Schloms et al., 2012). Brieﬂy,
conﬂuent cells were seeded into 12 well plates, 4×105 cells/mL/well,
and allowed to attach for 48 h after which the medium was replaced
with growth medium containing 0.1% cosmic calf serum. Cells were
incubated for 12 h after which extract (1 mg/mL) or SUB (10 or 30 µM)
was added, with and without forskolin, to determine the eﬀects on
basal and stimulated steroid production. Aliquots, 500 µl, were col-
lected after 48 h and the steroids extracted as previously described. The
steroid residue was resuspended in 150 µl methanol for analysis by
C.A. Sergeant et al. Journal of Ethnopharmacology 202 (2017) 290–301
292
Stellenbosch University  https://scholar.sun.ac.za
UPLC-LCMS. Steroids were separated using a Phenomenex UPLC
Kinetex PFP (2.1 mm×100 mm, 2.6 µm) column, analysed and quanti-
ﬁed by UPLC-APCI-MS (Schloms et al., 2012) as described above.
2.5. Transactivation and transrepression assays
The eﬀects of the extract and SUB on the GR were assayed in COS-1
cells which were plated in complete medium (DMEM containing 10%
fetal calf serum and 1% penicillin- streptomycin) at a density of 2×106
cells/mL in 10 cm culture dishes. After 24 h the cells were transiently
transfected with the appropriate expression vectors, using a TransIT®-
LT1 transfection reagent (Mirus, USA) according to the manufacturer's
instructions. For transactivation assays, 900 ng pRS-hGR and 9 μg
pTAT-2xGRE-Elb-luciferase, driven by the E1b promoter containing
two copies of the rat TAT-GRE (Sui, 1999) were used, while for
transrepression assays 1.5 µg pRS-hGR and 3 µg of the IL6-luc-
promoter reporter construct (p(IL6κB)350hu. IL6Pluc+) were used.
After 24 h, the transfected cells were replated into 24 well plates at a
density of 5×104 cells/well and incubated for 24 h. The cells were
washed with phosphate buﬀered saline (PBS) and incubated for 24 h
with serum-free medium containing dexamethasone (Dex) (10 µM), S.
frutescens (0.5 or 0.75 mg/mL) and SUB (10 or 30 µM) (for transacti-
vation) or serum-free medium containing PMA in the absence and
presence of Dex (10 µM), extract (0.5 or 0.75 mg/mL) and SUB (10 or
30 µM) (for transrepression).
The eﬀects of the extract and SUB on the MR were assayed in CHO
cells stably transfected with the rat MR, 11β-HSD2 and a pTAT3-gLuc
reporter gene (Morita et al., 1996). Cells were seeded at a density of
2.5×104 cells/mL/well in 12 well plates in complete growth media
(DMEM/F-12 containing 10% cosmic calf serum, 1% penicillin-
streptomycin and 0.1% gentamicin) and incubated for 48 h. The cells
were incubated for 24 h in experimental medium (DMEM/F-12 con-
taining 0.1% charcoal stripped cosmic calf serum, 1% penicillin-
streptomycin and 0.1% gentamicin) containing ALDO (10 nM), S.
frutescens (0.5 or 0.75 mg/mL) and SUB (10 or 30 µM) to investigate
agonist activity, and containing 10 nM ALDO in the absence and
presence of S. frutescens (0.5 or 0.75 mg/mL), SUB (10 or 30 µM) or
spironolactone (1 µM) to investigate antagonist activity.
Lysed cells were analysed as previously described (Africander et al.,
2011) for all the reporter assays. The luciferase activity, measured in
relative light units (RLUs), was normalized to protein concentration as
determined using a Pierce® BCA Protein Assay Kit (Rockford, IL, USA)
to correct for plating eﬃciency.
2.6. Cell viability
The viability of the COS-1, H295R and CHO cells in the presence of
S. frutescens extract and SUB was determined using an in vitro
cytotoxicity assay kit based on an MTT assay (Sigma-Aldrich) accord-
ing to the manufacturer's instructions. The concentrations of cells used
for these assays were 1×105 cells/mL for COS-1 cells, 4×105 cells/mL
for H295R cells and 2.5×104 cells/mL for CHO cells. SUB was assayed
at 10 and 30 µM and the extract was assayed at 0.5, 0.75, 1 and 2.6 mg/
mL. Cell viability was not aﬀected at these concentrations and no
detrimental or stimulatory eﬀects were observed. In addition, the 17-
dehydrogenase activity endogenous to COS1 cells was not aﬀected by S.
frutescens with the conversion of testosterone to A4 being ± 90% in the
presence of the extract (2.6 mg/mL).
2.7. Statistical analysis
Experiments were repeated in duplicate with three replicates within
each experiment (unless stated otherwise). Mean values of data
obtained in each experiment were analysed using one-way ANOVA
and appropriate posttests (as indicated in ﬁgure legends). The error
bars represent the standard error of the mean (SEM). All data
manipulations, graphical representations and statistical analysis were
performed using Graph Pad Prism 5 (GraphPad Software, Inc, CA,
USA).
3. Results
3.1. Analysis of the methanolic extract of S. frutescens and SU
compounds
The S. frutescens extract was analysed in both electronspray
ionization (ESI) negative and positive mode, with a clearer visualiza-
tion of the sutherlandins (1−4) and SU compounds (5–8) being
obtained in ESI negative mode (Fig. 2), depicted in the total ion
chromatogram (TIC). The sutherlandin and SU compounds exhibited a
similar proﬁle as previously reported with the former compounds
eluting ﬁrst followed by SUB, SUC, SUA and SUD. SUA and B were
collected upon fractionation of a mixture of SU compounds and
analysed by LC-MS in ESI positive negative (Fig. 3A) and negative
(Fig. 3B) modes with the resulting ions correlating to that previously
described (Albrecht et al., 2012). While both compounds have the same
exact mass, 652.41, the fragmentation patterns of SUA (not shown)
and SUB are also identical with the following extracted ions being
Fig. 2. Total ion chromatogram of the LC-MS analysis (ESI-) of a methanolic extract of S. frutescens. Retention times and masses are indicated at peaks 1–4 representing sutherlandins
A-D and peaks 5–8 representing SU B, C, A and D, respectively.
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identiﬁed in ESI positive mode m/z 653.4281 [M+H]+; m/z 635.4281
[M+H-H2O]
+; m/z 491.3741 [M+H-glu]+; m/z 473.3635 [M+H-glu-
H2O]
+; m/z 455.3532 [M+H-glu-2H2O]
+; m/z 437.3417 [M+H-glu-
3H2O]
+ and m/z 419.3275 [M+H-glu- 4H2O]
+. In ESI negative mode
the major ions previously reported for SUA and B were m/z 651.4080
[M-H]− and m/z 697.4161 [M+formate]−, respectively (Albrecht et al.,
2012). However, in our study m/z 697.4161 [M+formate]− was
detected, but not m/z 651.4080 [M-H]−.
Quantiﬁcation of the major SU compounds in the methanol extract
showed SUB was present at 3 mg/g S. frutescens dried plant material
and SUA, SUC and SUD at 2.3, 1.8 and 2.6 mg/g, respectively. We
subsequently focused our bioactivity studies on SUB and determined
the eﬀects of SUB on the catalytic activity of the steroidogenic enzymes
at the branch point of adrenal hormone biosynthesis.
3.2. Substrate conversion by CYP17A1, CYP21A2 and 3β-HSD2 in
COS-1 cells
The inﬂuence of the S. frutescens extract and SUB on the catalytic
activity of CYP17A1 and 3β-HSD2 towards PREG, and on that of
CYP17A1 and CYP21A2 towards PROG was investigated. The extract
had no signiﬁcant inhibitory eﬀect on PREG conversion (Fig. 4A) by
CYP17A1 however, PROG conversion (Fig. 4B) was inhibited signiﬁ-
cantly (P < 0.001). While the conversion of both PREG and PROG by
CYP17A1 was inhibited signiﬁcantly (P < 0.01) in the presence of SUB
(Fig. 4A and B), it was only the catalytic activity towards PROG that
was also signiﬁcantly inhibited at the lower concentration (P < 0.05).
The catalytic activity of CYP21A2 towards PROG (Fig. 4C) was
inhibited by the extract (P < 0.001), however, the enzyme was not
inﬂuenced by SUB. In contrast, 3β-HSD2 was inhibited signiﬁcantly (P
< 0.01) at both SUB concentrations of SUB while the extract had no
inhibitory eﬀect on the catalytic activity of 3β-HSD2 towards PREG
(Fig. 4D).
3.3. Steroid metabolite production in H295R cells
Having assessed the inhibitory eﬀects of the extracts and SUB on
the branch point steroidogenic enzymes, the inﬂuence of S. frutescens
on steroidogenesis in the H295R cell line was subsequently deter-
mined. This model system lends itself to investigations into the eﬀects
of compounds, natural products and endocrine disruptors on steroi-
dogenesis as H295R cells express all the steroidogenic enzymes
catalysing the biosynthesis of the mineralocorticoids, glucocorticoids
and adrenal androgens. In addition, a stress response can be induced
by exposure to forskolin which mimics the eﬀects of ACTH via the
activation of adenyl cyclase (cAMP) pathways in adrenal cells (Rainey
et al., 1994).
The eﬀects of SUB on hormone levels was ﬁrstly assayed under
basal conditions to determine whether the compounds would modulate
the steroid ﬂux due to their inhibition of CYP17A1 and 3β-HSD2.
Although not signiﬁcant, total steroid production decreased ± 1.25‐
fold in the presence of both concentrations (Table 1). A4, 11OH-A4,
16OH-PROG and cortisol were signiﬁcantly decreased (P < 0.05) and
while 11-dehydrocorticosterone (11-DHC) was signiﬁcantly increased
(P < 0.05) in the presence of 30 µM SUB only the former two steroid
metabolites were increased at the lower concentration.
The inﬂuence of the extract (1 mg/mL) was subsequently assessed
on basal and forskolin-stimulated steroid production. Eﬀects on basal
hormone levels (Table 2) were similar to that of the compounds, with a
± 1.4‐fold reduction in total steroid output, with most of the steroid
levels being aﬀected and the ∆5-steroid levels remaining below the
limit of detection. DHEAS levels however, increased signiﬁcantly (P <
0.01). 16OH-PROG levels were decreased signiﬁcantly (P < 0.01) as in
the case of SUB, indicating inhibition of CYP17A1 as this hormone is
not metabolized further in the adrenal. Steroids also decreasing
signiﬁcantly were deoxycortisol (P < 0.01) and cortisol (P < 0.001) in
the glucocorticoid pathway, as well as CORT (P < 0.01), while its
precursor DOC, increased signiﬁcantly (P < 0.001).
The eﬀects of S. frutescens on forskolin-stimulated steroid produc-
tion (Table 3) was far more pronounced. Steroid production increased
Fig. 3. LC-MS chromatogram of SUB in (A) ESI+ mode and (B) ESI- mode and SUB structure (insert). In ESI+ mode m/z 635.4281 [M+H-H2O]
+; m/z 491.3741 [M+H-glu]+; m/z
473.3635 [M+H-glu-H2O]
+; m/z 455.3532 [M+H-glu-2H2O]
+; m/z 437.3417 [M+H-glu-3H2O]
+ and m/z 419.3275 [M+H-glu- 4H2O]
+ were detected. In ESI- mode the major ions
detected was m/z 697.4161 [M+formate]− and 653.4281 [M+H]+.
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2.7-fold, from 4 to 10.8 μM upon stimulation which, in the presence of
extract, while not reaching basal levels, decreased signiﬁcantly to
6.6 μM. All steroids in the three pathways decreased, and while only
a few were not aﬀected signiﬁcantly, DHEAS levels in contrast
increased signiﬁcantly as in case of basal production.
3.4. Inﬂuence of S. frutescens and SUB on GR and MR mediated gene
transcription
We subsequently investigated whether S. frutescens may elicit
biological eﬀects via the steroid receptor family, particularly the GR
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Fig. 4. Inhibition of substrate (1 µM) conversion by S. frutescens and SUB in transiently transfected COS-1 cells. Percentage inhibition of (A) PREG and (B) PROG conversion by
CYP17A1; (C) PROG conversion by CYP21A2 and (D) PREG conversion by 3β-HSD2 in the presence of S. frutescens extract (2.6 mg/mL) and SUB (10 and 30 µM) (*, P < 0.05; **, P <
0.01; ***, P < 0.001; ns, not signiﬁcant).
Table 1
Steroids produced in H295R cells in the absence and presence of SUB after 48 h.
Steroid metabolite Basal +10 µM SUB +30 µM SUB
% of Total ± SEM % of Total ± SEM % of Total ± SEM
PREG ND ND ND
PROG 0.00 ± 0.00 0.05 ± 0.00 ns 0.05 ± 0.00 ns
DOC 0.15 ± 0.00 0.20 ± 0.00 ns 0.30 ± 0.00 ns
CORT 6.30 ± 0.50 6.85 ± 1.15 ns 7.40 ± 1.55 ns
18OH-CORT 0.35 ± 0.10 0.45 ± 0.1 ns 0.50 ± 0.15 ns
ALDO 0.05 ± 0.05 0.05 ± 0.05 ns 0.15 ± 0.15 ns
11-DHC 0.70 ± 0.05 1.40 ± 0.30 ns 2.05 ± 0.55↑ P < 0.05
17OH-PREG 0.00 ± 0.00 0.00 ± 0.00 ns 0.00 ± 0.00 ns
17OH-PROG 1.15 ± 0.05 1.10 ± 0.05 ns 1.15 ± 0.05 ns
16OH-PROG 1.20 ± 0.00 1.10 ± 0.05 ns 0.90 ± 0.1↓ P < 0.05
Deoxycortisol 35.8 ± 1.75 39.30 ± 1.5 ns 40.60 ± 1.50 ns
Cortisol 23.10 ± 0.75 22.40 ± 0.4 ns 21.35 ± 0.80↓ P < 0.05
Cortisone 0.20 ± 0.05 0.15 ± 0.05 ns 0.15 ± 0.00 ns
DHEA ND 0.48 ± 0.50 ns ND
DHEAS 0.25 ± 0.00 0.14 ± 0.05 ns 0.15 ± 0.05 ns
A4 24.60 ± 0.50 21.1 ± 0.5↓ P < 0.05 21.00 ± 1.00↓ P < 0.05
11OH-A4 4.85 ± 0.50 4.25 ± 0.20↓ P < 0.01 3.40 ± 0.15P < 0.001
Testosterone 1.30 ± 0.05 1.05 ± 0.15 ns 0.90 ± 0.20 ns
Total steroid (nM) 4130.00 ± 133 3300.00 ± 650 ns 3200.00 ± 1235 ns
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and MR. These receptors are ligand-dependent transcription factors
that exhibit signiﬁcant similarity in both their structures and mechan-
ism of action. Like all steroid receptors, the GR and MR regulate gene
expression by activating (transactivation) or repressing (transrepres-
sion) the transcription of target genes (Nicolaides et al., 2010; Nixon
et al., 2013). Transactivation occurs when the ligand-activated GR or
MR binds to GREs or mineralocorticoid response elements (MREs) in
the promoters of speciﬁc genes, while transrepression occurs via
protein-protein interactions with other transcription factors such as
NF-κB, which drives the expression of many genes involved in the
inﬂammatory response (Silverman and Sternberg, 2012).
The properties of the S. frutescens extract and SUB for transactiva-
tion of a synthetic GRE and transrepression of an IL-6 promoter-
reporter gene were assayed in COS-1 cells. All assays were carried out
using two S. frutescens concentrations, 0.5 and 0.75 mg/mL, and two
SUB concentrations, 10 or 30 µM. For transactivation, the cells
transiently expressing hGR and GRE-driven rat TAT-GRE-luciferase
were treated with Dex (10 µM), the synthetic glucocorticoid, or with
extract and SUB. Results show that, unlike Dex, neither the extract
(Fig. 5A) nor SUB (Fig. 5B) display glucocorticoid agonist activity via
the GRE at either concentration tested. For transrepression, COS-1
cells were transiently transfected with the hGR expression vector and
the IL-6-NF-κB luciferase promoter reporter construct. After stimula-
tion with 10 ng/mL PMA cells were exposed to Dex (10 µM), extract
and SUB. The IL-6 promoter was signiﬁcantly (P < 0.001) repressed by
S. frutescens extract and SUB, with Dex displaying the greatest
transrepression as expected (Fig. 6A and B).
Agonist and antagonist activity of S. frutescens towards the MR was
subsequently investigated in CHO cells stably expressing the rat MR,
11β-HSD2 and a pTAT3-gLuc reporter gene (Morita et al., 1996). Cells
were incubated with ALDO (10 nM), extract and SUB or 10 nM ALDO
in the presence of extract and SUB, or spironolactone (1 µM). Neither
the extract nor SUB displayed signiﬁcant agonist activity for the MR at
the concentrations assayed (Fig. 7A and B). However, comparable to
spironolactone, the well-known MR antagonist, the eﬀects of ALDO via
the MR was antagonized by both the extract and SUB (Fig. 8A and B).
Antagonism by SUB (P < 0.05) (Fig. 8B) was lower than that of the S.
frutescens extract (Fig. 8A), while the latter antagonized the eﬀect of
ALDO comparable to that of spironolactone (P < 0.001).
4. Discussion
Traditional medicinal applications of S. frutescens are commonly
used in the treatment of anxiety, stress and diabetes (Smith and
Myburgh, 2004; van Wyk and Wink, 2004; Van Wyk, 2015), conditions
linked to glucocorticoid dysfunction and inﬂammation, giving rise to
our study into the eﬀect of S. frutescens on adrenal hormone produc-
tion and downstream receptor activation.
Since the triterpenoid SUs have structures similar to those of the
steroid hormones it is plausible to assume that these compounds may
interact with the P450 enzymes catalysing hormone biosynthesis. The
P450 enzyme family, comprising of hepatic and steroidal P450
enzymes, are structurally conserved and studies suggest that herbal
remedies that interact with hepatic P450 enzymes could interact with
the steroidal P450 enzymes due to the structural homology of these
enzymes. It has also been demonstrated that adverse events associated
with herb-drug interactions may be attributed to the inhibition of
hepatic P450 enzymes by bioactive compounds (Mrozikiewicz et al.,
2010; Shi and Klotz, 2012; Zhou et al., 2003). Triterpenoid compounds
in plants extracts have been linked to pharmacological eﬀects which
Table 2
Steroids produced in H295R cells in the absence and presence of a methanolic extract of
S. frutescens after 48 h.
Steroid
metabolite
Basal S. frutescens 1 mg/mL
% of Total ± SEM % of Total ± SEM
PREG ND ND
PROG 0.00 ± 0.00 0.00 ± 0.00 ns
DOC 0.15 ± 0.00 0.50 ± 0.05↑ P < 0.01
CORT 6.30 ± 0.60 4.30 ± 0.60↓ P < 0.001
18OH-CORT 0.35 ± 0.10 0.40 ± 0.10 ns
ALDO 0.05 ± 0.05 0.05 ± 0.00 ns
11-DHC 0.70 ± 0.05 1.00 ± 0.15 ns
17OH-PREG 0.00 ± 0.00 0.00 ± 0.00 ns
17OH-PROG 1.15 ± 0.05 1.65 ± 0.10 ns
16OH-PROG 1.20 ± 0.00 1.20 ± 0.05↓ P < 0.01
Deoxycortisol 35.80 ± 1.76 37.00 ± 1.10↓ P < 0.01
Cortisol 23.10 ± 0.75 17.60 ± 6.00↓ P < 0.001
Cortisone 0.2 ± 0.05 0.25 ± 0.05 ns
DHEA ND ND
DHEAS 0.25 ± 0.00 0.85 ± 0.15↑ P < 0.01
A4 24.60 ± 0.40 28.80 ± 0.70 ns
11OH-A4 4.85 ± 0.30 5.50 ± 0.50 ns
Testosterone 1.30 ± 0.5 1.25 ± 0.10 ns
Total steroid
(nM)
4020.00 ± 90.00 2900.00 ± 135.5 ns
Table 3
Steroids produced in forskolin-stimulated H295R cells in the absence and presence of a methanolic extract of S. frutescens after 48 h.
Steroid metabolite 10 µM Forskolin 10 µM Forskolin+S. frutescens 1 mg/mL
% of Total ± SEM % of Total ± SEM
PREG ND ND
PROG 0.00 ± 0.00 0.05 ± 0.00↓ P < 0.05
DOC 0.10 ± 0.00 0.15 ± 0.05↓ P < 0.05
CORT 16.75 ± 0.40 11.30 ± 0.30↓ P < 0.001
18OH-CORT 0.95 ± 0.05 1.00 ± 0.05 ns
ALDO 0.30 ± 0.10 0.30 ± 0.05 ns
11-DHC 0.55 ± 0.15 1.30 ± 0.25↓ P < 0.05
17OH-PREG 0.85 ± 0.20 1.35 ± 0.05↓ P < 0.05
17OH-PROG 0.25 ± 0.05 0.35 ± 0.00 ns
16OH-PROG 0.40 ± 0.00 0.50 ± 0.00↓ P < 0.01
Deoxycortisol 10.85 ± 2.00 20.70 ± 2.25↓ P < 0.01
Cortisol 41.55 ± 3.40 31.05 ± 2.05↓ P < 0.05
Cortisone 0.10 ± 0.00 0.05 ± 0.00 ns
DHEA 1.25 ± 0.45 1.95 ± 0.75 ns
DHEAS 0.10 ± 0.00 0.50 ± 0.10↑ P < 0.01
A4 10.25 ± 1.60 14.50 ± 0.80↓ P < 0.05
11OH-A4 8.90 ± 1.05 5.95 ± 0.60↓ P < 0.05
Testosterone 0.40 ± 0.05 0.55 ± 0.05 ns
Total steroid (nM) 10,790.00 ± 1765.00 6595.50 ± 555.00↓ P < 0.001
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Fig. 5. S. frutescens and SUB exhibit no GR agonist activity for transactivation. Induction was assayed after 24 h in COS-1 cells transiently transfected with pRShGR and pTAT-GRE-
E1b-luc reporter constructs exposed to vehicle (EtOH) and DEX (10 µM), (A) S. frutescens extract (0.5 and 0.75 mg/mL) and (B) SUB (10 and 30 µM). Results are shown as fold
induction relative to EtOH set as 1 and results are representative of two experiments performed in triplicate. One-way ANOVA with Dunnett's posttest was used for statistical
signiﬁcance (***, P < 0.001; ns, non-signiﬁcant).
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Fig. 6. S. frutescens and SUB exhibit GR agonist activity for transrepression. COS-1 cells transiently expressing the IL-6-NFκB-luc promoter-reporter construct were stimulated with
PMA (10 ng/mL) and exposed to DEX (10 µM) and (A) S. frutescens extract (0.5 and 0.75 mg/mL) and (B) SUB (10 and 30 µM) for 24 h. Results are shown as the % repression of the
extract and SUB expressed as a % relative to the DEX response set as 100%. Results are representative of two experiments each performed in triplicate. One-way ANOVA with Dunnett's
posttest was used for statistical signiﬁcance (***, P < 0.001; ns, non-signiﬁcant).
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Fig. 7. S. frutescens and SUB exhibit no MR agonist activity for transactivation. CHO-11BHSD2 cells stably expressing rat MR and the pTAT3-gLuc reporter gene were incubated with
vehicle (EtOH) and ALDO (10 nM) and (A) S. frutescens extract (0.5 and 0.75 mg/mL) and (B) SUB (10 and 30 µM) for 24 h. Results shown are representative of two experiments
performed in triplicate. Fold induction relative to EtOH set as 1 is plotted. One-way ANOVA with Dunnett's posttest was used for statistical signiﬁcance (***, P < 0.001; ns, non-
signiﬁcant).
C.A. Sergeant et al. Journal of Ethnopharmacology 202 (2017) 290–301
297
Stellenbosch University  https://scholar.sun.ac.za
include the lowering of serum cholesterol levels as well as anti-
inﬂammatory, cardiovascular and hypoglycemic eﬀects (Desai et al.,
2009; Lockyer et al., 2012; Wu et al., 2011). We have reported the
modulation of adrenal P450 enzymes (Prevoo et al., 2004, 2008) with a
more recent study reporting on S. frutescens extracts modulating P450
enzymes in human liver microsomal preparations, inhibiting the
catalytic activities of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9
and CYP2C19 towards their known substrates in a dose dependent
manner (Fasinu et al., 2013). In addition, it has been shown that while
the ginsenosides present in ginseng are metabolized by hepatic P450
enzymes (Qi et al., 2011), they also inhibit these enzymes.
Furthermore, the glycosyl moeiety of the compounds inﬂuences
bioactivity, and has as such been shown to contribute to the resistance
of ginsenoside to metabolism by CYP3A4 when compared to the
metabolism of its aglycone. These data suggest that steric hindrances
caused by the location of the glycosyl groups may prevent the ginseno-
sides from binding to the active pocket of CYP3A4 and from being
metabolized (Hao et al., 2010). However, ginsenosides as well as the S.
frutescens triterpenoids may bind sites other than the active site and
may thus nevertheless hamper the catalytic activity of the P450
enzymes.
Although the SU compounds have similar cycloartane glycoside
structures, they do diﬀer markedly in their aglycone backbone speci-
ﬁcally in terms of hydroxyl and ketone moieties at C1, C3 C7 and C11.
SUA also has a C9/C11 double bond and an epoxy spanning C7/C10
over a 7-carbon ring structure while SUB, C and D have a methylene
bridge between C9 and C10 (Avula et al., 2010; Fu et al., 2008). These
structural diﬀerences permit these compounds to retain deﬁned three
dimensional structures which may contribute to diﬀerent bioactive
properties. In this study we turned our attention to SUB as the
compound was present at concentrations marginally higher than the
other SU compounds in the S. frutescens extract, with others having
reported it to be the major SU in S. frutescens (Albrecht et al., 2012;
Brownstein et al., 2015; Fu et al., 2010). While extraction methods
would contribute to SU yields, studies have shown that secondary
metabolites present in S. frutescens vary according to geographical
location of plants, harvesting seasons and processing methods
(Albrecht et al., 2012; Shaik et al., 2011). SUB speciﬁcally, has been
shown to vary 0–1% (of dry mass) of S. frutescens plants grown in
diﬀerent geographical locations (Albrecht et al., 2012). Our results are
in agreement with the expected range and the SUB yield constitutes
0.3% of the dry mass of S. frutescens.
We subsequently investigated the inﬂuence of a methanolic extract
of S. frutescens and SUB on the catalytic activities of CYP17A1,
CYP21A2 and 3β-HSD2 as these enzymes play a crucial role in adrenal
steroidogenesis competing for the same substrates at pivotal branch
points of the biosynthesis pathways with the modulation thereof
potentially aﬀecting downstream glucocorticoid, mineralocorticoid
and androgen production. The inhibition of CYP17A1 would result in
reduced cortisol and androgen production, whereas the inhibition of
CYP21A2 would result in the inhibition of glucocorticoid and miner-
alocorticoid metabolites. Interference with 3β-HSD2 would reduce
steroid metabolites in the three pathways. We previously showed that
both aqueous and methanolic S. frutescens extracts hampered sub-
strate binding to CYP17A1 and CYP21A1 and that the catalytic
activities of CYP17A1 and CYP21A2 were inhibited by the aqueous
extract. A mixture of triterpenoid compounds was also shown to inhibit
both PREG and PROG binding to P450 enzymes. Furthermore, the
triterpenoids were also able to bind to the P450 enzymes in the absence
of the steroid substrate (Prevoo et al., 2008). These data clearly
indicated that S. frutescens interacted and modulated the activity of
the steroidogenic P450 enzymes prompting further investigations. In
the present study we used the methanolic extract of S. frutescens to
investigate inhibitory eﬀects and showed the inhibition of S. frutescens
on CYP17A1 and CYP21A2 in the conversion of PROG, with the
inhibition of PREG conversion by CYP17A1 being signiﬁcantly lower.
Taken together, these data suggest that the extract would aﬀect the
production of adrenal steroids. The present study also showed that in
the presence of SUB only, the catalytic activity of CYP17A1 towards
both substrates was inhibited together with 3β-HSD2 suggesting that
the compound would aﬀect steroidogenesis at the branch point, albeit
somewhat diﬀerently when compared to the extract, modulating the
ﬂux in all steroidogenic pathways and aﬀecting total steroid produc-
tion. The data suggests that inhibition at the branch point and
subsequent changes in steroid output may, in part, therefore be
attributed to the SU compounds.
Downstream eﬀects of S. frutescens on steroid hormone production
in the H296R cell model showed this to be the case. Basal steroid
production was similar to that previously reported (Mangelis et al.,
2016; Rege et al., 2013; Schloms et al., 2012; Xing et al., 2011) and
while basal steroid production decreased in the presence of SUB
(Table 1), data showed a decreased steroid shunt in the androgen
pathway (1.5-fold) as well as in the glucocorticoid pathway (1.2-fold)
suggesting inhibition of CYP17A1. CYP17A1's inhibition was also
reﬂected in the 1.75-fold decrease in 16OH-PROG levels, a steroid
not metabolized further in the adrenal. The data also suggests
CYP11B1 inhibition with the signiﬁcantly decreased cortisol (1.4-fold)
and 11OHA4 (1.8-fold) levels. In addition, even though A4 production
was signiﬁcantly reduced, testosterone production did not change
signiﬁcantly. Although the adrenal is not the primary site of testoster-
one production, the production of this hormone is of importance in
females (Goymann and Wingﬁeld, 2014). 11-DHC production in-
creased signiﬁcantly indicative of the inactivation of CORT by 11β-
HSD2 which is expressed at low levels in the adrenal (Rege et al.,
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Fig. 8. S. frutescens and SUB exhibit MR antagonist activity for transactivation. CHO-11BHSD2 cells stably expressing rat MR and the pTAT3-gLuc reporter gene were incubated with
ALDO (10 nM) set at 100% or (A) ALDO in the presence of S. frutescens extract (0.5 and 0.75 mg/mL) or spironolactone (1 µM), and (B) ALDO in the presence of SUB (10 and 30 µM)
or spironolactone (1 µM) for 24 h. Results are representative of two experiments performed in triplicate ( ± SEM). One-way ANOVA with Dunnett's posttest was used for statistical
signiﬁcance (***, P < 0.001 ns, non-signiﬁcant).
C.A. Sergeant et al. Journal of Ethnopharmacology 202 (2017) 290–301
298
Stellenbosch University  https://scholar.sun.ac.za
2013). It is interesting to note that under basal conditions SUB
increased 11-DHC levels (2.3-fold) at the higher concentration.
Although both CYP17A1 and 3β-HSD2 were inhibited by SUB when
expressed in isolation, these modulatory eﬀects are not always obvious
in a complex model system with endogenous expression of steroido-
genic enzymes. Steroid conversion would, in the H295R model system,
also be dependent on competition between enzymes for the same
substrates, together with the availability of precursors. However,
analyses clearly indicates inhibition of CYP17A1 by SUB which would
impact on the availability of substrates for the downstream conversion
by 3β-HSD2 and CYP21A2. In contrast, in the presence of S. frutescens
extract, steroid ﬂux in the three pathways was aﬀected. Steroid
metabolites in the glucocorticoid pathway decreased 1.5-fold and 1.2-
fold in the androgen pathway. It would seem that Δ5-steroids
channelled towards DHEA were sulphonated eﬃciently, reﬂected in
the signiﬁcantly increased DHEAS levels (2.66-fold), resulting in
changes in downstream adrenal androgens levels and perhaps indicat-
ing stimulation of sulfotransferase (SULT2A1). In contrast to SUB, the
extract modulated the mineralocorticoid pathway resulting in a 1.7-
fold decrease in steroid metabolites. The ﬂux through the glucocorti-
coid pathway decreased 1.5-fold, comparable to SUB, resulting in a 1.8-
fold decrease in cortisol levels as well as a signiﬁcant decrease in the
levels of the precursor steroid, deoxycortisol. Interestingly the signiﬁ-
cant reduction in CORT production (2-fold) strongly suggests down-
stream inhibition of CYP11B1/2 which would contribute to the
increased DOC levels. The increased shunt towards the production of
inactive glucocorticoids we observed in our H295R assays may indicate
a modulation of 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2)
activity. The data furthermore also suggests a stimulatory activity for S.
frutescens towards SULT2A1, which would contribute towards the
inactivation of adrenal androgens with potential clinical applications in
disease conditions which are charcarterized by excess adrenal andro-
gens. Taken together, the catalytic activity of S. frutescens towards
these two enzymes warrant further investigations as these are closely
associated with metabolic diseases and clinical conditions.
Our data showed a signiﬁcant reduction of CORT production
observed under stress-mimicing conditions in the adrenal cell model
(Table 3) together with an in vivo study by Smith and Myburg 2004,
also showing that the intraperitonial administration of S. frutescens
extracts to male Wistar rats resulted in decreased CORT plasma levels
(P < 0.05) when rats were exposed to chronic immobilization stress
(Smith and Myburgh, 2004). It should be noted that CORT is the major
glucocorticoid in rats since CYP17A1 is not expressed in the rat adrenal
and thus cortisol is not produced. In the same study the authors also
reported that the administration of the extract resulted in decreased IL-
6 levels highlighting the anti-inﬂammatory properties of S. frutescens
in lowering the pro-inﬂammatory cytokine level under basal condi-
tions. However, in a subsequent study by Smith and van Vuuren
(2014), investigating central mechanisms of action after a single S.
frutescens dose was given by gavage, basal CORT levels did not change
signiﬁcantly compared to the placebo group and after acute immobi-
lization stress levels did not diﬀer signiﬁcantly from the placebo group.
However, CORT was signiﬁcantly increased in both groups, which was
attributed to hormone levels being assayed immediately after exposure
to the stress intervention. Interestingly, adding to S. frutescens's anti-
inﬂammatory properties is their observation that the stress-induced
down-regulation of the GR was abolished by the ingestion of the S.
frutescens extract.
The inhibitory eﬀects of the extract on CYP17A1 were apparent in
the signiﬁcantly reduced levels of 16OH-PROG (1.4-fold). It should be
noted that SUB, at 10 μM and 30 μM inhibited 16OH-PROG produc-
tion 1.36- and 1.75-fold, respectively, while the concentration of SUB
in the extract was ± 47 μM. The other SU compounds (A, C and D)
where present in the extract at ± 100 μM (collectively) and together
with the sutherlandin ﬂavonoid compounds would contribute to the
modulation of steroidogenesis. In addition to the sutherlandins, rutin,
kaaempferol-3-o-rutinoside, quercitrin, quercetin and kaempferol have
also been identiﬁed within S. frutescens extracts (Mbamalu et al.,
2016). We have shown that ﬂavonoid compounds, speciﬁcally rutin,
inhibited speciﬁc steroidogenic enzymes aﬀecting the outcome of
steroidogenesis in the H295R model (Schloms et al., 2012; Schloms
and Swart, 2014), aﬀects we also showed in in vivo studies. It should be
noted that while it is possible that these compounds may have diﬀerent
eﬀects on diﬀerent enzymes, either inhibitory or stimulatory, they may,
being present at such high concentrations, aggregate when the extract
is assayed under experimental conditions thus diminishing their
inﬂuence.
Stimulation of the H295R cells with forskolin resulted in a 2.6-fold
increase of total steroid production and while steroid metabolites
increased in the mineralocorticoid and glucocorticoid pathways and
to a lesser degree in the androgen pathway, stimulation was attenuated
signiﬁcantly, 2-, 1.6- and 1.5-fold, respectively, by the extract. DHEAS
levels were again increased signiﬁcantly even though CYP17A1 was
inhibited in the presence of the extract which resulted in a decreased
production of downstream androgens. CORT and cortisol production
were decreased 2.4- and 2.2-fold, respectively, while their precursor
steroid levels were signiﬁcantly increased, suggesting inhibition of
CYP11B1.
The data obtained indicate that the presence of S. frutescens extract
inﬂuenced glucocorticoid and mineralocorticoid production to a great-
er extent. The inhibition of DOC conversion appeared to be consistent
in the presence of the extract under stimulated and basal conditions.
DOC plays an integral role in glucocorticoid and mineralocorticoid
production as this steroid substrate can either be converted to CORT (a
glucocorticoid) by CYP11B1 or to ALDO (the major mineralocorticoid)
by CYP11B2. In addition to acting like a glucocorticoid in many
functions such as the stress response, DOC has also been shown to
act as a signiﬁcant mineralocorticoid in downstream signalling events
(Vinson, 2011). Both DOC and deoxycortisol have been shown to play a
signiﬁcant role in hypertension and hyperkalemia as both these
glucocorticoids can act as mineralocorticoids through binding to the
MR (Sugimoto et al., 2016).
Given the data demonstrating the reduction of CORT and cortisol,
as well as that of the steroid metabolites in the mineralocorticoid
pathway, both under basal and stimulated conditions, we subsequently
investigated the eﬀect of the extract on the GR and the MR to
determine downstream cellular eﬀects. Exogenous glucocorticoids
acting via the GR are widely used to treat inﬂammatory disorders.
The clinical usage of glucocorticoids is however limited, due to multiple
adverse side-eﬀects associated with prolonged use which include,
amongst others, mood and behavioural changes, adiposity and ster-
oid-induced diabetes (Whitehouse, 2011). These side-eﬀects are gen-
erally reported to be due to their capacity to transactivate gene
transcription (Baschant et al., 2013) while the therapeutic anti-
inﬂammatory properties are generally considered to be due to the
transrepression mechanism (Nixon et al., 2013). The latter concept has
however been called into question recently as it was found that the
negative side-eﬀects associated with anti-inﬂammatory treatments may
in fact result from both transactivation as well as transrepression
mechanisms of the GR (Coutinho and Chapman, 2011; Sundahl et al.,
2015). However, potential anti-inﬂammatory compounds with fewer
side-eﬀects which stimulate and ultimately modify GR-mediated gene
expression proﬁles, are still actively being sought (Vandevyver et al.,
2013). These compounds are referred to as dissociated compounds or
selective glucocorticoid receptor agonists (SEGRAs). One of the ﬁrst
SEGRAs to be described was Compound A, a non-steroidal compound
displaying no transactivation of GRE-mediated gene transcription
while repressing NF-κB-driven gene expression (De Bosscher et al.,
2005; Gossye et al., 2010). Collectively, our transactivation and
transrepression results show that the S. frutescens extract and SUB
can eﬃciently repress NF-κB-driven gene expression, without activat-
ing GRE-driven gene expression suggesting that the plant-derived SUB
C.A. Sergeant et al. Journal of Ethnopharmacology 202 (2017) 290–301
299
Stellenbosch University  https://scholar.sun.ac.za
is a SEGRA which may have anti-inﬂammatory applications.
In addition to regulating the inﬂammatory response, circulating
glucocorticoids have also been found to induce hypertension. Although
it was originally thought that essential hypertension was mediated by
sodium imbalances, recent data have suggested that the pathogenesis
and maintenance of glucocorticoid-induced hypertension is mediated
by the activation of the mineralocorticoid receptor (MR) by glucocorti-
coids (Whitworth et al., 2000). Typical hypertension treatments
include the administration of MR antagonists such as spironolactone.
Studies have furthermore shown a strong association between inﬂam-
mation and congestive heart failure. Although the release of pro-
inﬂammatory cytokines are major contributing factors to the onset of
inﬂammation-induced congestive heart failure (Dick and Epelman,
2016), glucocorticoids, the GR and the MR have also been shown to
play signiﬁcant roles (Fuller, 2015; Messaoudi et al., 2012). Although
the circulating glucocorticoid concentrations are signiﬁcantly higher
compared to ALDO ( ± 1000-fold), the binding of glucocorticoids to the
MR is regulated by the presence of 11βHSD2. 11βHSD2 converts
cortisol and CORT to their inactive forms, cortisone and 11-DHC
respectively which have no aﬃnity for the MR (Edwards, 1988).
Our results showed that the S. frutescens extract and SUB did not
activate MR mediated gene transcription, but instead antagonized the
eﬀects of ALDO via the MR. This result strongly suggests that the
extract and SUB could be used as in anti-hypertensive treatment. The
ﬁnding that S. frutescens also contain cardenolides, naturally occurring
cardiac glycosides, also suggest a potential application as a herbal
remedy in the treatment of congestive heart failure in addition to its
traditional use in treating inﬂammation (Shaik et al., 2011). The
ﬁndings that S. frutescens acts as a SERGA is novel, however, further
studies are required to show, beyond doubt, that the medicinal plant
acts as a dissociating GR ligand, preventing GR dimerization and
whether GR transrepression would also be detected in vivo. In
addition, investigations into the activation of downstream GR target
genes involved in anti-inﬂammatory responses would further contri-
bute towards elucidating the SERGA properties of S. frutescens.
The speciﬁc inhibition of adrenal steroidogenic enzymes by S.
frutescens at the branch point in steroidogenesis modulated hormone
production in the mineralocorticoid, glucocorticoid and androgens
pathways. Decreased glucocorticoid production together with the
repression of NF-κB-driven gene expression without GRE-driven gene
activation by S. frutescens unequivocally links the anti-stress and the
anti-inﬂammatory bioactivities of the medicinal plant to adrenal
hormone production and receptor interaction. In addition, the inhibi-
tory eﬀects observed in the mineralocorticoid pathway together with
the antagonistic eﬀects of S. frutescens on ALDO's activation of the MR
have furthermore revealed a novel facet in the plant's bioactivity in
terms of anti-hypertensive eﬀects.
5. Conclusion
The outcome of our steroidogenic enzyme assays show that S.
frutescens extracts aﬀect the catalytic activities of CYP17A1 and
CYP21A2 while not inﬂuencing 3β-HSD2. On the other hand, SUB
one of the major triterpenoids in S. frutescens, inhibited both CYP17A1
and 3β-HSD2 and would thus perturb steroidogenesis at the branch
point. Regarding the outcome in the human H295R adrenal cell model
it is clear that the extract and SUB modulate the ﬂux in the
steroidogenic pathways. However, the eﬀects of S. frutescens are most
prominent under conditions mimicking the stress response in which
the extract reduced steroid production in the three pathways with the
greatest modulation observed in the mineralocorticoid pathway. There
was a signiﬁcant reduction in glucocorticoid production (CORT and
cortisol) and an increased shunt towards DHEAS, contributing to the
decreased production of androgen precursors. These data conﬁrm the
inhibition of CYP17A1 while also suggesting that S. frutescens may
inhibit both CYP11B isoforms, which may possibly be attributed to the
SU and sutherlandin compounds being present at far higher concen-
trations than the 30 µM SUB assayed in this study. However, at this
concentration cortisol and 11OHA4 production was inhibited signiﬁ-
cantly. These eﬀects may contribute to the stress relieving and anti-
anxiety bioactivities of S. frutescens and to the potential anti-hyper-
tensive eﬀects. It has been suggested that S. frutescens elicits adapto-
gen-like eﬀects, favouring the body's ability to adapt to stressors,
increasing resistance to stress and disease by maintaining functional
CORT levels following a study showing that the medicinal plant
decreased CORT levels in rats subjected to chronic stress (Smith and
Myburgh, 2004). Our ﬁndings, together with the anti-inﬂammatory
and corticomimetic reports of triterpenoids (van Wyk and Wink, 2004)
and the fact that it is generally accepted that inﬂammatory responses
are associated with the pathiophysiology of hypertension and the
development of cardiovascular disease prompted our investigation into
the eﬀects on GR and MR driven gene transcription. This led to one of
the most important ﬁndings of our study - S. frutescens extracts and
SUB act like SEGRAs by selectively triggering transrepression and not
transactivation. Regarding the GR, S. frutescens and SUB exhibited no
transactivation potential on GRE-driven gene expression, and re-
pressed NF-κB-driven gene expression, while both exhibited MR
antagonist activity for transactivation. Although further studies are
required to determine the in vivo eﬀects, data suggest that S. frutescens
is a promising candidate in anti-inﬂammatory therapeutics with
reduced side-eﬀects as well as in anti-hypertensive strategies. It is also
possible that the anti-inﬂammatory and anti-hypertensive properties of
S. frutescens may be attributed to further downstream transcriptional
eﬀects via the GR and MR. These results should however not be viewed
in isolation as the complex pathophysiology of hypertension and
interactions between antagonists and the MR in cardiovascular disease
remains uncertain. Notwithstanding, our study has, for the ﬁrst time,
provided a scientiﬁc base for anti-inﬂammatory eﬀects reﬂected in S.
frutescens's eﬃcient repression of NF-κB-driven gene expression with-
out GRE-driven gene activation, and anti-hypertensive properties in
which S. frutescens was unable to activate MR mediated gene
transcription while antagonising ALDO's MR eﬀects.
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